"pdb","title","DOI","resolution","Mean_B_Factor","oligo","oligo_sequence","residue_links","oligo_mean_B_Factor","comments","warnings","errors"
"1AU1","HUMAN INTERFERON-BETA CRYSTAL STRUCTURE","10.1073/PNAS.94.22.11813 ",2.2,0,"1au1_oligo2","DGlcpb1-4DGlcpb1-2DGlcpb1-3DGlcpb1-4DGlcpb1-4[DQuipa1-6]DGlcpb1-ASN","G6D(7_C_)-[BGC(6_C_)-BGC(5_C_)-BGC(4_C_)-BGC(3_C_)-BGC(2_C_)]-BGC(1_C_)-ASN(80_A_)",73.0399,"","",""
"1AX0","ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH N-ACTYLGALACTOSAMINE","10.1006/JMBI.1998.1664 ",1.9,25.1,"1ax0_oligo2","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(17_A_)",33.6915,"","",""
"1AX1","ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH LACTOSE","10.1006/JMBI.1998.1664 ",1.95,32.4,"1ax1_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(17_A_)",39.5702,"","",""
"1AX2","ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH N-ACETYLLACTOSAMINE","10.1006/JMBI.1998.1664 ",1.95,27.5,"1ax2_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(17_A_)",36.984,"","",""
"1AXY","ERYTHRINA CORALLODENDRON LECTIN","10.1006/JMBI.1998.1664 ",1.95,27.4,"1axy_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(17_A_)",33.4228,"","",""
"1AXZ","ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH D-GALACTOSE","10.1006/JMBI.1998.1664 ",1.95,23.2,"1axz_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(17_A_)",29.3988,"","",""
"1CF5","BETA-MOMORCHARIN STRUCTURE AT 2.55 A","10.1107/S0907444999003297 ",2.55,0,"1cf5_oligo1","DXylpb1-2[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LAltp[6H]b1-3]DGlcpNAcb1-ASN","MAN(5_C_)-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-FUC(6_C_)]-NAG(1_C_)-ASN(51_A_)",92.5848,"","",""
"1CF5","BETA-MOMORCHARIN STRUCTURE AT 2.55 A","10.1107/S0907444999003297 ",2.55,0,"1cf5_oligo2","DXylpb1-2[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LAltp[6H]b1-3]DGlcpNAcb1-ASN","MAN(5_D_)-[XYP(4_D_)]-BMA(3_D_)-NAG(2_D_)-FUC(6_D_)]-NAG(1_D_)-ASN(51_B_)",87.2672,"","",""
"1CPO","CHLOROPEROXIDASE","10.1016/S0969-2126(01)00274-X ",1.9,0,"1cpo_oligo2","LArapb1-2DManpa1-THR","ARB(2_D_)-MAN(1_D_)-THR(275_A_)",39.8369,"","",""
"1CVI","CRYSTAL STRUCTURE OF HUMAN PROSTATIC ACID PHOSPHATASE","10.1002/(SICI)1097-0045(20000215)42:3<211::AID-PROS7>3.0.CO 2-U ",3.2,45.4,"1cvi_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(1188_A_)",95.1556,"","",""
"1DN2","FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2","10.1126/SCIENCE.287.5456.1279 ",2.7,0,"1dn2_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",42.0837,"","",""
"1DN2","FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2","10.1126/SCIENCE.287.5456.1279 ",2.7,0,"1dn2_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",40.4411,"","",""
"1DP5","THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT INHIBITOR","10.1038/72378 ",2.2,0,"1dp5_oligo1","DManpb1-2DManpa1-2[DManpa1-6]DManpa1-3[DManpb1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(9_C_)-MAN(8_C_)-[MAN(7_C_)-[BMA(6_C_)-MAN(5_C_)]-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(67_A_)",41.1271,"","",""
"1DPJ","THE STRUCTURE OF PROTEINASE A COMPLEXED WITH IA3 PEPTIDE INHIBITOR","10.1038/72378 ",1.8,0,"1dpj_oligo1","DManpb1-2DManpa1-2[DManpa1-2DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-[MAN(8_C_)-MAN(7_C_)-[BMA(6_C_)-MAN(5_C_)]-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(67_A_)",30.7005,"","",""
"1DWA","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 1: STRUCTURE PRIOR TO IRRADIATION","10.1107/S0907444999016261 ",2,18,"1dwa_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",31.0677,"","",""
"1DWA","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 1: STRUCTURE PRIOR TO IRRADIATION","10.1107/S0907444999016261 ",2,18,"1dwa_oligo3","DXylpb1-2[DManpa1-3][DManpAa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",28.6489,"","",""
"1DWF","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 2: STRUCTURE AFTER IRRADIATION WITH 9.1*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2,19.4,"1dwf_oligo3","DXylpb1-2[DManpa1-3][DManpAa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",30.6889,"","",""
"1DWF","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 2: STRUCTURE AFTER IRRADIATION WITH 9.1*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2,19.4,"1dwf_oligo2","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",33.1077,"","",""
"1DWG","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL: PART 3 STRUCTURE AFTER IRRADIATION WITH 18.2*10E15 PHOTONS/MM2.","10.1107/S0907444999016261 ",2,22.3,"1dwg_oligo3","DXylpb1-2[DManpa1-3][DManpAa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",33.6089,"","",""
"1DWG","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL: PART 3 STRUCTURE AFTER IRRADIATION WITH 18.2*10E15 PHOTONS/MM2.","10.1107/S0907444999016261 ",2,22.3,"1dwg_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",36.0277,"","",""
"1DWH","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 4: STRUCTURE AFTER IRRADIATION WITH 27.2*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2,25.7,"1dwh_oligo3","DXylpb1-2[DManpa1-3][DManpAa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",36.9989,"","",""
"1DWH","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 4: STRUCTURE AFTER IRRADIATION WITH 27.2*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2,25.7,"1dwh_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",39.4177,"","",""
"1DWI","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 5: STRUCTURE AFTER IRRADIATION WITH 54.0*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2,40.1,"1dwi_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",53.8377,"","",""
"1DWI","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 5: STRUCTURE AFTER IRRADIATION WITH 54.0*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2,40.1,"1dwi_oligo3","DXylpb1-2[DManpa1-3][DManpAa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",51.4189,"","",""
"1DWJ","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. REFINED PART 6: STRUCTURE AFTER A RADIATION DOSE OF 54*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2.4,42.6,"1dwj_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)-ASN(265_M_)",56.2611,"","",""
"1DWJ","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. REFINED PART 6: STRUCTURE AFTER A RADIATION DOSE OF 54*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2.4,42.6,"1dwj_oligo3","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(292_M_)",53.8593,"","",""
"1E05","PLASMA ALPHA ANTITHROMBIN-III","10.1016/S0022-2836(02)01382-7 ",2.62,53,"1e05_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[BMA(8_D_)-MAN(7_D_)]-GUP(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(192_L_)",119.17,"","",""
"1E4K","CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR III COMPLEX","10.1038/35018508 ",3.2,95.1,"1e4k_oligo1","DGalpa1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GLA(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",99.2311,"","",""
"1E4K","CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR III COMPLEX","10.1038/35018508 ",3.2,95.1,"1e4k_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",73.1865,"","",""
"1E4M","MYROSINASE FROM SINAPIS ALBA","10.1074/JBC.M006796200 ",1.2,14.5,"1e4m_oligo3","DXylpb1-2[DManpa1-3][LGulpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",22.7357,"","",""
"1E4M","MYROSINASE FROM SINAPIS ALBA","10.1074/JBC.M006796200 ",1.2,14.5,"1e4m_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",26.2439,"","",""
"1E6Q","MYROSINASE FROM SINAPIS ALBA WITH THE BOUND TRANSITION STATE ANALOGUE GLUCO-TETRAZOLE","10.1074/JBC.M006796200 ",1.35,16.2,"1e6q_oligo2","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",28.1375,"","",""
"1E6Q","MYROSINASE FROM SINAPIS ALBA WITH THE BOUND TRANSITION STATE ANALOGUE GLUCO-TETRAZOLE","10.1074/JBC.M006796200 ",1.35,16.2,"1e6q_oligo3","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",28.8593,"","",""
"1E6S","MYROSINASE FROM SINAPIS ALBA WITH BOUND GLUCO-HYDROXIMOLACTAM AND SULFATE","10.1074/JBC.M006796200 ",1.35,17.2,"1e6s_oligo4","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",27.5871,"","",""
"1E6S","MYROSINASE FROM SINAPIS ALBA WITH BOUND GLUCO-HYDROXIMOLACTAM AND SULFATE","10.1074/JBC.M006796200 ",1.35,17.2,"1e6s_oligo2","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",29.5754,"","",""
"1E6X","MYROSINASE FROM SINAPIS ALBA WITH A BOUND TRANSITION STATE ANALOGUE,D- GLUCONO-1,5-LACTONE","10.1074/JBC.M006796200 ",1.6,21.4,"1e6x_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",34.6181,"","",""
"1E6X","MYROSINASE FROM SINAPIS ALBA WITH A BOUND TRANSITION STATE ANALOGUE,D- GLUCONO-1,5-LACTONE","10.1074/JBC.M006796200 ",1.6,21.4,"1e6x_oligo3","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(5_C_)-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)",34.215,"","",""
"1E70","2-F-GLUCOSYLATED MYROSINASE FROM SINAPIS ALBA","10.1074/JBC.M006796200 ",1.65,31.8,"1e70_oligo3","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(5_C_)-[XYP(4_C_)]-MAN(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)",45.2864,"","",""
"1E70","2-F-GLUCOSYLATED MYROSINASE FROM SINAPIS ALBA","10.1074/JBC.M006796200 ",1.65,31.8,"1e70_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",47.5184,"","",""
"1E71","MYROSINASE FROM SINAPIS ALBA WITH BOUND ASCORBATE","10.1074/JBC.M006796200 ",1.5,19.8,"1e71_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",32.7296,"","",""
"1E71","MYROSINASE FROM SINAPIS ALBA WITH BOUND ASCORBATE","10.1074/JBC.M006796200 ",1.5,19.8,"1e71_oligo4","DXylpb1-2[DManpa1-3][LGulpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",31.513,"","",""
"1E72","MYROSINASE FROM SINAPIS ALBA WITH BOUND GLUCO-HYDROXIMOLACTAM AND SULFATE OR ASCORBATE","10.1074/JBC.M006796200 ",1.6,20.5,"1e72_oligo2","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",33.6342,"","",""
"1E72","MYROSINASE FROM SINAPIS ALBA WITH BOUND GLUCO-HYDROXIMOLACTAM AND SULFATE OR ASCORBATE","10.1074/JBC.M006796200 ",1.6,20.5,"1e72_oligo5","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(5_C_)-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)",29.2069,"","",""
"1E73","2-F-GLUCOSYLATED MYROSINASE FROM SINAPIS ALBA WITH BOUND L-ASCORBATE","10.1074/JBC.M006796200 ",1.5,20.2,"1e73_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",32.9706,"","",""
"1E73","2-F-GLUCOSYLATED MYROSINASE FROM SINAPIS ALBA WITH BOUND L-ASCORBATE","10.1074/JBC.M006796200 ",1.5,20.2,"1e73_oligo4","DXylpb1-2[DManpa1-3][LGulpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",33.0363,"","",""
"1EOM","CRYSTAL STRUCTURE OF THE COMPLEX OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F3 WITH A BIANTENNARY COMPLEX OCTASACCHARIDE","10.1021/BI0001731 ",2.1,20.6,"1eom_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_B_)-NAG(7_B_)-MAN(6_B_)-[GAL(5_B_)-NAG(4_B_)-MAN(3_B_)]-MAN(2_B_)-NAG(1_B_)",38.3739,"","",""
"1EX1","BETA-D-GLUCAN EXOHYDROLASE FROM BARLEY","10.1016/S0969-2126(99)80024-0 ",2.2,0,"1ex1_oligo1","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_B_)-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-[FCA(6_B_)]-NAG(1_B_)-ASN(498_A_)",62.2608,"","",""
"1F8Q","CRYSTAL STRUCTURE OF ALPHA-MOMORCHARIN IN ACETONITRILE-WATER MIXTURE","10.1016/S0167-4838(01)00235-7 ",2.2,0,"1f8q_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","XYS(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(227_A_)",57.6591,"","",""
"1FC1","CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION","10.1021/BI00512A001 ",2.9,0,"1fc1_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[DAltp[6H]a1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",23.2549,"","",""
"1FC1","CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION","10.1021/BI00512A001 ",2.9,0,"1fc1_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[DAltp[6H]a1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",30.6905,"","",""
"1FC2","CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION","10.1021/BI00512A001 ",2.8,0,"1fc2_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[DAltp[6H]a1-6]DGlcpNAcb1-ASN","FUC(9_A_)-[GAL(6_A_)-NAG(5_A_)-MAN(4_A_)-[NAG(8_A_)-MAN(7_A_)]-MAN(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(297_D_)",22.9883,"","",""
"1FQ4","CRYSTAL STRUCTURE OF A COMPLEX BETWEEN HYDROXYETHYLENE INHIBITOR CP- 108,420 AND YEAST ASPARTIC PROTEINASE A","10.1006/JMBI.2000.4181 ",2.7,0,"1fq4_oligo1","DGlcpb1-2DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BGC(5_B_)-BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",48.2635,"","",""
"1FQ7","X-RAY STRUCTURE OF INHIBITOR CP-72,647 BOUND TO SACCHAROPEPSIN","10.1006/JMBI.2000.4181 ",2.8,0,"1fq7_oligo3","DGlcpb1-2DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","KBG(5_B_)-BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",43.5969,"","",""
"1FRT","CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC","10.1038/372379A0 ",4.5,199,"1frt_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[DAltp[6H]a1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_C_)",515.103,"","",""
"1FX5","CRYSTAL STRUCTURE ANALYSIS OF ULEX EUROPAEUS LECTIN I","10.1006/JMBI.2000.4214 ",2.2,0,"1fx5_oligo2","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYL(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(23_A_)",57.5082,"","",""
"1FZD","STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420","10.1073/PNAS.95.16.9099 ",2.1,0,"1fzd_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_I_)-MAN(4_I_)-[MAN(6_I_)]-MAN(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(667_A_)",48.8518,"","",""
"1FZD","STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420","10.1073/PNAS.95.16.9099 ",2.1,0,"1fzd_oligo4","DGlcpNAcb1-2DManpa1-6[DManpb1-3]DManpa1-4DGlcpNAcb1-4NAG1-ASN","NAG(5_L_)-MAN(4_L_)-[MAN(6_L_)]-MAN(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(667_D_)",48.1047,"","",""
"1FZD","STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420","10.1073/PNAS.95.16.9099 ",2.1,0,"1fzd_oligo3","DGlcpNAcb1-2DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_K_)-MAN(4_K_)-[MAN(6_K_)]-MAN(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(667_C_)",48.0854,"","",""
"1FZD","STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420","10.1073/PNAS.95.16.9099 ",2.1,0,"1fzd_oligo2","DGlcpNAcb1-2DManpa1-6[DRhapa1-3]DManpb1-4DGlcpNAca1-C6N1O4","NAG(5_J_)-MAN(4_J_)-[MAN(6_J_)]-MAN(3_J_)-NDG(2_J_)-NAG(1_J_)",55.3113,"","",""
"1G0V","THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT, MVV","10.1074/JBC.M008520200 ",2,20.6,"1g0v_oligo1","DManpb1-2DManpa1-2[DManpa1-2DManpa1-6]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[BMA(6_C_)-MAN(5_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(67_A_)",31.4385,"","",""
"1G9F","CRYSTAL STRUCTURE OF THE SOYBEAN AGGLUTININ IN A COMPLEX WITH A BIANTENNARY BLOOD GROUP ANTIGEN ANALOG","10.1006/JMBI.2001.4639 ",2.5,23.8,"1g9f_oligo1","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-3]DGalpb1-ROH","GAL(5_C_)-NAG(4_C_)-[GAL(3_C_)-NAG(2_C_)]-GAL(1_C_)",26.8915,"","",""
"1H3V","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2,SG P212121","10.1016/S0022-2836(02)01250-0 ",3.1,0,"1h3v_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(8_D_)-[GAL(6_D_)-NAG(5_D_)-BMA(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",79.6368,"","",""
"1H3V","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2,SG P212121","10.1016/S0022-2836(02)01250-0 ",3.1,0,"1h3v_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",48.3753,"","",""
"1H3W","STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY","10.1016/S0022-2836(02)01250-0 ",2.85,0,"1h3w_oligo1","DGlcpNAcb1-2DManpb1-6DManpb1-4DGlcpNAca1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_A_)-[NAG(5_A_)-BMA(4_A_)-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(297_M_)",94.8221,"","",""
"1H3X","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G0F)2","10.1016/S0022-2836(02)01250-0 ",2.44,0,"1h3x_oligo1","DGlcpNAca1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",90.2742,"","",""
"1H3X","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G0F)2","10.1016/S0022-2836(02)01250-0 ",2.44,0,"1h3x_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",58.5281,"","",""
"1H3Y","CRYSTAL STRUCTURE OF A HUMAN IGG1 FC-FRAGMENT,HIGH SALT CONDITION","10.1016/S0022-2836(02)01250-0 ",4.1,0,"1h3y_oligo2","DGalpa1-4DGlcpNAca1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GLA(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",73.9137,"","",""
"1H3Y","CRYSTAL STRUCTURE OF A HUMAN IGG1 FC-FRAGMENT,HIGH SALT CONDITION","10.1016/S0022-2836(02)01250-0 ",4.1,0,"1h3y_oligo1","DGalpa1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GLA(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",36.1271,"","",""
"1H4P","CRYSTAL STRUCTURE OF EXO-1,3-BETA GLUCANSE FROM SACCHAROMYCES CEREVISIAE","10.1038/NSMB715 ",1.75,28,"1h4p_oligo1","DManpb1-2DManpa1-3[DManpa1-2DManpb1-6]DManpa1-6[DManpb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-BMA(7_C_)-[BMA(6_C_)-MAN(5_C_)]-MAN(4_C_)-[BMA(10_C_)-BMA(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(165_A_)",83.5686,"","",""
"1H4P","CRYSTAL STRUCTURE OF EXO-1,3-BETA GLUCANSE FROM SACCHAROMYCES CEREVISIAE","10.1038/NSMB715 ",1.75,28,"1h4p_oligo3","DManpb1-2DManpb1-3[DManpb1-3[DManpb1-6]DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(8_E_)-[BMA(7_E_)]-BMA(6_E_)-[BMA(5_E_)-BMA(4_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(165_B_)",80.0983,"","",""
"1HD4","SOLUTION STRUCTURE OF THE A-SUBUNIT OF HUMAN CHORIONIC GONADOTROPIN [MODELED WITH DIANTENNARY GLYCAN AT ASN78]","10.1021/BI992786N ","2.95026e-39",0,"1hd4_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_B_)-NAG(8_B_)-MAN(7_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(78_A_)",0,"","",""
"1HZH","CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN","10.1126/SCIENCE.1061692 ",2.7,90.1,"1hzh_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(9_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)",117.935,"","",""
"1HZH","CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN","10.1126/SCIENCE.1061692 ",2.7,90.1,"1hzh_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","GAL(9_A_)-NAG(8_A_)-MAN(7_A_)-[GAL(6_A_)-NAG(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)",160.95,"","",""
"1I1A","CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC","10.1016/S1097-2765(01)00230-1 ",2.8,78.2,"1i1a_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_C_)",121.533,"","",""
"1I1A","CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC","10.1016/S1097-2765(01)00230-1 ",2.8,78.2,"1i1a_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_D_)",199.986,"","",""
"1I1C","NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A","10.1016/S1097-2765(01)00230-1 ",2.7,41.2,"1i1c_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",91.0807,"","",""
"1I1C","NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A","10.1016/S1097-2765(01)00230-1 ",2.7,41.2,"1i1c_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",100.324,"","",""
"1IEQ","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1","10.1016/S0969-2126(01)00673-6 ",2.7,0,"1ieq_oligo2","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)-ASN(498_A_)",72.3941,"","",""
"1IEW","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 2-DEOXY-2-FLUORO-ALPHA-D-GLUCOSIDE","10.1016/S0969-2126(01)00673-6 ",2.55,0,"1iew_oligo2","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUL(6_C_)]-NAG(1_C_)-ASN(498_A_)",67.8349,"","",""
"1IEX","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 4I,4III,4V-S-TRITHIOCELLOHEXAOSE","10.1016/S0969-2126(01)00673-6 ",2.2,0,"1iex_oligo2","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(6_B_)]-NAG(1_B_)-ASN(498_A_)",87.07,"","",""
"1IGT","STRUCTURE OF IMMUNOGLOBULIN","10.1021/BI962514+ ",2.8,52,"1igt_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(314_B_)",67.7962,"","",""
"1IGT","STRUCTURE OF IMMUNOGLOBULIN","10.1021/BI962514+ ",2.8,52,"1igt_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[NAG(8_F_)-MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(314_D_)",142.475,"","",""
"1IGY","STRUCTURE OF IMMUNOGLOBULIN","10.1006/JMBI.1997.1508 ",3.2,57.1,"1igy_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NDG(2_E_)]-NAG(1_E_)-ASN(314_B_)",79.4591,"","",""
"1IGY","STRUCTURE OF IMMUNOGLOBULIN","10.1006/JMBI.1997.1508 ",3.2,57.1,"1igy_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[NAG(8_F_)-MAN(7_F_)]-BMA(3_F_)-NDG(2_F_)]-NAG(1_F_)-ASN(314_D_)",77.3494,"","",""
"1IQQ","CRYSTAL STRUCTURE OF JAPANESE PEAR S3-RNASE","10.1074/JBC.M107617200 ",1.5,14.2,"1iqq_oligo1","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(116_A_)",26.8881,"","",""
"1J8V","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 4'-NITROPHENYL 3I-THIOLAMINARITRIOSIDE","10.1105/TPC.010442 ",2.4,0,"1j8v_oligo2","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)-ASN(498_A_)",61.3233,"","",""
"1K9I","COMPLEX OF DC-SIGN AND GLCNAC2MAN3","10.1126/SCIENCE.1066371 ",2.5,49.1,"1k9i_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_O_)-MAN(4_O_)-[NAG(3_O_)-MAN(2_O_)]-MAN(1_O_)",41.8747,"","",""
"1K9I","COMPLEX OF DC-SIGN AND GLCNAC2MAN3","10.1126/SCIENCE.1066371 ",2.5,49.1,"1k9i_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_L_)-MAN(4_L_)-[NAG(3_L_)-MAN(2_L_)]-MAN(1_L_)",45.066,"","",""
"1K9I","COMPLEX OF DC-SIGN AND GLCNAC2MAN3","10.1126/SCIENCE.1066371 ",2.5,49.1,"1k9i_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_M_)-MAN(4_M_)-[NAG(3_M_)-MAN(2_M_)]-MAN(1_M_)",34.8735,"","",""
"1K9I","COMPLEX OF DC-SIGN AND GLCNAC2MAN3","10.1126/SCIENCE.1066371 ",2.5,49.1,"1k9i_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_N_)-MAN(4_N_)-[NAG(3_N_)-MAN(2_N_)]-MAN(1_N_)",41.1196,"","",""
"1K9I","COMPLEX OF DC-SIGN AND GLCNAC2MAN3","10.1126/SCIENCE.1066371 ",2.5,49.1,"1k9i_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_K_)-MAN(4_K_)-[NAG(3_K_)-MAN(2_K_)]-MAN(1_K_)",57.0844,"","",""
"1K9J","COMPLEX OF DC-SIGNR AND GLCNAC2MAN3","10.1126/SCIENCE.1066371 ",1.9,26.1,"1k9j_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_C_)-MAN(4_C_)-[NAG(3_C_)-MAN(2_C_)]-MAN(1_C_)",34.5642,"","",""
"1KJ2","MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX","10.1016/S1074-7613(02)00288-1 ",2.71,45.65,"1kj2_oligo1","DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_C_)-GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(8_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(21_A_)",94.329,"","",""
"1L6X","FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A CALLED Z34C","",1.65,24.8,"1l6x_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(10_C_)-[GAL(9_C_)-NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",34.0833,"","",""
"1LGB","INTERACTION OF A LEGUME LECTIN WITH THE N2 FRAGMENT OF HUMAN LACTOTRANSFERRIN OR WITH THE ISOLATED BIANTENNARY GLYCOPEPTIDE: ROLE OF THE FUCOSE MOIETY","10.1016/S0969-2126(00)00022-8 ",3.3,0,"1lgb_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[NAG(8_D_)-MAN(7_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(137_C_)",54.3261,"","",""
"1LGC","INTERACTION OF A LEGUME LECTIN WITH THE N2 FRAGMENT OF HUMAN LACTOTRANSFERRIN OR WITH THE ISOLATED BIANTENNARY GLYCOPEPTIDE: ROLE OF THE FUCOSE MOIETY","10.1016/S0969-2126(00)00022-8 ",2.8,0,"1lgc_oligo2","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_G_)-[NAG(9_G_)-MAN(8_G_)-[GAL(7_G_)-[FUC(6_G_)]-NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(512_H_)",52.396,"","",""
"1LGC","INTERACTION OF A LEGUME LECTIN WITH THE N2 FRAGMENT OF HUMAN LACTOTRANSFERRIN OR WITH THE ISOLATED BIANTENNARY GLYCOPEPTIDE: ROLE OF THE FUCOSE MOIETY","10.1016/S0969-2126(00)00022-8 ",2.8,0,"1lgc_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_K_)-[MAN(8_K_)-[SIA(7_K_)-GAL(6_K_)-NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(512_I_)",57.2812,"","",""
"1LGC","INTERACTION OF A LEGUME LECTIN WITH THE N2 FRAGMENT OF HUMAN LACTOTRANSFERRIN OR WITH THE ISOLATED BIANTENNARY GLYCOPEPTIDE: ROLE OF THE FUCOSE MOIETY","10.1016/S0969-2126(00)00022-8 ",2.8,0,"1lgc_oligo3","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_L_)-[MAN(8_L_)-[SIA(7_L_)-GAL(6_L_)-NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(512_J_)",59.1371,"","",""
"1LOF","X-RAY STRUCTURE OF A BIANTENNARY OCTASACCHARIDE-LECTIN COMPLEX AT 2.3 ANGSTROMS RESOLUTION","",2.3,0,"1lof_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_E_)-NAG(7_E_)-MAN(6_E_)-[GAL(5_E_)-NAG(4_E_)-MAN(3_E_)]-BMA(2_E_)-NAG(1_E_)",77.3305,"","",""
"1LOF","X-RAY STRUCTURE OF A BIANTENNARY OCTASACCHARIDE-LECTIN COMPLEX AT 2.3 ANGSTROMS RESOLUTION","",2.3,0,"1lof_oligo2","DGlcpNAcb1-2DManpa1-3DManpx1-","NAG(3_F_)-MAN(2_F_)-MAN(1_F_)",66.324,"","",""
"1LQ2","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE","10.1074/JBC.M307188200 ",2.7,0,"1lq2_oligo2","DGlcpNAcb1-2DManpa1-6DManpa1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_B_)-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-[FUC(6_B_)]-NAG(1_B_)-ASN(498_A_)",75.7435,"","",""
"1LTE","STRUCTURE OF A LEGUME LECTIN WITH AN ORDERED N-LINKED CARBOHYDRATE IN COMPLEX WITH LACTOSE","",2,0,"1lte_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYL(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(17_A_)",31.3476,"","",""
"1MCO","THREE-DIMENSIONAL STRUCTURE OF A HUMAN IMMUNOGLOBULIN WITH A HINGE DELETION","10.1073/PNAS.90.9.4271 ",3.2,0,"1mco_oligo2","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(10_A_)-[NAG(5_A_)-MAN(4_A_)-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(282_H_)",15,"","",""
"1MYR","MYROSINASE FROM SINAPIS ALBA","10.1016/S0969-2126(97)00221-9 ",1.64,16.7,"1myr_oligo8","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUC(5_C_)]-NAG(1_C_)-ASN(265_A_)",34.581,"","",""
"1MYR","MYROSINASE FROM SINAPIS ALBA","10.1016/S0969-2126(97)00221-9 ",1.64,16.7,"1myr_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-[XYP(4_D_)]-BMA(3_D_)-NAG(2_D_)-[FUC(7_D_)]-NAG(1_D_)-ASN(292_A_)",30.7501,"","",""
"1OQO","COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z","",2.3,42.9,"1oqo_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",68.4325,"","",""
"1OQO","COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z","",2.3,42.9,"1oqo_oligo1","DGlcpNAca1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NDG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",55.5502,"","",""
"1OW0","CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC","10.1038/NATURE01685 ",3.1,98.2,"1ow0_oligo2","DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-2DManpb1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUC(8_F_)-[SIA(7_F_)-GAL(6_F_)-NAG(5_F_)-BMA(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)",186.95,"","",""
"1OW0","CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC","10.1038/NATURE01685 ",3.1,98.2,"1ow0_oligo3","DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-2DManpb1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(8_E_)-[SIA(7_E_)-GAL(6_E_)-NAG(5_E_)-BMA(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)",186.95,"","",""
"1OW0","CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC","10.1038/NATURE01685 ",3.1,98.2,"1ow0_oligo6","DManpb1-4DManpb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_L_)-BMA(5_L_)-MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(156_D_)",170.465,"","",""
"1OW0","CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC","10.1038/NATURE01685 ",3.1,98.2,"1ow0_oligo8","DManpb1-4DManpb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_I_)-BMA(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(156_C_)",170.465,"","",""
"1P8J","CRYSTAL STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN","10.1038/NSB941 ",2.6,21.3,"1p8j_oligo1","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(11_I_)-[NAG(10_I_)-MAN(9_I_)-[GAL(8_I_)-NAG(7_I_)-[GAL(6_I_)-NAG(5_I_)]-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(440_A_)",52.6426,"","",""
"1PPF","X-RAY CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN LEUKOCYTE ELASTASE (PMN ELASTASE) AND THE THIRD DOMAIN OF THE TURKEY OVOMUCOID INHIBITOR","",1.8,0,"1ppf_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_A_)-[GAL(6_A_)-NAG(5_A_)-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(159_E_)",12.708,"","",""
"1PPG","THE REFINED 2.3 ANGSTROMS CRYSTAL STRUCTURE OF HUMAN LEUKOCYTE ELASTASE IN A COMPLEX WITH A VALINE CHLOROMETHYL KETONE INHIBITOR","10.1016/0014-5793(88)80118-2 ",2.3,0,"1ppg_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_A_)-[GAL(6_A_)-NAG(5_A_)-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(159_E_)",8.11784,"","",""
"1RER","CRYSTAL STRUCTURE OF THE HOMOTRIMER OF FUSION GLYCOPROTEIN E1 FROM SEMLIKI FOREST VIRUS.","10.1038/NATURE02239 ",3.2,0,"1rer_oligo1","DGlcpNAcb1-2DManpb1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_D_)-[NAG(5_D_)-BMA(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(141_A_)",134.071,"","",""
"1RER","CRYSTAL STRUCTURE OF THE HOMOTRIMER OF FUSION GLYCOPROTEIN E1 FROM SEMLIKI FOREST VIRUS.","10.1038/NATURE02239 ",3.2,0,"1rer_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(7_E_)-[MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(141_B_)",134.96,"","",""
"1SLA","X-RAY CRYSTALLOGRAPHY REVEALS CROSSLINKING OF MAMMALIAN LECTIN (GALECTIN-1) BY BIANTENNARY COMPLEX TYPE SACCHARIDES","10.1038/NSB1294-863 ",2.45,0,"1sla_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_C_)-NAG(7_C_)-MAN(6_C_)-[GAL(5_C_)-NAG(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",62.7982,"","",""
"1SLB","X-RAY CRYSTALLOGRAPHY REVEALS CROSSLINKING OF MAMMALIAN LECTIN (GALECTIN-1) BY BIANTENNARY COMPLEX TYPE SACCHARIDES","10.1038/NSB1294-863 ",2.3,0,"1slb_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_E_)-NAG(7_E_)-MAN(6_E_)-[GAL(5_E_)-NAG(4_E_)-MAN(3_E_)]-BMA(2_E_)-NAG(1_E_)",32.335,"","",""
"1SLB","X-RAY CRYSTALLOGRAPHY REVEALS CROSSLINKING OF MAMMALIAN LECTIN (GALECTIN-1) BY BIANTENNARY COMPLEX TYPE SACCHARIDES","10.1038/NSB1294-863 ",2.3,0,"1slb_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-ROH","GAL(7_F_)-NAG(6_F_)-MAN(5_F_)-[GAL(4_F_)-NAG(3_F_)-MAN(2_F_)]-MAN(1_F_)",43.4294,"","",""
"1SLC","X-RAY CRYSTALLOGRAPHY REVEALS CROSSLINKING OF MAMMALIAN LECTIN (GALECTIN-1) BY BIANTENNARY COMPLEX TYPE SACCHARIDES","10.1038/NSB1294-863 ",2.15,0,"1slc_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAca1-ROH","GAL(8_F_)-NAG(7_F_)-MAN(6_F_)-[GAL(5_F_)-NAG(4_F_)-MAN(3_F_)]-BMA(2_F_)-NDG(1_F_)",32.2076,"","",""
"1SLC","X-RAY CRYSTALLOGRAPHY REVEALS CROSSLINKING OF MAMMALIAN LECTIN (GALECTIN-1) BY BIANTENNARY COMPLEX TYPE SACCHARIDES","10.1038/NSB1294-863 ",2.15,0,"1slc_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_E_)-NAG(7_E_)-MAN(6_E_)-[GAL(5_E_)-NAG(4_E_)-MAN(3_E_)]-BMA(2_E_)-NAG(1_E_)",32.7994,"","",""
"1T83","CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)","10.1074/JBC.M100350200 ",3,0,"1t83_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NDG(2_E_)]-NAG(1_E_)-ASN(297_B_)",112.121,"","",""
"1T89","CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL)","10.1074/JBC.M100350200 ",3.5,0,"1t89_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NDG(2_E_)]-NAG(1_E_)-ASN(297_B_)",91.035,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo7","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_O_)-MAN(4_O_)-[NAG(3_O_)-MAN(2_O_)]-MAN(1_O_)",40.0495,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_K_)-MAN(4_K_)-[NAG(3_K_)-MAN(2_K_)]-MAN(1_K_)",35.3765,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_I_)-MAN(4_I_)-[NAG(3_I_)-MAN(2_I_)]-MAN(1_I_)",21.8505,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo8","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_P_)-MAN(4_P_)-[NAG(3_P_)-MAN(2_P_)]-MAN(1_P_)",49.7678,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_J_)-MAN(4_J_)-[NAG(3_J_)-MAN(2_J_)]-MAN(1_J_)",37.2491,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo6","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_N_)-MAN(4_N_)-[NAG(3_N_)-MAN(2_N_)]-MAN(1_N_)",38.9276,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_L_)-MAN(4_L_)-[NAG(3_L_)-MAN(2_L_)]-MAN(1_L_)",35.266,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_M_)-MAN(4_M_)-[NAG(3_M_)-MAN(2_M_)]-MAN(1_M_)",27.3398,"","",""
"1UMZ","XYLOGLUCAN ENDOTRANSGLYCOSYLASE IN COMPLEX WITH THE XYLOGLUCAN NONASACCHARIDE XLLG.","10.1105/TPC.020065 ",1.8,27.91,"1umz_oligo4","DGalpb1-2DXylpx1-","GAL(6_D_)-XYS(5_D_)",51.4011,"","",""
"1UMZ","XYLOGLUCAN ENDOTRANSGLYCOSYLASE IN COMPLEX WITH THE XYLOGLUCAN NONASACCHARIDE XLLG.","10.1105/TPC.020065 ",1.8,27.91,"1umz_oligo3","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpx1-","GAL(6_F_)-XYS(5_F_)-[XYS(4_F_)-BGC(3_F_)]-BGC(2_F_)-BGC(1_F_)",35.0648,"","",""
"1UZY","ERYTHRINA CRYSTAGALLI LECTIN","10.1093/GLYCOB/CWH114 ",2,28.6,"1uzy_oligo8","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_E_)-[XYP(4_E_)]-BMA(3_E_)-NAG(2_E_)-[FUL(6_E_)]-NAG(1_E_)-ASN(113_B_)",43.5699,"","",""
"1W9B","S. ALBA MYROSINASE IN COMPLEX WITH CARBA-GLUCOTROPAEOLIN","10.1039/B502990B ",1.7,19.4,"1w9b_oligo3","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(292_M_)",39.8715,"","",""
"1W9B","S. ALBA MYROSINASE IN COMPLEX WITH CARBA-GLUCOTROPAEOLIN","10.1039/B502990B ",1.7,19.4,"1w9b_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)-ASN(265_M_)",37.3985,"","",""
"1W9D","S. ALBA MYROSINASE IN COMPLEX WITH S-ETHYL PHENYLACETOTHIOHYDROXIMATE- O-SULFATE","10.1039/B502990B ",1.6,18.46,"1w9d_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)-ASN(265_M_)",37.1685,"","",""
"1W9D","S. ALBA MYROSINASE IN COMPLEX WITH S-ETHYL PHENYLACETOTHIOHYDROXIMATE- O-SULFATE","10.1039/B502990B ",1.6,18.46,"1w9d_oligo3","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(292_M_)",39.6415,"","",""
"1X38","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE","10.1021/BI0514818 ",1.7,38.79,"1x38_oligo3","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)-ASN(600_A_)",51.4674,"","",""
"1X38","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE","10.1021/BI0514818 ",1.7,38.79,"1x38_oligo2","DGlcpNAcb1-2DManpa1-6[DXylpb1-2]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[XYP(6_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(498_A_)",57.8196,"","",""
"1X39","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE","10.1021/BI0514818 ",1.8,32.56,"1x39_oligo3","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)-ASN(600_A_)",52.2907,"","",""
"1X39","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE","10.1021/BI0514818 ",1.8,32.56,"1x39_oligo2","DGlcpNAcb1-2DManpa1-6[DXylpb1-2]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[XYP(6_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(498_A_)",50.8142,"","",""
"1ZAG","HUMAN ZINC-ALPHA-2-GLYCOPROTEIN","10.1126/SCIENCE.283.5409.1914 ",2.8,54.3,"1zag_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_F_)-GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[NAG(9_F_)-MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(239_B_)",63.8662,"","",""
"1ZAG","HUMAN ZINC-ALPHA-2-GLYCOPROTEIN","10.1126/SCIENCE.283.5409.1914 ",2.8,54.3,"1zag_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(239_A_)",48.8521,"","",""
"2AE7","CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4-GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH PENTASACCHARIDE","10.1016/J.JMB.2005.07.050 ",2,32.2,"2ae7_oligo5","DGlcpNAcb1-2DManpa1-6DManpb1-ROH","NAG(3_E_)-MAN(2_E_)-MAN(1_E_)",43.3058,"","",""
"2AE7","CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4-GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH PENTASACCHARIDE","10.1016/J.JMB.2005.07.050 ",2,32.2,"2ae7_oligo4","DGlcpNAcb1-2DManpa1-ROH","NAG(2_D_)-MAN(1_D_)",40.9605,"","",""
"2AE7","CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4-GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH PENTASACCHARIDE","10.1016/J.JMB.2005.07.050 ",2,32.2,"2ae7_oligo6","DGlcpNAcb1-2DManpa1-ROH","NAG(2_F_)-MAN(1_F_)",54.895,"","",""
"2AEC","CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4-GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,2-MAN-ALPHA1,6-MAN- BETA-OR","10.1016/J.JMB.2005.07.050 ",2,31.4,"2aec_oligo5","DGlcpNAcb1-2DManpa1-6DManpb1-ROH","NAG(3_D_)-MAN(2_D_)-BMA(1_D_)",43.1009,"","",""
"2AEC","CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4-GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,2-MAN-ALPHA1,6-MAN- BETA-OR","10.1016/J.JMB.2005.07.050 ",2,31.4,"2aec_oligo6","DGlcpNAcb1-2DManpa1-6DManpb1-ROH","NAG(3_E_)-MAN(2_E_)-BMA(1_E_)",39.6597,"","",""
"2AEC","CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4-GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,2-MAN-ALPHA1,6-MAN- BETA-OR","10.1016/J.JMB.2005.07.050 ",2,31.4,"2aec_oligo7","DGlcpNAcb1-2DManpa1-6DManpb1-ROH","NAG(3_F_)-MAN(2_F_)-BMA(1_F_)",57.327,"","",""
"2AES","CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4-GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,2-MAN-ALPHA1,3-MAN- BETA-OR","10.1016/J.JMB.2005.07.050 ",2,35.5,"2aes_oligo6","DGlcpNAcb1-2DManpa1-3DManpb1-ROH","NAG(3_E_)-MAN(2_E_)-BMA(1_E_)",50.6518,"","",""
"2AES","CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4-GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,2-MAN-ALPHA1,3-MAN- BETA-OR","10.1016/J.JMB.2005.07.050 ",2,35.5,"2aes_oligo7","DGlcpNAcb1-2DManpa1-3DManpb1-ROH","NAG(3_F_)-MAN(2_F_)-BMA(1_F_)",65.9076,"","",""
"2AES","CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4-GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,2-MAN-ALPHA1,3-MAN- BETA-OR","10.1016/J.JMB.2005.07.050 ",2,35.5,"2aes_oligo5","DGlcpNAcb1-2DManpa1-3DManpb1-ROH","NAG(3_D_)-MAN(2_D_)-BMA(1_D_)",58.3718,"","",""
"2AR6","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH THE PENTASACCHARIDE M592","10.1111/J.1742-4658.2006.05248.X ",1.8,0,"2ar6_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_D_)-MAN(4_D_)-[NAG(3_D_)-MAN(2_D_)]-MAN(1_D_)",31.9809,"","",""
"2AR6","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH THE PENTASACCHARIDE M592","10.1111/J.1742-4658.2006.05248.X ",1.8,0,"2ar6_oligo2","DGlcpNAcb1-2DManpa1-ROH","NAG(2_C_)-MAN(1_C_)",32.0218,"","",""
"2ARB","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH THE GLCNAC(BETA1- 2)MAN DISACCHARIDE","10.1111/J.1742-4658.2006.05248.X ",1.8,0,"2arb_oligo2","DGlcpNAcb1-2DManpa1-ROH","NAG(2_D_)-MAN(1_D_)",27.2841,"","",""
"2ARB","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH THE GLCNAC(BETA1- 2)MAN DISACCHARIDE","10.1111/J.1742-4658.2006.05248.X ",1.8,0,"2arb_oligo1","DGlcpNAcb1-2DManpa1-ROH","NAG(2_C_)-MAN(1_C_)",31.4909,"","",""
"2ARX","PTEROCARPUS ANGOLENSIS SEED LECTIN IN COMPLEX WITH THE DECASACCHARIDE NA2F","10.1111/J.1742-4658.2006.05248.X ",2,0,"2arx_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAca1-ROH","NAG(7_D_)-MAN(6_D_)-[GAL(5_D_)-NAG(4_D_)-MAN(3_D_)]-BMA(2_D_)-NDG(1_D_)",41.1288,"","",""
"2AUY","PTEROCARPUS ANGOLENSIS LECTIN IN COMPLEX WITH THE TRISACCHARIDE GLCNAC(B1-2)MAN(A1-3)MAN","10.1111/J.1742-4658.2006.05248.X ",1.95,0,"2auy_oligo4","DGlcpNAcb1-2DManpa1-3DManpa1-OME","NAG(3_D_)-MAN(2_D_)-MMA(1_D_)",35.197,"","",""
"2AUY","PTEROCARPUS ANGOLENSIS LECTIN IN COMPLEX WITH THE TRISACCHARIDE GLCNAC(B1-2)MAN(A1-3)MAN","10.1111/J.1742-4658.2006.05248.X ",1.95,0,"2auy_oligo3","DGlcpNAcb1-2DManpa1-3DManpa1-OME","NAG(3_C_)-MAN(2_C_)-MMA(1_C_)",31.7012,"","",""
"2BS6","LECTIN FROM RALSTONIA SOLANACEARUM COMPLEXED WITH XYLOGLUCAN FRAGMENT","10.1074/JBC.M505184200 ",1.8,11.34,"2bs6_oligo1","LFucpa1-2DGalpb1-2DXylpa1-ROH","FUC(3_E_)-GAL(2_E_)-XYS(1_E_)",15.122,"","",""
"2BS6","LECTIN FROM RALSTONIA SOLANACEARUM COMPLEXED WITH XYLOGLUCAN FRAGMENT","10.1074/JBC.M505184200 ",1.8,11.34,"2bs6_oligo2","LFucpa1-2DGalpb1-2DXylpa1-ROH","FUC(3_F_)-GAL(2_F_)-XYS(1_F_)",19.3563,"","",""
"2BS6","LECTIN FROM RALSTONIA SOLANACEARUM COMPLEXED WITH XYLOGLUCAN FRAGMENT","10.1074/JBC.M505184200 ",1.8,11.34,"2bs6_oligo3","LFucpa1-2DGalpb1-2DXylpa1-ROH","FUC(3_D_)-GAL(2_D_)-XYS(1_D_)",18.0449,"","",""
"2CN3","CRYSTAL STRUCTURES OF CLOSTRIDIUM THERMOCELLUM XYLOGLUCANASE","10.1074/JBC.M603583200 ",1.95,15.64,"2cn3_oligo4","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(8_F_)-XYS(7_F_)-[XYS(6_F_)-[XYS(5_F_)-BGC(4_F_)]-BGC(3_F_)]-BGC(2_F_)-GLC(1_F_)",19.1898,"","",""
"2CN3","CRYSTAL STRUCTURES OF CLOSTRIDIUM THERMOCELLUM XYLOGLUCANASE","10.1074/JBC.M603583200 ",1.95,15.64,"2cn3_oligo2","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(9_D_)-XYS(8_D_)-[GAL(7_D_)-XYS(6_D_)-[XYS(5_D_)-BGC(4_D_)]-BGC(3_D_)]-BGC(2_D_)-GLC(1_D_)",19.0238,"","",""
"2CN3","CRYSTAL STRUCTURES OF CLOSTRIDIUM THERMOCELLUM XYLOGLUCANASE","10.1074/JBC.M603583200 ",1.95,15.64,"2cn3_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(8_C_)-XYS(7_C_)-[XYS(6_C_)-[XYS(5_C_)-BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-GLC(1_C_)",15.0176,"","",""
"2CN3","CRYSTAL STRUCTURES OF CLOSTRIDIUM THERMOCELLUM XYLOGLUCANASE","10.1074/JBC.M603583200 ",1.95,15.64,"2cn3_oligo3","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(8_E_)-XYS(7_E_)-[XYS(6_E_)-[XYS(5_E_)-BGC(4_E_)]-BGC(3_E_)]-BGC(2_E_)-GLC(1_E_)",16.4964,"","",""
"2DJG","RE-DETERMINATION OF THE NATIVE STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE I (CATHEPSIN C)","10.1042/BJ20061389 ",2.05,23.06,"2djg_oligo1","DManpb1-2DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-BMA(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(95_A_)",63.1211,"","",""
"2DTS","CRYSTAL STRUCTURE OF THE DEFUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1","10.1016/J.JMB.2007.02.034 ",2.2,37.02,"2dts_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",37.4082,"","",""
"2DTS","CRYSTAL STRUCTURE OF THE DEFUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1","10.1016/J.JMB.2007.02.034 ",2.2,37.02,"2dts_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",31.8688,"","",""
"2DW2","CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-5 CRYSTAL)","10.1016/J.FEBSLET.2007.04.057 ",2.7,0,"2dw2_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(8_D_)]-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(371_B_)",38.0175,"","",""
"2DW2","CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-5 CRYSTAL)","10.1016/J.FEBSLET.2007.04.057 ",2.7,0,"2dw2_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(8_C_)]-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(371_A_)",35.7425,"","",""
"2GJ7","CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX","10.1371/JOURNAL.PBIO.0040148 ",5,0,"2gj7_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",40.4411,"","",""
"2GJ7","CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX","10.1371/JOURNAL.PBIO.0040148 ",5,0,"2gj7_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",42.0837,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo27","DGalpb1-3DManpb1-2DManpx1-","GAL(7_U_)-MAN(6_U_)-MAN(5_U_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo12","DManpb1-2DManpa1-3DManpx1-","MAN(9_J_)-MAN(8_J_)-BMA(3_J_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo2","DManpb1-2DManpa1-3DManpx1-","MAN(5_D_)-MAN(4_D_)-MAN(3_D_)",129.08,"","",""
"2HOX","ALLIINASE FROM ALLIUM SATIVUM (GARLIC)","10.1016/J.JMB.2006.11.041 ",1.4,17.13,"2hox_oligo5","DXylpb1-2[DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(5_E_)-[XYP(4_E_)]-BMA(3_E_)-NAG(2_E_)-[FUC(6_E_)]-NAG(1_E_)-ASN(146_A_)",29.5699,"","",""
"2I37","CRYSTAL STRUCTURE OF A PHOTOACTIVATED RHODOPSIN","10.1073/PNAS.0608022103 ",4.15,177.2,"2i37_oligo2","DGlcpNAcb1-2DManpb1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_F_)-BMA(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(15_B_)",183,"","",""
"2IWG","COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC","10.1073/PNAS.0609174104 ",2.35,71.56,"2iwg_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(297_D_)",88.8714,"","",""
"2IWG","COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC","10.1073/PNAS.0609174104 ",2.35,71.56,"2iwg_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",88.8714,"","",""
"2J6E","CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION","10.1016/J.JMB.2007.02.085 ",3,0,"2j6e_oligo1","DGalpb1-4DGlcpNAca1-2DManpa1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-BMA(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",54.9007,"","",""
"2J6E","CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION","10.1016/J.JMB.2007.02.085 ",3,0,"2j6e_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-BMA(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",116.527,"","",""
"2JEQ","FAMILY 5 XYLOGLUCANASE FROM PAENIBACILLUS PABULI IN COMPLEX WITH LIGAND","10.1074/JBC.M700224200 ",1.94,21.02,"2jeq_oligo1","DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(7_B_)-XYS(6_B_)-[XYS(5_B_)-[BGC(4_B_)]-BGC(3_B_)]-BGC(2_B_)-BGC(1_B_)",31.6102,"","",""
"2QL1","STRUCTURAL CHARACTERIZATION OF A MUTATED, ADCC-ENHANCED HUMAN FC FRAGMENT","10.1016/J.MOLIMM.2007.10.042 ",2.53,36.25,"2ql1_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",74.3521,"","",""
"2R68","COMPLEX STRUCTURE OF SUCROSE PHOSPHATE SYNTHASE (SPS)-S6P OF HALOTHERMOTHRIX ORENII","10.1105/TPC.107.051193 ",2.4,43.64,"2r68_oligo1","DGlcpb2-1DFrufb","GLC(1_B_)-F6P(2_B_)",20.8,"","",""
"2RGS","FC-FRAGMENT OF MONOCLONAL ANTIBODY IGG2B FROM MUS MUSCULUS","10.1111/J.1365-2567.2008.02904.X ",2.13,25.87,"2rgs_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",27.267,"","",""
"2RGS","FC-FRAGMENT OF MONOCLONAL ANTIBODY IGG2B FROM MUS MUSCULUS","10.1111/J.1365-2567.2008.02904.X ",2.13,25.87,"2rgs_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",27.747,"","",""
"2VH9","CRYSTAL STRUCTURE OF NXG1-DELTAYNIIG IN COMPLEX WITH XLLG, A XYLOGLUCAN DERIVED OLIGOSACCHARIDE","10.1002/PROT.22291 ",2.1,14.71,"2vh9_oligo1","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpx1-","GAL(3_F_)-XYS(2_F_)-[GAL(3_G_)-XYS(2_G_)-[XYS(2_H_)-BGC(1_H_)]-BGC(1_G_)]-BGC(1_F_)",18.4704,"","",""
"2VH9","CRYSTAL STRUCTURE OF NXG1-DELTAYNIIG IN COMPLEX WITH XLLG, A XYLOGLUCAN DERIVED OLIGOSACCHARIDE","10.1002/PROT.22291 ",2.1,14.71,"2vh9_oligo2","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpx1-","GAL(3_C_)-XYS(2_C_)-[GAL(3_D_)-XYS(2_D_)-[XYS(2_E_)-BGC(1_E_)]-BGC(1_D_)]-BGC(1_C_)-BGC(303_A_)",18.2104,"","",""
"2VUO","CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT","10.1042/BJ20081355 ",1.95,26.63,"2vuo_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",40.3597,"","",""
"2VUO","CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT","10.1042/BJ20081355 ",1.95,26.63,"2vuo_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",42.0043,"","",""
"2VUZ","CRYSTAL STRUCTURE OF CODAKINE IN COMPLEX WITH BIANTENNARY NONASACCHARIDE AT 1.7A RESOLUTION","10.1074/JBC.M804353200 ",1.7,18.48,"2vuz_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(7_B_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",34.3566,"","",""
"2WDB","A FAMILY 32 CARBOHYDRATE-BINDING MODULE, FROM THE MU TOXIN PRODUCED BY CLOSTRIDIUM PERFRINGENS, IN COMPLEX WITH BETA-D-GLCNAC-BETA(1,2) MANNOSE","10.1016/J.JMB.2009.04.066 ",2.03,21.47,"2wdb_oligo2","DGlcpNAcb1-2DManpb1-ROH","NAG(2_F_)-MAN(1_F_)",35.1214,"","",""
"2WDB","A FAMILY 32 CARBOHYDRATE-BINDING MODULE, FROM THE MU TOXIN PRODUCED BY CLOSTRIDIUM PERFRINGENS, IN COMPLEX WITH BETA-D-GLCNAC-BETA(1,2) MANNOSE","10.1016/J.JMB.2009.04.066 ",2.03,21.47,"2wdb_oligo4","DGlcpNAcb1-2DManpb1-ROH","NAG(2_H_)-MAN(1_H_)",35.87,"","",""
"2WDB","A FAMILY 32 CARBOHYDRATE-BINDING MODULE, FROM THE MU TOXIN PRODUCED BY CLOSTRIDIUM PERFRINGENS, IN COMPLEX WITH BETA-D-GLCNAC-BETA(1,2) MANNOSE","10.1016/J.JMB.2009.04.066 ",2.03,21.47,"2wdb_oligo1","DGlcpNAcb1-2DManpb1-ROH","NAG(2_E_)-MAN(1_E_)",46.4164,"","",""
"2WDB","A FAMILY 32 CARBOHYDRATE-BINDING MODULE, FROM THE MU TOXIN PRODUCED BY CLOSTRIDIUM PERFRINGENS, IN COMPLEX WITH BETA-D-GLCNAC-BETA(1,2) MANNOSE","10.1016/J.JMB.2009.04.066 ",2.03,21.47,"2wdb_oligo3","DGlcpNAcb1-2DManpb1-ROH","NAG(2_G_)-MAN(1_G_)",26.3773,"","",""
"2WKK","IDENTIFICATION OF THE GLYCAN TARGET OF THE NEMATOTOXIC FUNGAL GALECTIN CGL2 IN CAENORHABDITIS ELEGANS","10.1371/JOURNAL.PPAT.1000717 ",1.5,20.91,"2wkk_oligo4","DGalpb1-2DLyxpx1-","GAL(2_H_)-FUC(1_H_)",52.3301,"","",""
"2WXD","A MICROMOLAR O-SULFATED THIOHYDROXIMATE INHIBITOR BOUND TO PLANT MYROSINASE","10.1107/S1744309109052865 ",1.6,12.44,"2wxd_oligo6","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_D_)-[MAN(5_D_)]-[XYP(4_D_)]-BMA(3_D_)-NAG(2_D_)-[FUC(7_D_)]-NAG(1_D_)",31.0797,"","",""
"2YFZ","CBM62 FROM CLOSTRIDIUM THERMOCELLUM XYL5A","10.1074/JBC.M110.217372 ",1.8,14.91,"2yfz_oligo1","DGalpb1-2DXylpa1-6[DGlcpb1-4]DGlcpb1-4DGlcpb1-ROH","GAL(4_B_)-XYS(3_B_)-[BGC(5_B_)]-BGC(2_B_)-BGC(1_B_)",36.6665,"","",""
"2YL8","INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS","10.1016/J.STR.2011.08.011 ",1.75,14.37,"2yl8_oligo1","DGlcpNAcb1-2DManpa1-ROH","NAG(2_B_)-MAN(1_B_)",14.8818,"","",""
"2YL9","INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS","10.1016/J.STR.2011.08.011 ",2.65,15.6,"2yl9_oligo1","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-ROH","NAG(4_E_)-MAN(3_E_)-BMA(2_E_)-NAG(1_E_)",60.2673,"","",""
"2YL9","INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS","10.1016/J.STR.2011.08.011 ",2.65,15.6,"2yl9_oligo4","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-ROH","NAG(4_H_)-MAN(3_H_)-BMA(2_H_)-NAG(1_H_)",58.663,"","",""
"2YL9","INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS","10.1016/J.STR.2011.08.011 ",2.65,15.6,"2yl9_oligo2","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-ROH","NAG(4_F_)-MAN(3_F_)-BMA(2_F_)-NAG(1_F_)",52.9502,"","",""
"2YL9","INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS","10.1016/J.STR.2011.08.011 ",2.65,15.6,"2yl9_oligo3","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-ROH","NAG(4_G_)-MAN(3_G_)-BMA(2_G_)-NAG(1_G_)",61.57,"","",""
"2YLA","INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS","10.1016/J.STR.2011.08.011 ",2.7,14.6,"2yla_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-ROH","NAG(5_H_)-[NAG(4_H_)-MAN(3_H_)]-BMA(2_H_)-NAG(1_H_)",62.5293,"","",""
"2YLA","INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS","10.1016/J.STR.2011.08.011 ",2.7,14.6,"2yla_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-ROH","NAG(5_F_)-[NAG(4_F_)-MAN(3_F_)]-BMA(2_F_)-NAG(1_F_)",59.0691,"","",""
"2YLA","INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS","10.1016/J.STR.2011.08.011 ",2.7,14.6,"2yla_oligo3","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-ROH","NAG(4_G_)-MAN(3_G_)-BMA(2_G_)-NAG(1_G_)",56.7895,"","",""
"2YLA","INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS","10.1016/J.STR.2011.08.011 ",2.7,14.6,"2yla_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-ROH","NAG(5_E_)-[NAG(4_E_)-MAN(3_E_)]-BMA(2_E_)-NAG(1_E_)",68.9054,"","",""
"3AGV","CRYSTAL STRUCTURE OF A HUMAN IGG-APTAMER COMPLEX","10.1093/NAR/GKQ615 ",2.15,54.6,"3agv_oligo12","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ROH","FUL(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NDG(1_D_)",80.3653,"","",""
"3AVE","CRYSTAL STRUCTURE OF THE FUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1","10.1016/J.JMB.2011.03.031 ",2,41.11,"3ave_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",69.476,"","",""
"3AVE","CRYSTAL STRUCTURE OF THE FUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1","10.1016/J.JMB.2011.03.031 ",2,41.11,"3ave_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",50.4686,"","",""
"3AY4","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1111/J.1365-2443.2011.01552.X ",2.2,43.49,"3ay4_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",48.3941,"","",""
"3AY4","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1111/J.1365-2443.2011.01552.X ",2.2,43.49,"3ay4_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(162_C_)",75.4793,"","",""
"3AY4","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1111/J.1365-2443.2011.01552.X ",2.2,43.49,"3ay4_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",49.5257,"","",""
"3BVW","GOLGI MANNOSIDASE II D204A CATALYTIC NUCLEOPHILE MUTANT COMPLEX WITH METHYL (2-DEOXY-2-ACETAMIDO-BETA-D-GLUCOPYRANOSYL)-(1->2)-ALPHA-D- MANNOPYRANOSYL- (1->3)-[ALPHA-D-MANNOPYRANOSYL-(1->6)-6-THIO-ALPHA-D- MANNOPYRANOSYL- (1->6)]-BETA-D-MANNOPYRANOSIDE","10.1021/JA711248Y ",1.2,"1.15243e-41","3bvw_oligo1","DGlcpNAcb1-2DManpa1-3[DLyxpa1-6]DManpb1-OME","Z4Y(4_B_)-[NAG(3_B_)-MAN(2_B_)]-YZ0(1_B_)",38.1853,"","",""
"3BVX","GOLGI MANNOSIDASE II D204A CATALYTIC NUCLEOPHILE MUTANT COMPLEX WITH METHYL (2-DEOXY-2-ACETAMIDO-BETA-D-GLUCOPYRANOSYL)-(1->2)-(ALPHA-D- MANNOPYRANOSYL)- (1->3)-[(ALPHA-D-MANNOPYRANOSYL)-(1->6)-(ALPHA-D- MANNOPYRANOSYL)-(1->6)]-BETA-D-MANNOPYRANOSIDE","10.1021/JA711248Y ",1.1,0,"3bvx_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-OME","MAN(5_B_)-MAN(4_B_)-[NAG(3_B_)-MAN(2_B_)]-YZ0(1_B_)",31.9624,"","",""
"3BWH","ATOMIC RESOLUTION STRUCTURE OF CUCURMOSIN, A NOVEL TYPE 1 RIP FROM THE SARCOCARP OF CUCURBITA MOSCHATA","10.1016/J.JSB.2008.06.011 ",1,9.72,"3bwh_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",49.1578,"","",""
"3C2S","STRUCTURAL CHARACTERIZATION OF A HUMAN FC FRAGMENT ENGINEERED FOR LACK OF EFFECTOR FUNCTIONS","10.1107/S0907444908007877 ",2.3,43.32,"3c2s_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",71.3893,"","",""
"3CA0","SAMBUCUS NIGRA AGGLUTININ II (SNA-II), HEXAGONAL CRYSTAL FORM","10.1002/PROT.22222 ",1.95,41.66,"3ca0_oligo2","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(63_A_)",53.8283,"","",""
"3CSY","CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR","10.1038/NATURE07082 ",3.4,115.8,"3csy_oligo8","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_X_)-[NAG(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)",142.661,"","",""
"3CSY","CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR","10.1038/NATURE07082 ",3.4,115.8,"3csy_oligo4","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_T_)-[NAG(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)",138.302,"","",""
"3CZN","GOLGI ALPHA-MANNOSIDASE II (D204A NUCLEOPHILE MUTANT) IN COMPLEX WITH GNMAN5GN","10.1073/PNAS.0802206105 ",1.4,17.67,"3czn_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAca1-ROH","MAN(7_B_)-[MAN(6_B_)]-MAN(5_B_)-[NAG(4_B_)-MAN(3_B_)]-BMA(2_B_)-NDG(1_B_)",18.7778,"","",""
"3D6G","FC FRAGMENT OF IGG1 (HERCEPTIN) WITH PROTEIN-A MIMETIC PEPTIDE DENDRIMER LIGAND.","10.1021/JP909405B ",2.3,72.42,"3d6g_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",68.4889,"","",""
"3D6G","FC FRAGMENT OF IGG1 (HERCEPTIN) WITH PROTEIN-A MIMETIC PEPTIDE DENDRIMER LIGAND.","10.1021/JP909405B ",2.3,72.42,"3d6g_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",71.969,"","",""
"3DO3","HUMAN 1GG1 FC FRAGMENT, 2.5 ANGSTROM STRUCTURE","",2.5,0,"3do3_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",55.7868,"","",""
"3DO3","HUMAN 1GG1 FC FRAGMENT, 2.5 ANGSTROM STRUCTURE","",2.5,0,"3do3_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",74.4228,"","",""
"3FFO","F17B-G LECTIN DOMAIN WITH BOUND GLCNAC(BETA1-2)MAN","10.3390/BIOLOGY2030894 ",2.1,49.85,"3ffo_oligo1","DGlcpNAcb1-2DManpb1-ROH","NAG(2_B_)-BMA(1_B_)",71.255,"","",""
"3FJT","CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE","10.1016/J.MOLIMM.2009.01.026 ",2.5,63.81,"3fjt_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",98.0298,"","",""
"3FJT","CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE","10.1016/J.MOLIMM.2009.01.026 ",2.5,63.81,"3fjt_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",107.811,"","",""
"3FRU","NEONATAL FC RECEPTOR, PH 6.5","10.1016/S0969-2126(98)00008-2 ",2.2,51.6,"3fru_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(7_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-BMA(3_G_)-NDG(2_G_)]-NAG(1_G_)-ASN(225_A_)",75.6945,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo4","DManpb1-2DManpa1-2DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[BMA(6_I_)-MAN(5_I_)-BMA(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(459_A_)",134.506,"","",""
"3H83","2.06 ANGSTROM RESOLUTION STRUCTURE OF A HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE (HPT-1) FROM BACILLUS ANTHRACIS STR. 'AMES ANCESTOR'","",2.06,19.93,"3h83_oligo3","DGlcpb2-1DFrufb","GLC(1_G_)-FRU(2_G_)",50.8804,"","",""
"3H83","2.06 ANGSTROM RESOLUTION STRUCTURE OF A HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE (HPT-1) FROM BACILLUS ANTHRACIS STR. 'AMES ANCESTOR'","",2.06,19.93,"3h83_oligo2","DGlcpb2-1DFrufb","GLC(1_F_)-FRU(2_F_)",50.4255,"","",""
"3HN3","HUMAN BETA-GLUCURONIDASE AT 1.7 A RESOLUTION","",1.7,15.53,"3hn3_oligo2","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[BMA(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(173_B_)",23.925,"","",""
"3HNS","CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE","10.1016/J.JMB.2009.06.074 ",2,27.76,"3hns_oligo1","DArafb1-2DArafa1-3[DArafb1-2DArafa1-5]DArafa1-5DArafa1-OME","BXX(6_A_)-BXY(5_A_)-[BXX(4_A_)-BXY(3_A_)]-BXY(2_A_)-AXR(1_A_)",31.6194,"","",""
"3HNT","CS-35 FAB COMPLEX WITH A LINEAR, TERMINAL OLIGOARABINOFURANOSYL TETRASACCHARIDE FROM LIPOARABINOMANNAN","10.1016/J.JMB.2009.06.074 ",1.8,25.65,"3hnt_oligo1","DArafb1-2DArafa1-5DArafa1-5DArafa1-OME","BXX(4_A_)-BXY(3_A_)-BXY(2_A_)-AXR(1_A_)",21.2881,"","",""
"3HNV","CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL TETRASACCHARIDE (BRANCH PART OF HEXASACCHARIDE)","10.1016/J.JMB.2009.06.074 ",2,27,"3hnv_oligo1","DArafb1-2DArafa1-3DArafa1-5DArafa1-OME","BXX(4_A_)-BXY(3_A_)-BXY(2_A_)-AXR(1_A_)",58.8742,"","",""
"3NV3","CRYSTAL STRUCTURE OF HUMAN GALECTIN-9 C-TERMINAL CRD IN COMPLEX WITH BIANTENNARY OLIGOSACCHARIDE","10.1074/JBC.M110.163402 ",1.57,0,"3nv3_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-ROH","GAL(3_B_)-NAG(2_B_)-MAN(1_B_)",29.9688,"","",""
"3Q3A","CRYSTAL STRUCTURE OF P DOMAIN FROM NORWALK VIRUS STRAIN VIETNAM 026 IN COMPLEX WITH HBGA TYPE H2 (TRIGLYCAN)","10.1128/JVI.00246-11 ",1.4,23.2,"3q3a_oligo4","LFucpb1-2DGalpb1-4DGlcpNAcb1-ROH","FUL(3_C_)-GAL(2_C_)-NAG(1_C_)",24.8906,"","",""
"3QUM","CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY","10.1016/J.JMB.2011.10.007 ",3.2,73.27,"3qum_oligo2","DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-4DManpa1-3[DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-2[DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-6]DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(15_E_)-[SIA(14_E_)-GAL(13_E_)-NAG(12_E_)-[SIA(11_E_)-GAL(10_E_)-NAG(9_E_)]-MAN(8_E_)-[SIA(7_E_)-GAL(6_E_)-NAG(5_E_)-MAN(4_E_)]-MAN(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(61_P_)",112.455,"","",""
"3RY6","COMPLEX OF FCGAMMARIIA (CD32) AND THE FC OF HUMAN IGG1","10.4049/JIMMUNOL.1101467 ",3.8,0,"3ry6_oligo2","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(12_E_)-[SIA(11_E_)-GAL(10_E_)-NAG(9_E_)-MAN(8_E_)-[SIA(7_E_)-GAL(6_E_)-NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",58.4448,"","",""
"3RY6","COMPLEX OF FCGAMMARIIA (CD32) AND THE FC OF HUMAN IGG1","10.4049/JIMMUNOL.1101467 ",3.8,0,"3ry6_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(10_D_)-[NAG(9_D_)-MAN(8_D_)-[SIA(7_D_)-GAL(6_D_)-NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NDG(1_D_)-ASN(297_A_)",60.0921,"","",""
"3S5Y","PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE","10.1016/J.CHEMBIOL.2011.10.012 ",2.11,38.34,"3s5y_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(139_A_)",100.866,"","",""
"3S5Y","PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE","10.1016/J.CHEMBIOL.2011.10.012 ",2.11,38.34,"3s5y_oligo5","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)-ASN(192_A_)",72.6659,"","",""
"3S5Y","PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE","10.1016/J.CHEMBIOL.2011.10.012 ",2.11,38.34,"3s5y_oligo6","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[XYP(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(192_B_)",69.113,"","",""
"3S5Z","PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE","10.1016/J.CHEMBIOL.2011.10.012 ",2,33.72,"3s5z_oligo3","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[XYP(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(192_B_)",80.7607,"","",""
"3S5Z","PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE","10.1016/J.CHEMBIOL.2011.10.012 ",2,33.72,"3s5z_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(192_A_)",78.3548,"","",""
"3SGJ","UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE","10.1073/PNAS.1108455108 ",2.2,41.35,"3sgj_oligo3","DGlcpNAcb1-2DManpa1-6DManp[3<R1>]b1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",42.0992,"","",""
"3SGJ","UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE","10.1073/PNAS.1108455108 ",2.2,41.35,"3sgj_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",49.3643,"","",""
"3SGK","UNIQUE CARBOHYDRATE/CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING OF FCGIII AND ANTIBODIES LACKING CORE FUCOSE","10.1073/PNAS.1108455108 ",2.4,63.58,"3sgk_oligo3","DGlcpNAcb1-2DManpb1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(8_E_)]-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",61.4043,"","",""
"3SGK","UNIQUE CARBOHYDRATE/CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING OF FCGIII AND ANTIBODIES LACKING CORE FUCOSE","10.1073/PNAS.1108455108 ",2.4,63.58,"3sgk_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_D_)-MAN(6_D_)-[NAG(8_D_)]-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",47.0327,"","",""
"3UGF","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS","10.1111/J.1365-313X.2011.04858.X ",1.7,20.03,"3ugf_oligo8","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-[FUC(6_J_)]-NAG(1_J_)-ASN(400_B_)",37.3547,"","",""
"3V7M","CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) IN THE PRESENCE OF ZN2+","",2.02,47.93,"3v7m_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(297_A_)",70.5152,"","",""
"3V8C","CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) DOUBLE MUTANT (H310 AND H435 IN K)","",2.77,57.56,"3v8c_oligo6","DGlcpNAcb1-2DManpx1-","NAG(2_C_)-MAN(1_C_)",81.4324,"","",""
"3V95","CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC AND IGG1 T125(YB2/0) IN THE PRESENCE OF EDTA","",2.7,39.73,"3v95_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",38.9226,"","",""
"3V95","CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC AND IGG1 T125(YB2/0) IN THE PRESENCE OF EDTA","",2.7,39.73,"3v95_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",67.4025,"","",""
"3VUN","CRYSTAL STRUCTURE OF A INFLUENZA A VIRUS (A/AICHI/2/1968 H3N2) HEMAGGLUTININ IN C2 SPACE GROUP.","",3,84.66,"3vun_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_J_)-[GAL(6_J_)-NAG(5_J_)-MAN(4_J_)-[NAG(8_J_)-MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(81_C_)",87.8973,"","",""
"3VUN","CRYSTAL STRUCTURE OF A INFLUENZA A VIRUS (A/AICHI/2/1968 H3N2) HEMAGGLUTININ IN C2 SPACE GROUP.","",3,84.66,"3vun_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[NAG(8_G_)-MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(81_A_)",90.6585,"","",""
"3VUN","CRYSTAL STRUCTURE OF A INFLUENZA A VIRUS (A/AICHI/2/1968 H3N2) HEMAGGLUTININ IN C2 SPACE GROUP.","",3,84.66,"3vun_oligo7","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_M_)-[GAL(6_M_)-NAG(5_M_)-MAN(4_M_)-[NAG(8_M_)-MAN(7_M_)]-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(81_E_)",91.0734,"","",""
"3VYK","CRYSTAL STRUCTURE OF C-TYPE LECTIN DOMAIN OF MURINE DENDRITIC CELL INHIBITORY RECEPTOR 2 IN COMPLEX WITH N-GLYCAN","10.1074/JBC.M113.513572 ",1.5,19.15,"3vyk_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpa1-OME","NAG(5_B_)-MAN(4_B_)-[NAG(6_B_)]-[NAG(3_B_)-MAN(2_B_)]-MMA(1_B_)",20.6395,"","",""
"3W81","HUMAN ALPHA-L-IDURONIDASE","10.1073/PNAS.1306939110 ",2.3,34.51,"3w81_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(190_B_)",105.573,"","",""
"3WCS","CRYSTAL STRUCTURE OF PLANT LECTIN (LIGAND-BOUND FORM)","10.1093/GLYCOB/CWU004 ",1.75,30.16,"3wcs_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-ROH","GAL(3_C_)-NAG(2_C_)-MAN(1_C_)",22.6936,"","",""
"3WCS","CRYSTAL STRUCTURE OF PLANT LECTIN (LIGAND-BOUND FORM)","10.1093/GLYCOB/CWU004 ",1.75,30.16,"3wcs_oligo1","DGlcpNAcb1-2DManpa1-ROH","NAG(2_D_)-MAN(1_D_)",44.7264,"","",""
"3WJJ","CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(P238D), IN COMPLEX WITH FCGRIIB","10.1093/PROTEIN/GZT022 ",2.6,63.49,"3wjj_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",81.7589,"","",""
"3WJJ","CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(P238D), IN COMPLEX WITH FCGRIIB","10.1093/PROTEIN/GZT022 ",2.6,63.49,"3wjj_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",80.7042,"","",""
"3WJL","CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(V12), IN COMPLEX WITH FCGRIIB","10.1093/PROTEIN/GZT022 ",2.86,65.55,"3wjl_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",119.817,"","",""
"3WJL","CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(V12), IN COMPLEX WITH FCGRIIB","10.1093/PROTEIN/GZT022 ",2.86,65.55,"3wjl_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",64.4536,"","",""
"3WJM","CRYSTAL STRUCTURE OF BOMBYX MORI SP2/SP3 HETEROHEXAMER","10.1002/PRO.2457 ",2.8,53.4,"3wjm_oligo8","DManpb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_L_)-MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(211_F_)",81.6827,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo8","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_X_)-[GAL(6_X_)-NAG(5_X_)-MAN(4_X_)-[NAG(8_X_)-MAN(7_X_)]-BMA(3_X_)-NAG(2_X_)]-NAG(1_X_)-ASN(297_N_)",89.819,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_Q_)-[GAL(6_Q_)-NAG(5_Q_)-MAN(4_Q_)-[NAG(8_Q_)-MAN(7_Q_)]-BMA(3_Q_)-NAG(2_Q_)]-NAG(1_Q_)-ASN(297_C_)",77.8989,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_S_)-[GAL(6_S_)-NAG(5_S_)-MAN(4_S_)-[NAG(8_S_)-MAN(7_S_)]-BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(297_A_)",62.0332,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_R_)-[GAL(6_R_)-NAG(5_R_)-MAN(4_R_)-[NAG(8_R_)-MAN(7_R_)]-BMA(3_R_)-NAG(2_R_)]-NAG(1_R_)-ASN(297_B_)",83.8199,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo7","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_W_)-[GAL(6_W_)-NAG(5_W_)-MAN(4_W_)-[NAG(8_W_)-MAN(7_W_)]-BMA(3_W_)-NAG(2_W_)]-NAG(1_W_)-ASN(297_M_)",69.9621,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_V_)-[GAL(6_V_)-NAG(5_V_)-MAN(4_V_)-[NAG(8_V_)-MAN(7_V_)]-BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(297_J_)",83.2386,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_T_)-[GAL(6_T_)-NAG(5_T_)-MAN(4_T_)-[NAG(8_T_)-MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(297_D_)",59.0888,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo5","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_U_)-[GAL(6_U_)-NAG(5_U_)-MAN(4_U_)-[NAG(8_U_)-MAN(7_U_)]-BMA(3_U_)-NAG(2_U_)]-NAG(1_U_)-ASN(297_I_)",66.7113,"","",""
"3WLH","CRYSTAL STRUCTURE ANALYSIS OF PLANT EXOHYDROLASE","10.1038/S41467-019-09691-Z ",1.65,26.49,"3wlh_oligo5","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","XYP(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUL(5_D_)]-NAG(1_D_)-ASN(600_A_)",60.6452,"","",""
"3WLH","CRYSTAL STRUCTURE ANALYSIS OF PLANT EXOHYDROLASE","10.1038/S41467-019-09691-Z ",1.65,26.49,"3wlh_oligo4","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUL(6_C_)]-NAG(1_C_)-ASN(498_A_)",56.9233,"","",""
"3WLJ","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 3-DEOXY-GLUCOSE","10.1038/S41467-019-09691-Z ",1.67,26.37,"3wlj_oligo5","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","XYP(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUL(5_D_)]-NAG(1_D_)-ASN(600_A_)",55.0276,"","",""
"3WLJ","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 3-DEOXY-GLUCOSE","10.1038/S41467-019-09691-Z ",1.67,26.37,"3wlj_oligo4","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUL(6_C_)]-NAG(1_C_)-ASN(498_A_)",64.0915,"","",""
"3WLK","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 4-DEOXY-GLUCOSE","10.1038/S41467-019-09691-Z ",1.8,29.96,"3wlk_oligo3","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(498_X_)",67.0644,"","",""
"3WLK","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 4-DEOXY-GLUCOSE","10.1038/S41467-019-09691-Z ",1.8,29.96,"3wlk_oligo4","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","XYP(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUL(5_C_)]-NAG(1_C_)-ASN(600_X_)",70.2164,"","",""
"3WLL","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH PEG400","10.1038/S41467-019-09691-Z ",1.8,30.34,"3wll_oligo2","DGlcpNAcb1-2DManpa1-6[DXylpb1-2]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[XYP(6_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(498_A_)",54.6636,"","",""
"3WLL","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH PEG400","10.1038/S41467-019-09691-Z ",1.8,30.34,"3wll_oligo3","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)-ASN(600_A_)",63.4634,"","",""
"3WLN","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH OCTYL-S-GLUCOSIDE","10.1038/S41467-019-09691-Z ",2,32.21,"3wln_oligo2","DGlcpNAcb1-2DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(498_A_)",81.3987,"","",""
"3WN5","CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA","10.1016/J.MOLIMM.2013.11.017 ",2.78,54.66,"3wn5_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_L_)-[GAL(6_L_)-NAG(5_L_)-MAN(4_L_)-[NAG(8_L_)-MAN(7_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(297_E_)",70.6244,"","",""
"3WN5","CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA","10.1016/J.MOLIMM.2013.11.017 ",2.78,54.66,"3wn5_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_K_)-[NAG(7_K_)-MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(297_D_)",57.258,"","",""
"3WN5","CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA","10.1016/J.MOLIMM.2013.11.017 ",2.78,54.66,"3wn5_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[NAG(8_H_)-MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",67.0639,"","",""
"3WN5","CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA","10.1016/J.MOLIMM.2013.11.017 ",2.78,54.66,"3wn5_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[NAG(8_G_)-MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",54.1912,"","",""
"3WOG","CRYSTAL STRUCTURE PLANT LECTIN IN COMPLEX WITH LIGAND","10.1093/GLYCOB/CWU004 ",2,35.38,"3wog_oligo1","DGlcpNAcb1-2DManpa1-ROH","NAG(2_C_)-MAN(1_C_)",30.3082,"","",""
"3WOG","CRYSTAL STRUCTURE PLANT LECTIN IN COMPLEX WITH LIGAND","10.1093/GLYCOB/CWU004 ",2,35.38,"3wog_oligo2","DGlcpNAcb1-2DManpa1-ROH","NAG(2_D_)-MAN(1_D_)",51.0423,"","",""
"3ZO0","MOUSE IGG2A IN COMPLEX WITH MOUSE TRIM21 PRYSPRY","10.1073/PNAS.0800159105 ",1.99,36.52,"3zo0_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",32.8146,"","",""
"3ZYR","STRUCTURE OF THE LECTIN FROM PLATYPODIUM ELEGANS IN COMPLEX WITH HEPTASACCHARIDE","10.1074/JBC.M112.375816 ",1.65,11.04,"3zyr_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",15.7529,"","",""
"3ZYR","STRUCTURE OF THE LECTIN FROM PLATYPODIUM ELEGANS IN COMPLEX WITH HEPTASACCHARIDE","10.1074/JBC.M112.375816 ",1.65,11.04,"3zyr_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(299_A_)",13.1886,"","",""
"4A5G","RAPHANUS SATIVUS ANIONIC PEROXIDASE.","",2.05,29.53,"4a5g_oligo7","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_C_)-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)-ASN(5_A_)",37.563,"","",""
"4A5G","RAPHANUS SATIVUS ANIONIC PEROXIDASE.","",2.05,29.53,"4a5g_oligo2","DXylpb1-2[DManpb1-3]DManpb1-4DGlcpNAca1-4[LFucpb1-3]DGlcpNAcb1-ASN","BMA(5_G_)-[XYP(4_G_)]-BMA(3_G_)-NAG(2_G_)-[FUL(6_G_)]-NAG(1_G_)-ASN(187_A_)",60.9746,"","",""
"4A5G","RAPHANUS SATIVUS ANIONIC PEROXIDASE.","",2.05,29.53,"4a5g_oligo5","DXylpb1-2DManp[3<R1>]b1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_I_)-BMA(3_I_)-NAG(2_I_)-[FUC(6_I_)]-NAG(1_I_)",47.7823,"","",""
"4AVV","STRUCTURE OF CPHPC BOUND TO SERUM AMYLOID P COMPONENT","10.1107/S1399004714013455 ",1.6,18.9,"4avv_oligo12","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(9_G_)-MAN(8_G_)-[SIA(7_G_)-GAL(6_G_)-NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(32_D_)",33.5094,"","",""
"4BM7","CRYSTAL STRUCTURE OF IGG FC F241A MUTANT WITH NATIVE GLYCOSYLATION","10.1021/JA4014375 ",1.95,45.81,"4bm7_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",73.9148,"","",""
"4BSV","HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 1","10.4161/MABS.25632 ",1.75,25.78,"4bsv_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(9_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[NAG(8_F_)-MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)",73.5696,"","",""
"4BSV","HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 1","10.4161/MABS.25632 ",1.75,25.78,"4bsv_oligo3","DGlcpNAcb1-2DManpx1-","NAG(2_E_)-MAN(1_E_)",67.4936,"","",""
"4BSV","HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 1","10.4161/MABS.25632 ",1.75,25.78,"4bsv_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcx1-","GAL(5_D_)-NAG(4_D_)-MAN(3_D_)-BMA(2_D_)-NAG(1_D_)",37.9626,"","",""
"4BSW","HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2","10.4161/MABS.25632 ",2.15,45.51,"4bsw_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.1684,"","",""
"4BSW","HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2","10.4161/MABS.25632 ",2.15,45.51,"4bsw_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",73.5148,"","",""
"4BSW","HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2","10.4161/MABS.25632 ",2.15,45.51,"4bsw_oligo3","DGlcpNAcb1-2DManpx1-","NAG(8_D_)-MAN(7_D_)",99.9535,"","",""
"4BYH","CRYSTAL STRUCTURE OF SIALYLATED IGG FC","10.1073/PNAS.1310657110 ",2.3,66.11,"4byh_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_D_)-[GAL(9_D_)-NAG(8_D_)-MAN(7_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",61.7989,"","",""
"4BYH","CRYSTAL STRUCTURE OF SIALYLATED IGG FC","10.1073/PNAS.1310657110 ",2.3,66.11,"4byh_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_C_)-[SIA(7_C_)-GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(9_C_)-MAN(8_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",91.0439,"","",""
"4C54","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN IGG4 FC","10.1016/J.JMB.2013.10.039 ",1.9,0,"4c54_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",44.019,"","",""
"4C54","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN IGG4 FC","10.1016/J.JMB.2013.10.039 ",1.9,0,"4c54_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",59.663,"","",""
"4C55","CRYSTAL STRUCTURE OF SERUM-DERIVED HUMAN IGG4 FC","10.1016/J.JMB.2013.10.039 ",2.35,0,"4c55_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",82.7285,"","",""
"4C55","CRYSTAL STRUCTURE OF SERUM-DERIVED HUMAN IGG4 FC","10.1016/J.JMB.2013.10.039 ",2.35,0,"4c55_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[NAG1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",52.4188,"","",""
"4CDH","CRYSTALLOGRAPHIC STRUCTURE OF THE HUMAN IGG1 ALPHA 2-6 SIALILATED FC- FRAGMENT","10.1016/J.STR.2014.09.001 ",2.3,43.12,"4cdh_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(10_C_)-[GAL(9_C_)-NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(78_A_)",55.2306,"","",""
"4CDH","CRYSTALLOGRAPHIC STRUCTURE OF THE HUMAN IGG1 ALPHA 2-6 SIALILATED FC- FRAGMENT","10.1016/J.STR.2014.09.001 ",2.3,43.12,"4cdh_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(78_B_)",68.154,"","",""
"4DQO","CRYSTAL STRUCTURE OF PG16 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109","10.1038/NSMB.2600 ",2.44,0,"4dqo_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_B_)-[MAN(9_B_)]-MAN(8_B_)-[SIA(7_B_)-GAL(6_B_)-NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(173_C_)",69.023,"","",""
"4DVL","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 2'-3'-CYCLO-UMP","10.1016/J.STR.2012.03.018 ",2.75,62.41,"4dvl_oligo2","DManpb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[BMA(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(4_B_)",63.0053,"","",""
"4DZ8","HUMAN IGG1 FC FRAGMENT HETERODIMER","10.1016/J.JMB.2012.04.020 ",1.91,32.06,"4dz8_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",59.2558,"","",""
"4DZ8","HUMAN IGG1 FC FRAGMENT HETERODIMER","10.1016/J.JMB.2012.04.020 ",1.91,32.06,"4dz8_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",34.3539,"","",""
"4F7B","STRUCTURE OF THE LYSOSOMAL DOMAIN OF LIMP-2","10.1038/NATURE12684 ",3,84.68,"4f7b_oligo19","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(412_B_)",124.786,"","",""
"4F7B","STRUCTURE OF THE LYSOSOMAL DOMAIN OF LIMP-2","10.1038/NATURE12684 ",3,84.68,"4f7b_oligo2","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_H_)-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(412_A_)",82.9984,"","",""
"4F7B","STRUCTURE OF THE LYSOSOMAL DOMAIN OF LIMP-2","10.1038/NATURE12684 ",3,84.68,"4f7b_oligo10","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Y_)-[NAG(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(412_E_)",97.8735,"","",""
"4F7B","STRUCTURE OF THE LYSOSOMAL DOMAIN OF LIMP-2","10.1038/NATURE12684 ",3,84.68,"4f7b_oligo5","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_T_)-MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(412_D_)",96.1451,"","",""
"4FQC","CRYSTAL STRUCTURE OF PGT121 FAB BOUND TO A COMPLEX-TYPE SIALYLATED N- GLYCAN","10.1073/PNAS.1217207109 ",2.4,32.26,"4fqc_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_A_)-[NAG(9_A_)-MAN(8_A_)-[SIA(7_A_)-GAL(6_A_)-NAG(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(105_H_)",38.303,"","",""
"4GC2","CRYSTAL STRUCTURE OF THE BACTERIOCIN LLPA FROM PSEUDOMONAS SP. IN COMPLEX WITH GLCNAC BETA(1-2)MAN ALPHA(1-3)[GLCNAC BETA(1-2)MAN ALPHA(1-6)]MAN","10.1371/JOURNAL.PPAT.1003199 ",2.12,0,"4gc2_oligo1","DGlcpNAcb1-2DRhapa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_C_)-MAN(4_C_)-[NAG(3_C_)-MAN(2_C_)]-MAN(1_C_)",60.7284,"","",""
"4HAF","CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2 ANTIBODY (PRIMITIVE CRYSTAL FORM)","10.1016/J.MOLIMM.2013.03.018 ",2.04,35.1,"4haf_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.2141,"","",""
"4HAG","CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2 ANTIBODY (CENTERED CRYSTAL FORM)","10.1016/J.MOLIMM.2013.03.018 ",3.4,193.5,"4hag_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_B_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(297_A_)",227.074,"","",""
"4J12","MONOMERIC FC","10.1074/JBC.M113.457689 ",1.9,49.35,"4j12_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_B_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(297_A_)",95.8401,"","",""
"4JS1","CRYSTAL STRUCTURE OF HUMAN BETA-GALACTOSIDE ALPHA-2,6- SIALYLTRANSFERASE 1 IN COMPLEX WITH CYTIDINE AND PHOSPHATE","10.1107/S0907444913015412 ",2.09,0,"4js1_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_B_)-NAG(8_B_)-MAN(7_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(149_A_)",99.1286,"","",""
"4JS2","CRYSTAL STRUCTURE OF HUMAN BETA-GALACTOSIDE ALPHA-2,6- SIALYLTRANSFERASE 1 IN COMPLEX WITH CMP","10.1107/S0907444913015412 ",2.3,0,"4js2_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_B_)-NAG(8_B_)-MAN(7_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(149_A_)",96.6658,"","",""
"4JY4","CRYSTAL STRUCTURE OF HUMAN FAB PGT121, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY","10.1371/JOURNAL.PPAT.1003342 ",2.8,0,"4jy4_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[MAN(8_C_)-[SIA(7_C_)-GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(103_B_)",73.8247,"","",""
"4KU1","ROLE OF THE HINGE AND C-GAMMA-2/C-GAMMA-3 INTERFACE IN IMMUNOGLOBIN G1 FC DOMAIN MOTIONS: IMPLICATIONS FOR FC ENGINEERING","10.1016/J.JMB.2014.01.011 ",1.9,31.64,"4ku1_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(10_C_)-[GAL(9_C_)-NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",63.871,"","",""
"4KU1","ROLE OF THE HINGE AND C-GAMMA-2/C-GAMMA-3 INTERFACE IN IMMUNOGLOBIN G1 FC DOMAIN MOTIONS: IMPLICATIONS FOR FC ENGINEERING","10.1016/J.JMB.2014.01.011 ",1.9,31.64,"4ku1_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",40.4316,"","",""
"4L4J","CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2-SIGMA ANTIBODY","10.1016/J.YMETH.2013.06.035 ",1.92,39.9,"4l4j_oligo2","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",89.4141,"","",""
"4L4J","CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2-SIGMA ANTIBODY","10.1016/J.YMETH.2013.06.035 ",1.92,39.9,"4l4j_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",43.027,"","",""
"4MA1","UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB","10.1074/JBC.M113.528224 ",2.32,48.25,"4ma1_oligo4","DGalpa1-3DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcx1-","MAN(8_G_)-[GLA(7_G_)-GAL(6_G_)-NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)",94.7876,"","",""
"4N0U","TERNARY COMPLEX BETWEEN NEONATAL FC RECEPTOR, SERUM ALBUMIN AND FC","10.1074/JBC.M113.537563 ",3.8,143.8,"4n0u_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_E_)",124.464,"","",""
"4Q4F","CRYSTAL STRUCTURE OF LIMP-2 (SPACE GROUP C2)","10.1038/NCOMMS5321 ",2.8,71.18,"4q4f_oligo3","DManp[6P]b1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","M6D(6_F_)-MAN(5_F_)-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(325_A_)",93.016,"","",""
"4Q6Y","CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)","10.1016/J.JMB.2014.07.006 ",3,0,"4q6y_oligo1","DGlcpNAcb1-2DManpx1-","NAG(5_E_)-MAN(4_E_)",124.834,"","",""
"4Q6Y","CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)","10.1016/J.JMB.2014.07.006 ",3,0,"4q6y_oligo4","DGlcpNAcb1-2DManpx1-","NAG(9_F_)-MAN(8_F_)",101.099,"","",""
"4Q6Y","CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)","10.1016/J.JMB.2014.07.006 ",3,0,"4q6y_oligo12","DGlcpNAcb1-2DManpx1-","NAG(8_H_)-MAN(7_H_)",131.787,"","",""
"4Q6Y","CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)","10.1016/J.JMB.2014.07.006 ",3,0,"4q6y_oligo11","DGalpb1-4DGlcpNAcb1-2DManpx1-","GAL(6_H_)-NAG(5_H_)-MAN(4_H_)",88.9836,"","",""
"4Q6Y","CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)","10.1016/J.JMB.2014.07.006 ",3,0,"4q6y_oligo3","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","SIA(7_F_)-GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",63.3129,"","",""
"4Q6Y","CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)","10.1016/J.JMB.2014.07.006 ",3,0,"4q6y_oligo8","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpx1-","GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-BMA(3_G_)",81.3295,"","",""
"4Q6Y","CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)","10.1016/J.JMB.2014.07.006 ",3,0,"4q6y_oligo6","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcx1-","NAG(7_E_)-MAN(6_E_)-BMA(3_E_)-NAG(2_E_)",90.6542,"","",""
"4Q6Y","CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)","10.1016/J.JMB.2014.07.006 ",3,0,"4q6y_oligo9","DGlcpNAcb1-2DManpx1-","NAG(9_G_)-MAN(8_G_)",102.795,"","",""
"4Q74","F241A FC","10.1016/J.JMB.2014.07.006 ",2.19,0,"4q74_oligo6","DGlcpNAcb1-2DManpx1-","NAG(8_D_)-MAN(7_D_)",70.1518,"","",""
"4Q74","F241A FC","10.1016/J.JMB.2014.07.006 ",2.19,0,"4q74_oligo4","DGalpb1-4DGlcpNAcb1-2DManpx1-","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)",57.2407,"","",""
"4Q74","F241A FC","10.1016/J.JMB.2014.07.006 ",2.19,0,"4q74_oligo5","DGalpb1-4DGlcpNAcb1-2DManpx1-","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)",66.8812,"","",""
"4Q7D","WILD TYPE FC (WTFC)","10.1016/J.JMB.2014.07.006 ",2.35,0,"4q7d_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",69.09,"","",""
"4Q7D","WILD TYPE FC (WTFC)","10.1016/J.JMB.2014.07.006 ",2.35,0,"4q7d_oligo2","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(8_C_)-[NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",52.2443,"","",""
"4QGT","THE CRYSTAL STRUCTURE OF HUMAN IGG FC DOMAIN WITH ENHANCED AROMATIC SEQUON","10.1021/ACSCHEMBIO.5B01035 ",2.99,0,"4qgt_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",101.025,"","",""
"4QGT","THE CRYSTAL STRUCTURE OF HUMAN IGG FC DOMAIN WITH ENHANCED AROMATIC SEQUON","10.1021/ACSCHEMBIO.5B01035 ",2.99,0,"4qgt_oligo1","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",245.651,"","",""
"4RGA","PHAGE 1358 RECEPTOR BINDING PROTEIN IN COMPLEX WITH THE TRISACCHARIDE GLCNAC-GALF-GLCOME","10.1111/MMI.12978 ",2.1,47.57,"4rga_oligo2","DGlcpNAcb1-2DGalfb1-6DGlcpa1-OME","NAG(3_D_)-GZL(2_D_)-GYP(1_D_)",61.1312,"","",""
"4RGA","PHAGE 1358 RECEPTOR BINDING PROTEIN IN COMPLEX WITH THE TRISACCHARIDE GLCNAC-GALF-GLCOME","10.1111/MMI.12978 ",2.1,47.57,"4rga_oligo1","DGlcpNAcb1-2DGalfb1-6DGlcpa1-OME","NAG(3_C_)-GZL(2_C_)-GYP(1_C_)",58.1023,"","",""
"4TW0","CRYSTAL STRUCTURE OF SCARB2 IN ACIDIC CONDITION (PH4.8)","10.1007/S13238-014-0087-3 ",3.65,60.28,"4tw0_oligo5","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_P_)-MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(412_C_)",80.1247,"","",""
"4TW0","CRYSTAL STRUCTURE OF SCARB2 IN ACIDIC CONDITION (PH4.8)","10.1007/S13238-014-0087-3 ",3.65,60.28,"4tw0_oligo17","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_U_)-MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(412_D_)",82.5742,"","",""
"4TW0","CRYSTAL STRUCTURE OF SCARB2 IN ACIDIC CONDITION (PH4.8)","10.1007/S13238-014-0087-3 ",3.65,60.28,"4tw0_oligo12","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_K_)-MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(412_B_)",82.1698,"","",""
"4TW0","CRYSTAL STRUCTURE OF SCARB2 IN ACIDIC CONDITION (PH4.8)","10.1007/S13238-014-0087-3 ",3.65,60.28,"4tw0_oligo7","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(412_A_)",79.772,"","",""
"4UO5","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",2.7,72.05,"4uo5_oligo3","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(5_O_)-MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)",140.111,"","",""
"4UO8","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-3SLN","10.1073/PNAS.1406606111 ",3,83.04,"4uo8_oligo2","DManpb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(285_A_)",139.408,"","",""
"4W4N","CRYSTAL STRUCTURE OF HUMAN FC AT 1.80 A","10.1038/NCOMMS7866 ",1.8,43.23,"4w4n_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",61.1245,"","",""
"4W4N","CRYSTAL STRUCTURE OF HUMAN FC AT 1.80 A","10.1038/NCOMMS7866 ",1.8,43.23,"4w4n_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",31.415,"","",""
"4W4O","HIGH-RESOLUTION CRYSTAL STRUCTURE OF FC BOUND TO ITS HUMAN RECEPTOR FC-GAMMA-RI","10.1038/NCOMMS7866 ",1.8,42.26,"4w4o_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",54.0719,"","",""
"4W4O","HIGH-RESOLUTION CRYSTAL STRUCTURE OF FC BOUND TO ITS HUMAN RECEPTOR FC-GAMMA-RI","10.1038/NCOMMS7866 ",1.8,42.26,"4w4o_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",47.3679,"","",""
"4W88","CRYSTAL STRUCTURE OF XEG5A, A GH5 XYLOGLUCAN-SPECIFIC ENDO-BETA-1,4- GLUCANASE FROM RUMINAL METAGENOMIC LIBRARY, IN COMPLEX WITH A XYLOGLUCAN OLIGOSACCHARIDE AND TRIS","10.1021/ACS.BIOCHEM.5B00011 ",1.58,24.74,"4w88_oligo1","DGalpb1-2DXylpa1-6[DGlcpb1-4]DGlcpb1-ROH","GAL(3_C_)-XYS(2_C_)-[BGC(4_C_)]-BGC(1_C_)",41.3732,"","",""
"4W88","CRYSTAL STRUCTURE OF XEG5A, A GH5 XYLOGLUCAN-SPECIFIC ENDO-BETA-1,4- GLUCANASE FROM RUMINAL METAGENOMIC LIBRARY, IN COMPLEX WITH A XYLOGLUCAN OLIGOSACCHARIDE AND TRIS","10.1021/ACS.BIOCHEM.5B00011 ",1.58,24.74,"4w88_oligo2","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(6_D_)-XYS(5_D_)-[XYS(4_D_)-BGC(3_D_)]-BGC(2_D_)-BGC(1_D_)",44.1751,"","",""
"4W8B","CRYSTAL STRUCTURE OF XEG5B, A GH5 XYLOGLUCAN-SPECIFIC BETA-1,4- GLUCANASE FROM RUMINAL METAGENOMIC LIBRARY, IN COMPLEX WITH XXLG","10.1021/ACS.BIOCHEM.5B00011 ",1.15,9.96,"4w8b_oligo2","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DXylpa1-ROH","GAL(8_B_)-XYS(7_B_)-[XYS(6_B_)-[XYS(5_B_)-BGC(4_B_)]-BGC(3_B_)]-BGC(2_B_)-GLC(1_B_)",14.0792,"","",""
"4WI2","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC (WILD-TYPE)","",1.9,0,"4wi2_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.86,"","",""
"4WI2","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC (WILD-TYPE)","",1.9,0,"4wi2_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",92.3777,"","",""
"4WI3","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A","",2.7,0,"4wi3_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",161.436,"","",""
"4WI3","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A","",2.7,0,"4wi3_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",160.251,"","",""
"4WI4","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION S254A","",2.8,0,"4wi4_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",134.939,"","",""
"4WI4","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION S254A","",2.8,0,"4wi4_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",150.74,"","",""
"4WI5","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H310A","",2.8,0,"4wi5_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",182.481,"","",""
"4WI5","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H310A","",2.8,0,"4wi5_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",178.87,"","",""
"4WI6","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION N434A","",2.2,0,"4wi6_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",72.1728,"","",""
"4WI6","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION N434A","",2.2,0,"4wi6_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",102.249,"","",""
"4WI7","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H435A","",1.9,0,"4wi7_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",69.8317,"","",""
"4WI7","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H435A","",1.9,0,"4wi7_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",57.2102,"","",""
"4WI8","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION Y436A","",2.8,0,"4wi8_oligo3","DGlcpNAcb1-2DManpx1-","NAG(2_E_)-BMA(1_E_)",104.677,"","",""
"4WI8","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION Y436A","",2.8,0,"4wi8_oligo1","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(6_D_)-[NAG(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",144.051,"","",""
"4WI8","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION Y436A","",2.8,0,"4wi8_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",87.8138,"","",""
"4WI9","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A/H310A","",2.65,0,"4wi9_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",131.71,"","",""
"4WI9","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A/H310A","",2.65,0,"4wi9_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcx1-","NAG(6_D_)-MAN(5_D_)-[NAG(4_D_)-MAN(3_D_)]-BMA(2_D_)-NAG(1_D_)",125.241,"","",""
"4X1H","OPSIN/G(ALPHA) PEPTIDE COMPLEX STABILIZED BY NONYL-GLUCOSIDE","10.1016/J.STR.2015.09.015 ",2.29,0,"4x1h_oligo1","DManpb1-2DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",80.6723,"","",""
"4X4K","STRUCTURE OF LACCASE FROM BOTRYTIS ACLADA WITH FULL COPPER CONTENT","10.1107/S2053230X1502052X ",2.3,39.24,"4x4k_oligo1","DManpb1-2DManpb1-6DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(194_A_)",70.1142,"","",""
"4X4M","STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING","10.1073/PNAS.1418812112 ",3.49,0,"4x4m_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(6_J_)-MAN(5_J_)-[NAG(4_J_)-MAN(3_J_)]-BMA(2_J_)-NAG(1_J_)-NAG(1001_D_)-ASN(297_D_)",186.422,"","",""
"4X4M","STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING","10.1073/PNAS.1418812112 ",3.49,0,"4x4m_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_I_)-[GAL(6_I_)-NAG(5_I_)-MAN(4_I_)-[NAG(8_I_)-MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_C_)",145.232,"","",""
"4X4M","STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING","10.1073/PNAS.1418812112 ",3.49,0,"4x4m_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",122.935,"","",""
"4X4M","STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING","10.1073/PNAS.1418812112 ",3.49,0,"4x4m_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_H_)-[NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",152.959,"","",""
"4X98","IMMUNOGLOBULIN FC HETERODIMER VARIANT","10.1016/J.MOLIMM.2015.02.017 ",2.5,0,"4x98_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",98.6668,"","",""
"4X98","IMMUNOGLOBULIN FC HETERODIMER VARIANT","10.1016/J.MOLIMM.2015.02.017 ",2.5,0,"4x98_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.2932,"","",""
"4X99","IMMUNOGLOBULIN FC HETERODIMERS VARIANT","10.1016/J.MOLIMM.2015.02.017 ",2.5,0,"4x99_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",62.246,"","",""
"4X99","IMMUNOGLOBULIN FC HETERODIMERS VARIANT","10.1016/J.MOLIMM.2015.02.017 ",2.5,0,"4x99_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",105.177,"","",""
"4Z8S","STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD)-NATIVE-1","10.1007/S12038-015-9573-X ",2.36,28.97,"4z8s_oligo2","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)-ASN(114_B_)",42.7549,"","",""
"4ZET","BLOOD DENDRITIC CELL ANTIGEN 2 (BDCA-2) COMPLEXED WITH GALGLCNACMAN","10.1074/JBC.M115.660613 ",2.9,32.12,"4zet_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-ROH","GAL(3_D_)-NAG(2_D_)-MAN(1_D_)",42.1464,"","",""
"4ZET","BLOOD DENDRITIC CELL ANTIGEN 2 (BDCA-2) COMPLEXED WITH GALGLCNACMAN","10.1074/JBC.M115.660613 ",2.9,32.12,"4zet_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-ROH","GAL(3_C_)-NAG(2_C_)-MAN(1_C_)",21.5476,"","",""
"4ZFU","STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH N-ACETYL D GALACTOSAMINE","10.1007/S12038-015-9573-X ",2.53,23.74,"4zfu_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)-ASN(114_B_)",52.245,"","",""
"4ZFW","STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH GALACTOSE.","10.1007/S12038-015-9573-X ",2.54,24.24,"4zfw_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)",52.3271,"","",""
"4ZGR","STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH T-ANTIGEN.","10.1007/S12038-015-9573-X ",1.97,28.77,"4zgr_oligo4","DXylpb1-2DManpb1-4DGlcpNAcx1-","XYP(309_B_)-BMA(2_F_)-NAG(1_F_)",64.1038,"","",""
"4ZLB","STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH LACTOSE","10.1007/S12038-015-9573-X ",2.55,31.36,"4zlb_oligo1","DXylpb1-2DManpb1-4DGlcpNAcx1-","XYP(307_B_)-BMA(2_E_)-NAG(1_E_)",49.0354,"","",""
"4ZNE","IGG1 FC-FCGAMMARI ECD COMPLEX","10.1107/S1399004715018015 ",2.42,34.24,"4zne_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_J_)",72.298,"","",""
"4ZNE","IGG1 FC-FCGAMMARI ECD COMPLEX","10.1107/S1399004715018015 ",2.42,34.24,"4zne_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-MAN(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_E_)",63.5537,"","",""
"4ZO8","CRYSTAL STRUCTURE OF MUTANT (D270A) BETA-GLUCOSIDASE FROM LISTERIA INNOCUA IN COMPLEX WITH SOPHOROSE","10.1371/JOURNAL.PONE.0148870 ",2,17.76,"4zo8_oligo2","DGlcpb1-2DGlcpb1-ROH","BGC(2_D_)-BGC(1_D_)",18.3145,"","",""
"4ZO8","CRYSTAL STRUCTURE OF MUTANT (D270A) BETA-GLUCOSIDASE FROM LISTERIA INNOCUA IN COMPLEX WITH SOPHOROSE","10.1371/JOURNAL.PONE.0148870 ",2,17.76,"4zo8_oligo1","DGlcpb1-2DGlcpb1-ROH","BGC(2_C_)-BGC(1_C_)",11.9386,"","",""
"4ZXB","STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN, IRDELTABETA CONSTRUCT, IN COMPLEX WITH FOUR FAB MOLECULES","10.1016/J.STR.2015.12.014 ",3.3,134.1,"4zxb_oligo4","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[NAG(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(397_E_)",181.128,"","",""
"5AOG","STRUCTURE OF SORGHUM PEROXIDASE","10.1007/S00775-015-1313-Z ",1.27,27.05,"5aog_oligo2","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_C_)-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)-ASN(234_A_)",33.715,"","",""
"5AV7","CRYSTAL STRUCTURE OF CALSEPA LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",1.85,23.1,"5av7_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpa1-OME","NAG(5_F_)-MAN(4_F_)-[NAG(6_F_)]-[NAG(3_F_)-MAN(2_F_)]-MMA(1_F_)",26.8536,"","",""
"5AV7","CRYSTAL STRUCTURE OF CALSEPA LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",1.85,23.1,"5av7_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpa1-OME","NAG(5_E_)-MAN(4_E_)-[NAG(6_E_)]-[NAG(3_E_)-MAN(2_E_)]-MMA(1_E_)",27.2962,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_I_)-NAG(4_I_)-MAN(3_I_)-[NAG(8_I_)]-[NAG(7_I_)-MAN(6_I_)]-BMA(2_I_)-NAG(1_I_)",45.0045,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_N_)-NAG(4_N_)-MAN(3_N_)-[NAG(8_N_)]-[NAG(7_N_)-MAN(6_N_)]-BMA(2_N_)-NAG(1_N_)",65.7048,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_J_)-NAG(4_J_)-MAN(3_J_)-[NAG(8_J_)]-[NAG(7_J_)-MAN(6_J_)]-BMA(2_J_)-NAG(1_J_)",44.5369,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo8","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_P_)-NAG(4_P_)-MAN(3_P_)-[NAG(8_P_)]-[NAG(7_P_)-MAN(6_P_)]-BMA(2_P_)-NAG(1_P_)",79.072,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo7","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_O_)-NAG(4_O_)-MAN(3_O_)-[NAG(8_O_)]-[NAG(7_O_)-MAN(6_O_)]-BMA(2_O_)-NAG(1_O_)",67.8809,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo5","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_M_)-NAG(4_M_)-MAN(3_M_)-[NAG(8_M_)]-[NAG(7_M_)-MAN(6_M_)]-BMA(2_M_)-NAG(1_M_)",54.1475,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_K_)-NAG(4_K_)-MAN(3_K_)-[NAG(8_K_)]-[NAG(7_K_)-MAN(6_K_)]-BMA(2_K_)-NAG(1_K_)",56.6309,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_L_)-NAG(4_L_)-MAN(3_L_)-[NAG(8_L_)]-[NAG(7_L_)-MAN(6_L_)]-BMA(2_L_)-NAG(1_L_)",56.638,"","",""
"5B0R","BETA-1,2-MANNOBIOSE PHOSPHORYLASE FROM LISTERIA INNOCUA - BETA-1,2- MANNOBIOSE COMPLEX","10.1016/J.FEBSLET.2015.11.034 ",1.8,29.42,"5b0r_oligo4","DManpb1-2DManpb1-ROH","BMA(2_D_)-BMA(1_D_)",21.0914,"","",""
"5B0R","BETA-1,2-MANNOBIOSE PHOSPHORYLASE FROM LISTERIA INNOCUA - BETA-1,2- MANNOBIOSE COMPLEX","10.1016/J.FEBSLET.2015.11.034 ",1.8,29.42,"5b0r_oligo3","DManpb1-2DManpb1-ROH","BMA(2_C_)-BMA(1_C_)",19.0145,"","",""
"5B0S","BETA-1,2-MANNOBIOSE PHOSPHORYLASE FROM LISTERIA INNOCUA - BETA-1,2- MANNOTRIOSE COMPLEX","10.1016/J.FEBSLET.2015.11.034 ",2.1,39.36,"5b0s_oligo4","DManpb1-2DManpb1-2DManpa1-ROH","BMA(3_C_)-BMA(2_C_)-MAN(1_C_)",35.83,"","",""
"5B0S","BETA-1,2-MANNOBIOSE PHOSPHORYLASE FROM LISTERIA INNOCUA - BETA-1,2- MANNOTRIOSE COMPLEX","10.1016/J.FEBSLET.2015.11.034 ",2.1,39.36,"5b0s_oligo5","DManpb1-2DManpb1-2DManpa1-ROH","BMA(3_D_)-BMA(2_D_)-MAN(1_D_)",37.5376,"","",""
"5B1X","CRYSTAL STRUCTURE OF HUMAN DENDRITIC CELL INHIBITORY RECEPTOR (DCIR) C-TYPE LECTIN DOMAIN IN COMPLEX WITH BIANTENNARY GLYCAN","10.1002/1873-3468.12162 ",2.9,0,"5b1x_oligo1","DGlcpNAcb1-2DManpa1-ROH","NAG(2_F_)-MAN(1_F_)",13.6145,"","",""
"5B1X","CRYSTAL STRUCTURE OF HUMAN DENDRITIC CELL INHIBITORY RECEPTOR (DCIR) C-TYPE LECTIN DOMAIN IN COMPLEX WITH BIANTENNARY GLYCAN","10.1002/1873-3468.12162 ",2.9,0,"5b1x_oligo3","DGlcpNAcb1-2DManpa1-ROH","NAG(2_G_)-MAN(1_G_)",12.9345,"","",""
"5B1X","CRYSTAL STRUCTURE OF HUMAN DENDRITIC CELL INHIBITORY RECEPTOR (DCIR) C-TYPE LECTIN DOMAIN IN COMPLEX WITH BIANTENNARY GLYCAN","10.1002/1873-3468.12162 ",2.9,0,"5b1x_oligo2","DGlcpNAcb1-2DManpa1-ROH","NAG(2_E_)-MAN(1_E_)",13.4582,"","",""
"5B1X","CRYSTAL STRUCTURE OF HUMAN DENDRITIC CELL INHIBITORY RECEPTOR (DCIR) C-TYPE LECTIN DOMAIN IN COMPLEX WITH BIANTENNARY GLYCAN","10.1002/1873-3468.12162 ",2.9,0,"5b1x_oligo4","DGlcpNAcb1-2DManpa1-ROH","NAG(2_H_)-MAN(1_H_)",12.3491,"","",""
"5BW7","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1371/JOURNAL.PONE.0140120 ",3,62.43,"5bw7_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",72.0614,"","",""
"5BW7","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1371/JOURNAL.PONE.0140120 ",3,62.43,"5bw7_oligo4","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_G_)-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(45_C_)",126.292,"","",""
"5BW7","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1371/JOURNAL.PONE.0140120 ",3,62.43,"5bw7_oligo3","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_F_)-[NAG(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(162_C_)",93.4722,"","",""
"5BW7","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1371/JOURNAL.PONE.0140120 ",3,62.43,"5bw7_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",77.391,"","",""
"5D4Q","CRYSTAL STRUCTURE OF GASDALIE IGG1 FC","10.1016/J.JSB.2016.02.001 ",2.39,0,"5d4q_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",99.5748,"","",""
"5D4Q","CRYSTAL STRUCTURE OF GASDALIE IGG1 FC","10.1016/J.JSB.2016.02.001 ",2.39,0,"5d4q_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",72.2706,"","",""
"5D6D","CRYSTAL STRUCTURE OF GASDALIE IGG1 FC IN COMPLEX WITH FCGRIIIA","10.1016/J.JSB.2016.02.001 ",3.13,0,"5d6d_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",49.7178,"","",""
"5D6D","CRYSTAL STRUCTURE OF GASDALIE IGG1 FC IN COMPLEX WITH FCGRIIIA","10.1016/J.JSB.2016.02.001 ",3.13,0,"5d6d_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",56.2964,"","",""
"5DI8","FC KNOB-HOLE HETERODIMER T366W + T366S/L368A/Y407V","10.1016/J.STR.2016.02.013 ",1.9,32.81,"5di8_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",42.6784,"","",""
"5DI8","FC KNOB-HOLE HETERODIMER T366W + T366S/L368A/Y407V","10.1016/J.STR.2016.02.013 ",1.9,32.81,"5di8_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",48.1348,"","",""
"5DJ0","FC HETERODIMER DESIGN 11.2 Y349S/K370Y + E357D/S364Q","10.1016/J.STR.2016.02.013 ",2.28,35.83,"5dj0_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",56.1274,"","",""
"5DJ0","FC HETERODIMER DESIGN 11.2 Y349S/K370Y + E357D/S364Q","10.1016/J.STR.2016.02.013 ",2.28,35.83,"5dj0_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",52.1898,"","",""
"5DJ2","FC HETERODIMER DESIGN 7.4 Y407A + T366V/K409V","10.1016/J.STR.2016.02.013 ",2.56,33.38,"5dj2_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",53.9367,"","",""
"5DJ2","FC HETERODIMER DESIGN 7.4 Y407A + T366V/K409V","10.1016/J.STR.2016.02.013 ",2.56,33.38,"5dj2_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",49.7502,"","",""
"5DJ6","FC HETERODIMER DESIGN 6.1 F405W/Y407A + T366M","10.1016/J.STR.2016.02.013 ",2,33.23,"5dj6_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",48.6548,"","",""
"5DJ6","FC HETERODIMER DESIGN 6.1 F405W/Y407A + T366M","10.1016/J.STR.2016.02.013 ",2,33.23,"5dj6_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",44.8356,"","",""
"5DJ8","FC HETERODIMER DESIGN 7.7 D399M/Y407A + T366V/K409I","10.1016/J.STR.2016.02.013 ",2.4,35.3,"5dj8_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",53.3258,"","",""
"5DJ8","FC HETERODIMER DESIGN 7.7 D399M/Y407A + T366V/K409I","10.1016/J.STR.2016.02.013 ",2.4,35.3,"5dj8_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",49.2726,"","",""
"5DJA","FC HETERODIMER DESIGN 9.1 Y407M + T366I","10.1016/J.STR.2016.02.013 ",2.9,36.93,"5dja_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",51.2286,"","",""
"5DJA","FC HETERODIMER DESIGN 9.1 Y407M + T366I","10.1016/J.STR.2016.02.013 ",2.9,36.93,"5dja_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",55.4084,"","",""
"5DJC","FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F","10.1016/J.STR.2016.02.013 ",2.1,43.67,"5djc_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_I_)-[GAL(6_I_)-NAG(5_I_)-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_D_)",47.2822,"","",""
"5DJC","FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F","10.1016/J.STR.2016.02.013 ",2.1,43.67,"5djc_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",49.1042,"","",""
"5DJC","FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F","10.1016/J.STR.2016.02.013 ",2.1,43.67,"5djc_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",66.0385,"","",""
"5DJC","FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F","10.1016/J.STR.2016.02.013 ",2.1,43.67,"5djc_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_J_)-[GAL(6_J_)-NAG(5_J_)-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(297_E_)",65.4632,"","",""
"5DJD","FC HETERODIMER DESIGN 5.1 T366V + Y407F","10.1016/J.STR.2016.02.013 ",2.3,37.32,"5djd_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",59.0298,"","",""
"5DJD","FC HETERODIMER DESIGN 5.1 T366V + Y407F","10.1016/J.STR.2016.02.013 ",2.3,37.32,"5djd_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",54.7122,"","",""
"5DJX","FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G","10.1016/J.STR.2016.02.013 ",2.25,27.74,"5djx_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_J_)-[GAL(6_J_)-NAG(5_J_)-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(297_E_)",50.4009,"","",""
"5DJX","FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G","10.1016/J.STR.2016.02.013 ",2.25,27.74,"5djx_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_I_)-[GAL(6_I_)-NAG(5_I_)-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_D_)",37.675,"","",""
"5DJX","FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G","10.1016/J.STR.2016.02.013 ",2.25,27.74,"5djx_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",59.0361,"","",""
"5DJX","FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G","10.1016/J.STR.2016.02.013 ",2.25,27.74,"5djx_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",41.2795,"","",""
"5DJY","FC HETERODIMER DESIGN 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A","10.1016/J.STR.2016.02.013 ",2.15,36.44,"5djy_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",51.116,"","",""
"5DJY","FC HETERODIMER DESIGN 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A","10.1016/J.STR.2016.02.013 ",2.15,36.44,"5djy_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",47.1226,"","",""
"5DJZ","FC HETERODIMER DESIGN 7.8 D399M/Y407A + T366V/K409V","10.1016/J.STR.2016.02.013 ",1.9,35.23,"5djz_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",44.7762,"","",""
"5DK0","FC HETERODIMER DESIGN 20.8.34 Y349S/T366M/K370Y/K409V + E356G/E357D/S364Q/Y407A","10.1016/J.STR.2016.02.013 ",2.3,46.09,"5dk0_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",55.3636,"","",""
"5DK0","FC HETERODIMER DESIGN 20.8.34 Y349S/T366M/K370Y/K409V + E356G/E357D/S364Q/Y407A","10.1016/J.STR.2016.02.013 ",2.3,46.09,"5dk0_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",65.5225,"","",""
"5DK2","FC HETERODIMER E356K/D399K + K392D/K409D","10.1016/J.STR.2016.02.013 ",2.6,52.12,"5dk2_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(297_E_)",97.8827,"","",""
"5DK2","FC HETERODIMER E356K/D399K + K392D/K409D","10.1016/J.STR.2016.02.013 ",2.6,52.12,"5dk2_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_A_)",54.0703,"","",""
"5DK2","FC HETERODIMER E356K/D399K + K392D/K409D","10.1016/J.STR.2016.02.013 ",2.6,52.12,"5dk2_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_B_)",51.3615,"","",""
"5DK3","CRYSTAL STRUCTURE OF PEMBROLIZUMAB, A FULL LENGTH IGG4 ANTIBODY","10.1038/NSMB.3129 ",2.28,64.17,"5dk3_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",101.243,"","",""
"5DK3","CRYSTAL STRUCTURE OF PEMBROLIZUMAB, A FULL LENGTH IGG4 ANTIBODY","10.1038/NSMB.3129 ",2.28,64.17,"5dk3_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_D_)-[NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_G_)",88.2457,"","",""
"5E8E","CRYSTAL STRUCTURE OF THROMBIN BOUND TO AN EXOSITE 1-SPECIFIC IGA FAB","10.1111/JTH.13171 ",1.9,35.11,"5e8e_oligo4","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_D_)-GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(373_H_)",72.9396,"","",""
"5EZI","CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - HEXAGONAL FORM","10.7554/ELIFE.20383 ",1.61,0,"5ezi_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_A_)-[NAG(8_A_)-MAN(7_A_)-[GAL(6_A_)-NAG(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(33_H_)",63.5516,"","",""
"5FKS","UNRAVELING THE FIRST STEP OF XYLOGLUCAN DEGRADATION BY THE SOIL SAPROPHYTE CELLVIBRIO JAPONICUS THROUGH THE FUNCTIONAL AND STRUCTURAL CHARACTERIZATION OF A POTENT GH74 ENDO-XYLOGLUCANASE","10.1111/FEBS.13696 ",1.99,0,"5fks_oligo1","DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(7_B_)-XYS(6_B_)-[XYS(5_B_)-[BGC(4_B_)]-BGC(3_B_)]-BGC(2_B_)-BGC(1_B_)",21.2905,"","",""
"5FKS","UNRAVELING THE FIRST STEP OF XYLOGLUCAN DEGRADATION BY THE SOIL SAPROPHYTE CELLVIBRIO JAPONICUS THROUGH THE FUNCTIONAL AND STRUCTURAL CHARACTERIZATION OF A POTENT GH74 ENDO-XYLOGLUCANASE","10.1111/FEBS.13696 ",1.99,0,"5fks_oligo2","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(9_C_)-XYS(8_C_)-[GAL(7_C_)-XYS(6_C_)-[XYS(5_C_)-BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-BGC(1_C_)",27.5899,"","",""
"5FMB","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HEPES BUFFER","10.1074/JBC.M115.708495 ",1.91,27.27,"5fmb_oligo33","DManpb1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[BMA(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",48.5129,"","",""
"5FMC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND BIS-TRIS PROPANE BUFFER","10.1074/JBC.M115.708495 ",1.84,25.2,"5fmc_oligo30","DManpb1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",45.3161,"","",""
"5FMD","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NYSTOSE","10.1074/JBC.M115.708495 ",1.78,25.93,"5fmd_oligo35","DManpb1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[BMA(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",43.8558,"","",""
"5G61","S.PNEUMONIAE ABC-TRANSPORTER SUBSTRATE BINDING PROTEIN FUSA IN COMPLEX WITH FRUCTO-NYSTOSE","10.1016/J.STR.2016.11.008 ",2.4,34,"5g61_oligo1","LTalp[2<R1>]b2-1DSorfb","ZEE(1_E_)-UEA(2_E_)",109.664,"","",""
"5G61","S.PNEUMONIAE ABC-TRANSPORTER SUBSTRATE BINDING PROTEIN FUSA IN COMPLEX WITH FRUCTO-NYSTOSE","10.1016/J.STR.2016.11.008 ",2.4,34,"5g61_oligo5","LTalpb2-1DSorfb","ZEE(1_F_)-UEA(2_F_)",67.3765,"","",""
"5G61","S.PNEUMONIAE ABC-TRANSPORTER SUBSTRATE BINDING PROTEIN FUSA IN COMPLEX WITH FRUCTO-NYSTOSE","10.1016/J.STR.2016.11.008 ",2.4,34,"5g61_oligo13","LTalpb2-1DSorfb","ZEE(1_H_)-UEA(2_H_)",109.664,"","",""
"5G61","S.PNEUMONIAE ABC-TRANSPORTER SUBSTRATE BINDING PROTEIN FUSA IN COMPLEX WITH FRUCTO-NYSTOSE","10.1016/J.STR.2016.11.008 ",2.4,34,"5g61_oligo9","LTalpb2-1DSorfb","ZEE(1_G_)-UEA(2_G_)",72.0327,"","",""
"5G62","S.PNEUMONIAE ABC-TRANSPORTER SUBSTRATE BINDING PROTEIN FUSA EF-HAND MUTANT IN COMPLEX WITH FRUCTO-NYSTOSE","10.1016/J.STR.2016.11.008 ",1.99,0,"5g62_oligo2","LTalpb2-1DSorfb","ZEE(1_C_)-UEA(2_C_)",109.664,"","",""
"5GGP","CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN PROTEIN O-MANNOSE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE IN COMPLEX WITH GLCNAC- BETA1,2-MAN-PEPTIDE","10.1073/PNAS.1525545113 ",1.6,0,"5ggp_oligo2","DGlcpNAcb1-2DManpa1-THR","NAG(2_F_)-MAN(1_F_)-THR(4_D_)",14.5964,"","",""
"5GGP","CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN PROTEIN O-MANNOSE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE IN COMPLEX WITH GLCNAC- BETA1,2-MAN-PEPTIDE","10.1073/PNAS.1525545113 ",1.6,0,"5ggp_oligo1","DGlcpNAcb1-2DManpa1-THR","NAG(2_E_)-MAN(1_E_)-THR(4_C_)",15.4832,"","",""
"5GSQ","CRYSTAL STRUCTURE OF IGG FC WITH A HOMOGENEOUS GLYCOFORM AND ANTIBODY- DEPENDENT CELLULAR CYTOTOXICITY","10.1021/ACSCHEMBIO.7B00140 ",1.85,28.21,"5gsq_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_A_)",29.2103,"","",""
"5GSQ","CRYSTAL STRUCTURE OF IGG FC WITH A HOMOGENEOUS GLYCOFORM AND ANTIBODY- DEPENDENT CELLULAR CYTOTOXICITY","10.1021/ACSCHEMBIO.7B00140 ",1.85,28.21,"5gsq_oligo3","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_G_)-GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[MAN(8_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(297_C_)",33.4821,"","",""
"5GSQ","CRYSTAL STRUCTURE OF IGG FC WITH A HOMOGENEOUS GLYCOFORM AND ANTIBODY- DEPENDENT CELLULAR CYTOTOXICITY","10.1021/ACSCHEMBIO.7B00140 ",1.85,28.21,"5gsq_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(297_B_)",34.3694,"","",""
"5GZK","ENDO-BETA-1,2-GLUCANASE FROM CHITINOPHAGA PINENSIS - SOPHOROTRIOSE AND GLUCOSE COMPLEX","10.1074/JBC.M116.762724 ",1.7,18.85,"5gzk_oligo2","DGlcpb1-2DGlcpb1-2DGlcpb1-ROH","BGC(3_D_)-BGC(2_D_)-BGC(1_D_)",28.0194,"","",""
"5GZK","ENDO-BETA-1,2-GLUCANASE FROM CHITINOPHAGA PINENSIS - SOPHOROTRIOSE AND GLUCOSE COMPLEX","10.1074/JBC.M116.762724 ",1.7,18.85,"5gzk_oligo1","DGlcpb1-2DGlcpb1-2DGlcpb1-ROH","BGC(3_C_)-BGC(2_C_)-BGC(1_C_)",30.2839,"","",""
"5H40","CRYSTAL STRUCTURE OF 1,2-BETA-OLIGOGLUCAN PHOSPHORYLASE FROM LACHNOCLOSTRIDIUM PHYTOFERMENTANS IN COMPLEX WITH SOPHOROSE","10.1038/SREP42671 ",2.2,27.7,"5h40_oligo2","DGlcpb1-2DGlcpb1-ROH","BGC(2_C_)-BGC(1_C_)",18.7445,"","",""
"5H40","CRYSTAL STRUCTURE OF 1,2-BETA-OLIGOGLUCAN PHOSPHORYLASE FROM LACHNOCLOSTRIDIUM PHYTOFERMENTANS IN COMPLEX WITH SOPHOROSE","10.1038/SREP42671 ",2.2,27.7,"5h40_oligo1","DGlcpb1-2DGlcpb1-ROH","BGC(2_D_)-BGC(1_D_)",22.2009,"","",""
"5H41","CRYSTAL STRUCTURE OF 1,2-BETA-OLIGOGLUCAN PHOSPHORYLASE FROM LACHNOCLOSTRIDIUM PHYTOFERMENTANS IN COMPLEX WITH SOPHOROSE, ISOFAGOMINE, SULFATE ION","10.1038/SREP42671 ",2,27.38,"5h41_oligo4","DGlcpb1-2DGlcpa1-ROH","BGC(2_D_)-GLC(1_D_)",26.7536,"","",""
"5H41","CRYSTAL STRUCTURE OF 1,2-BETA-OLIGOGLUCAN PHOSPHORYLASE FROM LACHNOCLOSTRIDIUM PHYTOFERMENTANS IN COMPLEX WITH SOPHOROSE, ISOFAGOMINE, SULFATE ION","10.1038/SREP42671 ",2,27.38,"5h41_oligo3","DGlcpb1-2DGlcpa1-ROH","BGC(2_C_)-GLC(1_C_)",26.96,"","",""
"5HVW","MONOMERIC IGG4 FC","10.1371/JOURNAL.PONE.0160345 ",1.95,66.13,"5hvw_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",103.175,"","",""
"5HY9","GLYCOSYLATED, DISULFIDE-LINKED KNOB-INTO-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.7,92.03,"5hy9_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-BMA(4_C_)-[NAG(8_C_)-BMA(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",47.8242,"","",""
"5HY9","GLYCOSYLATED, DISULFIDE-LINKED KNOB-INTO-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.7,92.03,"5hy9_oligo2","DGlcpNAcb1-2DManpb1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[NAG(5_D_)-BMA(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",94.4974,"","",""
"5HYE","GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P212121)","10.1093/PROTEIN/GZX041 ",1.89,62.68,"5hye_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_B_)-[GAL(6_B_)-NAG(5_B_)-BMA(4_B_)-[NAG(8_B_)-BMA(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",49.8034,"","",""
"5HYE","GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P212121)","10.1093/PROTEIN/GZX041 ",1.89,62.68,"5hye_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-BMA(4_D_)-[NAG(8_D_)-BMA(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_C_)",109.557,"","",""
"5HYF","GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P6122)","10.1093/PROTEIN/GZX041 ",1.8,39.51,"5hyf_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_B_)-[GAL(6_B_)-NAG(5_B_)-BMA(4_B_)-[NAG(8_B_)-BMA(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",54.3523,"","",""
"5HYI","GLYCOSYLATED, DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.9,95.59,"5hyi_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",115.86,"","",""
"5HYI","GLYCOSYLATED, DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.9,95.59,"5hyi_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[NAG(8_G_)-MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_C_)",134.99,"","",""
"5HYI","GLYCOSYLATED, DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.9,95.59,"5hyi_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[NAG(8_H_)-MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_D_)",118.569,"","",""
"5HYI","GLYCOSYLATED, DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.9,95.59,"5hyi_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[NAG(8_F_)-MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",132.336,"","",""
"5IW3","ANTI-CD20 MONOCLONAL ANTIBODY FC FRAGMENT","",2.05,26.87,"5iw3_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(320_A_)",41.8844,"","",""
"5IW6","ANTI-CD20 MONOCLONAL ANTIBODY FC FRAGMENT","",2.34,58.38,"5iw6_oligo2","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-BMA(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(320_B_)",98.8407,"","",""
"5IW6","ANTI-CD20 MONOCLONAL ANTIBODY FC FRAGMENT","",2.34,58.38,"5iw6_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-BMA(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(320_A_)",85.8538,"","",""
"5J3H","HUMAN INSULIN RECEPTOR DOMAINS L1-CR IN COMPLEX WITH PEPTIDE S519C16 AND 83-7 FV","10.1074/JBC.M116.732180 ",3.27,122.8,"5j3h_oligo3","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_G_)-[MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(255_E_)",118.412,"","",""
"5J5J","CRYSTAL STRUCTURE OF A CHIMERA OF HUMAN DESMOCOLLIN-2 EC1 AND HUMAN DESMOGLEIN-2 EC2-EC5","10.1073/PNAS.1606272113 ",3.29,0,"5j5j_oligo1","DGalpb1-4DGlcpNAcb1-3DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(31_A_)",205.562,"","",""
"5J67","STRUCTURE OF ASTROTACTIN-2, A CONSERVED VERTEBRATE-SPECIFIC AND PERFORIN-LIKE MEMBRANE PROTEIN INVOLVED IN NEURONAL DEVELOPMENT","10.1098/RSOB.160053 ",3.16,136.3,"5j67_oligo1","DManpa1-2DManpa1-3[DManpb1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)]-MAN(4_G_)-[MAN(10_G_)-MAN(9_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(732_C_)",116.384,"","",""
"5J67","STRUCTURE OF ASTROTACTIN-2, A CONSERVED VERTEBRATE-SPECIFIC AND PERFORIN-LIKE MEMBRANE PROTEIN INVOLVED IN NEURONAL DEVELOPMENT","10.1098/RSOB.160053 ",3.16,136.3,"5j67_oligo3","DManpa1-2DManpa1-3[DManpb1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(732_B_)",134.432,"","",""
"5J67","STRUCTURE OF ASTROTACTIN-2, A CONSERVED VERTEBRATE-SPECIFIC AND PERFORIN-LIKE MEMBRANE PROTEIN INVOLVED IN NEURONAL DEVELOPMENT","10.1098/RSOB.160053 ",3.16,136.3,"5j67_oligo4","DManpa1-2DManpa1-3[DManpb1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_H_)-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)]-MAN(4_H_)-[MAN(10_H_)-MAN(9_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(732_D_)",131.109,"","",""
"5J67","STRUCTURE OF ASTROTACTIN-2, A CONSERVED VERTEBRATE-SPECIFIC AND PERFORIN-LIKE MEMBRANE PROTEIN INVOLVED IN NEURONAL DEVELOPMENT","10.1098/RSOB.160053 ",3.16,136.3,"5j67_oligo2","DManpa1-2DManpa1-3[DManpb1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_E_)-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)]-MAN(4_E_)-[MAN(10_E_)-MAN(9_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(732_A_)",129.625,"","",""
"5JIH","CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB STAB19)","10.1016/J.STR.2017.04.014 ",1.66,0,"5jih_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",70.2827,"","",""
"5JIH","CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB STAB19)","10.1016/J.STR.2017.04.014 ",1.66,0,"5jih_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",97.3946,"","",""
"5JII","CRYSTAL STRUCTURE OF HUMAN IGG1-FC","10.1016/J.STR.2017.04.014 ",1.79,49.2,"5jii_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",81.111,"","",""
"5JII","CRYSTAL STRUCTURE OF HUMAN IGG1-FC","10.1016/J.STR.2017.04.014 ",1.79,49.2,"5jii_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",68.3536,"","",""
"5JIK","CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB H10-03-6)","10.1016/J.STR.2017.04.014 ",1.82,0,"5jik_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",86.5242,"","",""
"5K64","CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB 448)","10.1080/19420862.2017.1364825 ",2.44,100.5,"5k64_oligo3","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",108.831,"","",""
"5K65","CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB CT6)","10.1080/19420862.2017.1364825 ",2.5,0,"5k65_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",80.7227,"","",""
"5KOE","THE STRUCTURE OF ARABIDOPSIS THALIANA FUT1 IN COMPLEX WITH XXLG","10.1111/TPJ.13628 ",1.79,24.59,"5koe_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(8_E_)-XYS(7_E_)-[XYS(6_E_)-[XYS(5_E_)-BGC(4_E_)]-BGC(3_E_)]-BGC(2_E_)-BGC(1_E_)",33.5007,"","",""
"5KOR","ARABIDOPSIS THALIANA FUCOSYLTRANSFERASE 1 (FUT1) IN COMPLEX WITH GDP AND A XYLO-OLIGOSSACHARIDE","10.1105/TPC.16.00519 ",2.2,0,"5kor_oligo1","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(9_E_)-XYS(8_E_)-[GAL(7_E_)-XYS(6_E_)-[XYS(5_E_)-BGC(4_E_)]-BGC(3_E_)]-BGC(2_E_)-BGC(1_E_)",69.8107,"","",""
"5KOR","ARABIDOPSIS THALIANA FUCOSYLTRANSFERASE 1 (FUT1) IN COMPLEX WITH GDP AND A XYLO-OLIGOSSACHARIDE","10.1105/TPC.16.00519 ",2.2,0,"5kor_oligo2","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(9_F_)-XYS(8_F_)-[GAL(7_F_)-XYS(6_F_)-[XYS(5_F_)-BGC(4_F_)]-BGC(3_F_)]-BGC(2_F_)-BGC(1_F_)",58.4319,"","",""
"5KXB","WISTERIA FLORIBUNDA LECTIN IN COMPLEX WITH GALNAC","10.1074/JBC.M116.750463 ",2.33,38.27,"5kxb_oligo1","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_E_)-[XYP(4_E_)]-BMA(3_E_)-NAG(2_E_)-[FUC(6_E_)]-NAG(1_E_)-ASN(146_A_)",54.8266,"","",""
"5KXD","WISTERIA FLORIBUNDA LECTIN IN COMPLEX WITH GALNAC(BETA1-4)GLCNAC (LACDINAC) AT PH 6.5","10.1074/JBC.M116.750463 ",1.95,22.83,"5kxd_oligo2","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-[XYP(4_F_)]-BMA(3_F_)-NAG(2_F_)-[FUC(7_F_)]-NAG(1_F_)-ASN(146_C_)",50.0965,"","",""
"5KXE","WISTERIA FLORIBUNDA LECTIN IN COMPLEX WITH GALNAC(BETA1-4)GLCNAC (LACDINAC) AT PH 4.2","10.1074/JBC.M116.750463 ",2.09,28.47,"5kxe_oligo2","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-[XYP(4_F_)]-BMA(3_F_)-NAG(2_F_)-[FUC(7_F_)]-NAG(1_F_)-ASN(146_B_)",57.9507,"","",""
"5LAL","STRUCTURE OF ARABIDOPSIS DIRIGENT PROTEIN ATDIR6","10.1104/PP.16.01281 ",1.4,29.51,"5lal_oligo3","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(207_B_)]-[XYP(4_E_)]-BMA(3_E_)-NAG(2_E_)-[FUC(6_E_)]-NAG(1_E_)-ASN(59_B_)",30.3717,"","",""
"5LAL","STRUCTURE OF ARABIDOPSIS DIRIGENT PROTEIN ATDIR6","10.1104/PP.16.01281 ",1.4,29.51,"5lal_oligo4","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_F_)-[MAN(5_F_)]-[XYP(4_F_)]-BMA(3_F_)-NAG(2_F_)-[FUC(7_F_)]-NAG(1_F_)",66.741,"","",""
"5LAL","STRUCTURE OF ARABIDOPSIS DIRIGENT PROTEIN ATDIR6","10.1104/PP.16.01281 ",1.4,29.51,"5lal_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(206_A_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(207_A_)]-NAG(1_C_)-ASN(59_A_)",31.8898,"","",""
"5LG1","ROOM TEMPERATURE STRUCTURE OF HUMAN IGG4-FC FROM CRYSTALS ANALYSED IN SITU","10.1016/J.MOLIMM.2016.11.021 ",2.7,0,"5lg1_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",144.153,"","",""
"5LG1","ROOM TEMPERATURE STRUCTURE OF HUMAN IGG4-FC FROM CRYSTALS ANALYSED IN SITU","10.1016/J.MOLIMM.2016.11.021 ",2.7,0,"5lg1_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",86.3385,"","",""
"5M3V","BEAT FC","10.1074/JBC.M117.782433 ",1.97,56.56,"5m3v_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.1388,"","",""
"5M3V","BEAT FC","10.1074/JBC.M117.782433 ",1.97,56.56,"5m3v_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",127.389,"","",""
"5MUI","GLYCOSIDE HYDROLASE BT_0996","10.1038/NATURE21725 ",1.77,24.84,"5mui_oligo1","LArafb1-2LRhapa1-2[LRhapa1-3]LArapa1-4[LFucp[2Me,4Ac]a1-2]DGalpb1-2DXylf[5H,3<R1>]a1-3LRhapa1-ROH","RAM(7_B_)-[FUB(6_B_)-RAM(5_B_)]-ARA(4_B_)-8PK(8_B_)]-GAL(3_B_)-8OQ(2_B_)-RAM(1_B_)",37.5468,"","",""
"5MUJ","BT0996 RGII CHAIN B COMPLEX","10.1038/NATURE21725 ",1.37,16.85,"5muj_oligo1","LRhapa1-2[LRhapa1-3]LArapa1-4[LFucp[2Me,4Ac]a1-2]DGalpb1-2DXylf[5H,3<R1>]a1-4LRhapa1-3DEryf[3<R2>]a1-ROH","RAM(7_B_)-[RAM(6_B_)]-ARA(5_B_)-8PK(8_B_)]-GAL(4_B_)-8OQ(3_B_)-RAM(2_B_)-XXM(1_B_)",25.5304,"","",""
"5MWK","GLYCOSIDE HYDROLASE BT_0986","10.1038/NATURE21725 ",2,30.9,"5mwk_oligo1","LRhapa1-2LArapa1-4[LFucp[2Me][2Me]a1-2]DGalpb1-2DXylf[5H,3<R1>]a1-3LRhapa1-ROH","RAM(5_B_)-ARA(4_B_)-8PK(6_B_)]-GAL(3_B_)-8OQ(2_B_)-RAM(1_B_)",34.1644,"","",""
"5NSC","FC DEKK HETERODIMER VARIANT","10.1074/JBC.M117.793497 ",2.3,0,"5nsc_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",41.9274,"","",""
"5NSC","FC DEKK HETERODIMER VARIANT","10.1074/JBC.M117.793497 ",2.3,0,"5nsc_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",54.7873,"","",""
"5NSG","FC DEDE HOMODIMER VARIANT","10.1074/JBC.M117.793497 ",2.22,0,"5nsg_oligo1","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_B_)-[NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",41.4239,"","",""
"5O4E","CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6","10.1080/19420862.2017.1364825 ",2.15,0,"5o4e_oligo4","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(297_D_)",117.143,"","",""
"5O4E","CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6","10.1080/19420862.2017.1364825 ",2.15,0,"5o4e_oligo3","DGlcpNAcb1-2DManpx1-","NAG(2_I_)-MAN(1_I_)",130.024,"","",""
"5O4E","CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6","10.1080/19420862.2017.1364825 ",2.15,0,"5o4e_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",88.7826,"","",""
"5O4E","CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6","10.1080/19420862.2017.1364825 ",2.15,0,"5o4e_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",93.0537,"","",""
"5OYE","GH5 ENDO-XYLOGLUCANASE FROM CELLVIBRIO JAPONICUS","10.1186/S13068-018-1039-6 ",1.9,53.36,"5oye_oligo2","DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(7_C_)-XYS(6_C_)-[XYS(5_C_)-[BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-BGC(1_C_)",54.6092,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo9","DGalpb1-4DGlcpNAcb1-4[DGlcpNAcb1-2]DManpa1-3[DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(13_J_)-[GAL(12_J_)-NAG(11_J_)-[GAL(10_J_)-NAG(9_J_)]-MAN(8_J_)-[GAL(6_J_)-NAG(5_J_)-[NAG(7_J_)]-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(156_G_)",325.076,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo15","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-6][DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(16_P_)-[GAL(14_P_)-NAG(13_P_)-[SIA(12_P_)-GAL(11_P_)-NAG(10_P_)]-MAN(9_P_)-[NAG(15_P_)]-[NAG(8_P_)-[SIA(7_P_)-GAL(6_P_)-NAG(5_P_)]-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(276_G_)",374.56,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo12","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(9_M_)-MAN(8_M_)-[SIA(7_M_)-GAL(6_M_)-NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(197_G_)",304.839,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_R_)-MAN(6_R_)-[NAG(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(301_G_)",336.253,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo10","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_K_)-[GAL(9_K_)-NAG(8_K_)-MAN(7_K_)-[GAL(6_K_)-NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(160_G_)",336.057,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_P_)-[MAN(7_P_)-[GAL(6_P_)-NAG(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(276_G_)",265.286,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo6","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-[NAG(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(301_G_)",217.53,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo1","DGalpb1-4DGlcpNAcb1-4[DGlcpNAcb1-2]DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(11_J_)-[GAL(10_J_)-NAG(9_J_)-MAN(8_J_)-[GAL(6_J_)-NAG(5_J_)-[NAG(7_J_)]-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(156_G_)",240.369,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo9","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_M_)-MAN(7_M_)-[GAL(6_M_)-NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(197_G_)",232.465,"","",""
"5TPS","STRUCTURE OF A FC HETERODIMER","",2.7,0,"5tps_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_B_)",95.754,"","",""
"5TPS","STRUCTURE OF A FC HETERODIMER","",2.7,0,"5tps_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",64.6678,"","",""
"5U4Y","IGG FC BOUND TO 3 HELIX OF THE B-DOMAIN FROM PROTEIN A","10.1093/PROTEIN/GZX029 ",2.5,53.9,"5u4y_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_F_)-[NAG(5_F_)-MAN(4_F_)-[MAN(6_F_)]-MAN(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",76.7339,"","",""
"5U4Y","IGG FC BOUND TO 3 HELIX OF THE B-DOMAIN FROM PROTEIN A","10.1093/PROTEIN/GZX029 ",2.5,53.9,"5u4y_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-MAN(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",107.693,"","",""
"5U52","2 HELIX MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A (Z34C0 BOUND TO IGG1 FC (MONOCLINIC FORM)","10.1093/PROTEIN/GZX029 ",1.94,0,"5u52_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",47.7893,"","",""
"5U52","2 HELIX MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A (Z34C0 BOUND TO IGG1 FC (MONOCLINIC FORM)","10.1093/PROTEIN/GZX029 ",1.94,0,"5u52_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",48.6973,"","",""
"5U66","MODIFIED SINGLE HELIX FROM THE B-DOMAIN OF PROTEIN A BOUND TO IGG1 FC","10.1093/PROTEIN/GZX029 ",1.7,35.31,"5u66_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",68.1113,"","",""
"5UBX","CRYSTAL STRUCTURE OF A MUTANT MIGG2B FC HETERODIMER IN COMPLEX WITH PROTEIN A PEPTIDE ANALOG Z34C","10.1080/19420862.2017.1375639 ",2.7,0,"5ubx_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcx1-","NAG(6_C_)-MAN(5_C_)-[NAG(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",134.542,"","",""
"5UBX","CRYSTAL STRUCTURE OF A MUTANT MIGG2B FC HETERODIMER IN COMPLEX WITH PROTEIN A PEPTIDE ANALOG Z34C","10.1080/19420862.2017.1375639 ",2.7,0,"5ubx_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",83.5589,"","",""
"5UPH","LIPIDS BOUND LYSOSOMAL INTEGRAL MEMBRANE PROTEIN 2","10.1038/S41467-017-02044-8 ",3,130.7,"5uph_oligo6","DManp[6P]b1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","M6D(6_E_)-MAN(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(325_A_)",186.153,"","",""
"5V4E","ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)","10.1038/NI.3770 ",3.22,0,"5v4e_oligo4","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_L_)-[NAG(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(297_E_)",105.421,"","",""
"5V4E","ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)","10.1038/NI.3770 ",3.22,0,"5v4e_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_I_)-[NAG(7_I_)-MAN(6_I_)-[NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_A_)",90.4752,"","",""
"5V4E","ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)","10.1038/NI.3770 ",3.22,0,"5v4e_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_M_)-[NAG(7_M_)-MAN(6_M_)-[NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(297_G_)",77.144,"","",""
"5V4E","ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)","10.1038/NI.3770 ",3.22,0,"5v4e_oligo6","DGlcpNAcb1-2DManpa1-2[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_N_)-[NAG(7_N_)-MAN(6_N_)-[NAG(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(297_H_)",89.8702,"","",""
"5V4E","ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)","10.1038/NI.3770 ",3.22,0,"5v4e_oligo1","DGlcpNAcb1-2DManpa1-6DManpx1-","NAG(3_K_)-MAN(2_K_)-BMA(1_K_)",109.735,"","",""
"5V4E","ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)","10.1038/NI.3770 ",3.22,0,"5v4e_oligo3","DGlcpNAcb1-2DManpa1-3DManpx1-","NAG(3_J_)-MAN(2_J_)-BMA(1_J_)",118.436,"","",""
"5V6K","CRYSTAL STRUCTURE OF THE SECOND BETA-PRISM DOMAIN OF RBMC FROM V. CHOLERAE BOUND TO N-ACETYLGLUCOSAMINYL-BETA-1,2-MANNOSE","10.1371/JOURNAL.PPAT.1006841 ",1.8,16.89,"5v6k_oligo1","DGlcpNAcb1-2DManpa1-ROH","NAG(2_B_)-MAN(1_B_)",17.8982,"","",""
"5VAA","CRYSTAL STRUCTURE OF MOUSE IGG2A FC T370K MUTANT","10.1038/S41598-017-02823-9 ",1.55,28.45,"5vaa_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",29.6555,"","",""
"5VAA","CRYSTAL STRUCTURE OF MOUSE IGG2A FC T370K MUTANT","10.1038/S41598-017-02823-9 ",1.55,28.45,"5vaa_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",49.3079,"","",""
"5VCS","ALPHA-1,6-MANNOSYL-GLYCOPROTEIN 2-BETA-N-ACETYLGLUCOSAMINYLTRANSFERASE WITH BOUND ACCEPTOR","10.1073/PNAS.1716988115 ",2.8,51.78,"5vcs_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(5_D_)-[NAG(4_D_)-MAN(3_D_)]-BMA(2_D_)-NAG(1_D_)",52.8076,"","",""
"5VCS","ALPHA-1,6-MANNOSYL-GLYCOPROTEIN 2-BETA-N-ACETYLGLUCOSAMINYLTRANSFERASE WITH BOUND ACCEPTOR","10.1073/PNAS.1716988115 ",2.8,51.78,"5vcs_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(5_C_)-[NAG(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",48.2335,"","",""
"5VGP","FC FRAGMENT OF HUMAN IGG1 ANTIBODY, FROM NIST MAB","10.1107/S2053230X18009834 ",2.12,56.63,"5vgp_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(300_B_)",82.6261,"","",""
"5VGP","FC FRAGMENT OF HUMAN IGG1 ANTIBODY, FROM NIST MAB","10.1107/S2053230X18009834 ",2.12,56.63,"5vgp_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(300_A_)",54.129,"","",""
"5VH5","CRYSTAL STRUCTURE OF FC FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB","10.1080/19420862.2017.1320463 ",1.75,39.71,"5vh5_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManp[3<R1>]b1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(300_A_)",57.0187,"","",""
"5VME","CRYSTAL STRUCTURE OF HUMAN IGG1 FC K248E, T437R MUTANT","10.1080/19420862.2017.1358838 ",3.1,0,"5vme_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",118.47,"","",""
"5VME","CRYSTAL STRUCTURE OF HUMAN IGG1 FC K248E, T437R MUTANT","10.1080/19420862.2017.1358838 ",3.1,0,"5vme_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_D_)-[NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",159.271,"","",""
"5VU0","CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN AFUCOSYLATED/GALACTOSYLATED HUMAN IGG1 FC AND FC GAMMA RECEPTOR IIIA (CD16A) WITH MAN5 N-GLYCANS","10.1021/ACSCHEMBIO.8B00342 ",2.26,47.18,"5vu0_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",45.5687,"","",""
"5VU0","CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN AFUCOSYLATED/GALACTOSYLATED HUMAN IGG1 FC AND FC GAMMA RECEPTOR IIIA (CD16A) WITH MAN5 N-GLYCANS","10.1021/ACSCHEMBIO.8B00342 ",2.26,47.18,"5vu0_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",63.5374,"","",""
"5W5L","CRYSTAL STRUCTURE OF HUMAN IGG1-SIGMA FC FRAGMENT","10.3390/ANTIB6030012 ",1.9,0,"5w5l_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",45.4652,"","",""
"5W5L","CRYSTAL STRUCTURE OF HUMAN IGG1-SIGMA FC FRAGMENT","10.3390/ANTIB6030012 ",1.9,0,"5w5l_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",69.578,"","",""
"5W5M","CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA1 FC FRAGMENT","10.3390/ANTIB6030012 ",1.9,0,"5w5m_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",91.9092,"","",""
"5W5M","CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA1 FC FRAGMENT","10.3390/ANTIB6030012 ",1.9,0,"5w5m_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",57.9635,"","",""
"5W5N","CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA2 FC FRAGMENT","10.3390/ANTIB6030012 ",1.85,0,"5w5n_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",45.7772,"","",""
"5W5N","CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA2 FC FRAGMENT","10.3390/ANTIB6030012 ",1.85,0,"5w5n_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",85.4825,"","",""
"5WAV","FC ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.","",2.6,58.2,"5wav_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",98.6161,"","",""
"5WAV","FC ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.","",2.6,58.2,"5wav_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",63.6848,"","",""
"5XFH","CRYSTAL STRUCTURE OF ORYSATA LECTIN IN COMPLEX WITH BIANTENNARY N- GLYCAN","10.1093/GLYCOB/CWX081 ",1.9,0,"5xfh_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-ROH","NAG(6_C_)-MAN(5_C_)-[GAL(4_C_)-NAG(3_C_)-MAN(2_C_)]-BMA(1_C_)",33.5074,"","",""
"5XFI","CRYSTAL STRUCTURE OF CALSEPA LECTIN IN COMPLEX WITH BIANTENNARY N- GLYCAN","10.1093/GLYCOB/CWX081 ",1.65,0,"5xfi_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(8_D_)-MAN(7_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",26.4665,"","",""
"5XFI","CRYSTAL STRUCTURE OF CALSEPA LECTIN IN COMPLEX WITH BIANTENNARY N- GLYCAN","10.1093/GLYCOB/CWX081 ",1.65,0,"5xfi_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",26.2062,"","",""
"5XJE","CRYSTAL STRUCTURE OF FUCOSYLATED IGG1 FC COMPLEXED WITH BIS- GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1038/S41598-017-13845-8 ",2.4,55.11,"5xje_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",63.0309,"","",""
"5XJE","CRYSTAL STRUCTURE OF FUCOSYLATED IGG1 FC COMPLEXED WITH BIS- GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1038/S41598-017-13845-8 ",2.4,55.11,"5xje_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",66.3192,"","",""
"5XJF","CRYSTAL STRUCTURE OF FUCOSYLATED IGG FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1038/S41598-017-13845-8 ",2.5,66.32,"5xjf_oligo1","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(45_C_)",138.449,"","",""
"5XJF","CRYSTAL STRUCTURE OF FUCOSYLATED IGG FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1038/S41598-017-13845-8 ",2.5,66.32,"5xjf_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",76.3318,"","",""
"5XJF","CRYSTAL STRUCTURE OF FUCOSYLATED IGG FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1038/S41598-017-13845-8 ",2.5,66.32,"5xjf_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",76.8007,"","",""
"5XMH","CRYSTAL STRUCTURE OF AN IGM RHEUMATOID FACTOR YES8C IN COMPLEX WITH IGG1 FC","10.1074/JBC.M117.814475 ",2.8,52,"5xmh_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",65.8827,"","",""
"5XMH","CRYSTAL STRUCTURE OF AN IGM RHEUMATOID FACTOR YES8C IN COMPLEX WITH IGG1 FC","10.1074/JBC.M117.814475 ",2.8,52,"5xmh_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(297_B_)",86.2577,"","",""
"5XWD","CRYSTAL STRUCTURE OF THE COMPLEX OF 059-152-FV AND EGFR-ECD","10.1371/JOURNAL.PONE.0193158 ",2.89,0,"5xwd_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_B_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(328_A_)",121.818,"","",""
"5XXN","CRYSTAL STRUCTURE OF MUTANT (D286N) BETA-GLUCOSIDASE FROM BACTEROIDES THETAIOTAOMICRON IN COMPLEX WITH SOPHOROSE","10.1002/1873-3468.12911 ",2.05,22.48,"5xxn_oligo2","DGlcpb1-2DGlcpb1-ROH","BGC(2_D_)-BGC(1_D_)",18.0586,"","",""
"5XXN","CRYSTAL STRUCTURE OF MUTANT (D286N) BETA-GLUCOSIDASE FROM BACTEROIDES THETAIOTAOMICRON IN COMPLEX WITH SOPHOROSE","10.1002/1873-3468.12911 ",2.05,22.48,"5xxn_oligo1","DGlcpb1-2DGlcpb1-ROH","BGC(2_C_)-BGC(1_C_)",19.6327,"","",""
"5XXO","CRYSTAL STRUCTURE OF MUTANT (D286N) GH3 BETA-GLUCOSIDASE FROM BACTEROIDES THETAIOTAOMICRON IN COMPLEX WITH SOPHOROTRIOSE","10.1002/1873-3468.12911 ",2.02,22.74,"5xxo_oligo1","DGlcpb1-2DGlcpb1-2DGlcpb1-ROH","BGC(3_C_)-BGC(2_C_)-BGC(1_C_)",17.8961,"","",""
"5Y56","FC MUTANT (K392D/K409D/D399K)","10.1074/JBC.M116.771188 ",2.65,0,"5y56_oligo2","DGalpb1-4DGlcpNAca1-2DManpa1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NDG(5_C_)-MAN(4_C_)-[NAG(8_C_)-BMA(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",121.516,"","",""
"5YC5","CRYSTAL STRUCTURE OF HUMAN IGG-FC IN COMPLEX WITH AGLYCAN AND OPTIMIZED FC GAMMA RECEPTOR IIIA","10.1038/S41598-018-22199-8 ",2.71,54.1,"5yc5_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",59.185,"","",""
"5YC5","CRYSTAL STRUCTURE OF HUMAN IGG-FC IN COMPLEX WITH AGLYCAN AND OPTIMIZED FC GAMMA RECEPTOR IIIA","10.1038/S41598-018-22199-8 ",2.71,54.1,"5yc5_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",61.4107,"","",""
"5YSD","CRYSTAL STRUCTURE OF BETA-1,2-GLUCOOLIGOSACCHARIDE BINDING PROTEIN IN COMPLEX WITH SOPHOROTRIOSE","10.1074/JBC.RA117.001536 ",2.1,56.68,"5ysd_oligo2","DGlcpb1-2DGlcpb1-2DGlcpa1-ROH","BGC(3_D_)-BGC(2_D_)-GLC(1_D_)",28.1088,"","",""
"5YSD","CRYSTAL STRUCTURE OF BETA-1,2-GLUCOOLIGOSACCHARIDE BINDING PROTEIN IN COMPLEX WITH SOPHOROTRIOSE","10.1074/JBC.RA117.001536 ",2.1,56.68,"5ysd_oligo1","DGlcpb1-2DGlcpb1-2DGlcpa1-ROH","BGC(3_C_)-BGC(2_C_)-GLC(1_C_)",20.5718,"","",""
"5YSE","CRYSTAL STRUCTURE OF BETA-1,2-GLUCOOLIGOSACCHARIDE BINDING PROTEIN IN COMPLEX WITH SOPHOROTETRAOSE","10.1074/JBC.RA117.001536 ",1.6,46.92,"5yse_oligo2","DGlcpb1-2DGlcpb1-2DGlcpb1-2DGlcpa1-ROH","BGC(4_D_)-BGC(3_D_)-BGC(2_D_)-GLC(1_D_)",24.4668,"","",""
"5YSE","CRYSTAL STRUCTURE OF BETA-1,2-GLUCOOLIGOSACCHARIDE BINDING PROTEIN IN COMPLEX WITH SOPHOROTETRAOSE","10.1074/JBC.RA117.001536 ",1.6,46.92,"5yse_oligo1","DGlcpb1-2DGlcpb1-2DGlcpb1-2DGlcpa1-ROH","BGC(4_C_)-BGC(3_C_)-BGC(2_C_)-GLC(1_C_)",15.5634,"","",""
"5YSF","CRYSTAL STRUCTURE OF BETA-1,2-GLUCOOLIGOSACCHARIDE BINDING PROTEIN IN COMPLEX WITH SOPHOROPENTAOSE","10.1074/JBC.RA117.001536 ",1.9,32.85,"5ysf_oligo2","DGlcpb1-2DGlcpb1-2DGlcpb1-2DGlcpb1-2DGlcpb1-ROH","BGC(5_D_)-BGC(4_D_)-BGC(3_D_)-BGC(2_D_)-BGC(1_D_)",29.3827,"","",""
"5YSF","CRYSTAL STRUCTURE OF BETA-1,2-GLUCOOLIGOSACCHARIDE BINDING PROTEIN IN COMPLEX WITH SOPHOROPENTAOSE","10.1074/JBC.RA117.001536 ",1.9,32.85,"5ysf_oligo1","DGlcpb1-2DGlcpb1-2DGlcpb1-2DGlcpb1-2DGlcpb1-ROH","BGC(5_C_)-BGC(4_C_)-BGC(3_C_)-BGC(2_C_)-BGC(1_C_)",23.8042,"","",""
"5ZIC","CRYSTAL STRUCTURE OF HUMAN GNT-V LUMINAL DOMAIN IN COMPLEX WITH ACCEPTOR SUGAR","10.1038/S41467-018-05931-W ",2.1,0,"5zic_oligo2","DGlcpNAcb1-2DLyxpa1-6DManpb1-ROH","NAG(3_D_)-Z4Y(2_D_)-BMA(1_D_)",46.3573,"","",""
"5ZIC","CRYSTAL STRUCTURE OF HUMAN GNT-V LUMINAL DOMAIN IN COMPLEX WITH ACCEPTOR SUGAR","10.1038/S41467-018-05931-W ",2.1,0,"5zic_oligo1","DGlcpNAcb1-2DLyxpa1-6DManpb1-ROH","NAG(3_C_)-Z4Y(2_C_)-BMA(1_C_)",37.2104,"","",""
"6AQ5","X-RAY CRYSTAL STRUCTURE OF ERYTHRINA CRISTA-GALLI LECTIN IN COMPLEX WITH EPILACTOSE","",2.19,0,"6aq5_oligo1","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_D_)-[XYP(4_D_)]-BMA(3_D_)-NAG(2_D_)-[FUC(6_D_)]-NAG(1_D_)-ASN(113_A_)",50.841,"","",""
"6AQ6","X-RAY CRYSTAL STRUCTURE OF ERYTHRINA CRISTA-GALLI LECTIN IN COMPLEX WITH N-ACETYLLACTOSAMINE","10.1021/ACS.JCIM.8B00120 ",1.9,0,"6aq6_oligo1","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_D_)-[XYP(4_D_)]-BMA(3_D_)-NAG(2_D_)-[FUC(6_D_)]-NAG(1_D_)-ASN(113_A_)",36.4621,"","",""
"6BBD","STRUCTURE OF N-GLYCOSYLATED PORCINE SURFACTANT PROTEIN-D COMPLEXED WITH GLYCEROL","10.1074/JBC.RA117.001430 ",1.9,47.29,"6bbd_oligo1","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(303_A_)",64.9433,"","",""
"6BBE","STRUCTURE OF N-GLYCOSYLATED PORCINE SURFACTANT PROTEIN-D","10.1074/JBC.RA117.001430 ",1.9,47.45,"6bbe_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_B_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(303_A_)",63.2997,"","",""
"6BHQ","MOUSE IMMUNOGLOBULIN G 2C FC FRAGMENT WITH COMPLEX-TYPE GLYCAN","10.1371/JOURNAL.PONE.0192123 ",2.05,0,"6bhq_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",99.2546,"","",""
"6BHQ","MOUSE IMMUNOGLOBULIN G 2C FC FRAGMENT WITH COMPLEX-TYPE GLYCAN","10.1371/JOURNAL.PONE.0192123 ",2.05,0,"6bhq_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",59.9193,"","",""
"6BZ4","HUMAN IGG1 LACKING COMPLEMENT-DEPENDENT CYTOTOXICITY: HU3S193 FC MUTANT K322A","10.1042/BCJ20180139 ",2.4,0,"6bz4_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",120.514,"","",""
"6BZ4","HUMAN IGG1 LACKING COMPLEMENT-DEPENDENT CYTOTOXICITY: HU3S193 FC MUTANT K322A","10.1042/BCJ20180139 ",2.4,0,"6bz4_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",105.338,"","",""
"6C26","THE CRYO-EM STRUCTURE OF A EUKARYOTIC OLIGOSACCHARYL TRANSFERASE COMPLEX","10.1038/NATURE25755 ",3.5,"1.35632e-19","6c26_oligo1","DManpb1-2DManpb1-2DManpb1-2[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_D_)-[BMA(6_D_)-BMA(5_D_)-BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(539_A_)",52.3196,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo7","DGlcpNAcb1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[MAN(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(156_G_)",305.989,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(88_G_)",260.109,"","",""
"6CHF","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 1)","10.1016/J.STR.2020.03.001 ",2.4,0,"6chf_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",130.212,"","",""
"6CHF","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 1)","10.1016/J.STR.2020.03.001 ",2.4,0,"6chf_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",77.8394,"","",""
"6CJC","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 3)","10.1016/J.STR.2020.03.001 ",2.58,0,"6cjc_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",104.43,"","",""
"6CJC","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 3)","10.1016/J.STR.2020.03.001 ",2.58,0,"6cjc_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",96.2532,"","",""
"6CJX","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 2)","10.1016/J.STR.2020.03.001 ",2.44,0,"6cjx_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",140.362,"","",""
"6CJX","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 2)","10.1016/J.STR.2020.03.001 ",2.44,0,"6cjx_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",167.937,"","",""
"6D4E","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG1.","10.1080/19420862.2019.1589852 ",2.8,0,"6d4e_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",110.489,"","",""
"6D4E","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG1.","10.1080/19420862.2019.1589852 ",2.8,0,"6d4e_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",111.014,"","",""
"6D4I","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG2","10.1080/19420862.2019.1589852 ",2.95,0,"6d4i_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",95.3006,"","",""
"6D4I","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG2","10.1080/19420862.2019.1589852 ",2.95,0,"6d4i_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",95.5868,"","",""
"6D4M","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG3","10.1080/19420862.2019.1589852 ",3.47,0,"6d4m_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",107.192,"","",""
"6D4M","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG3","10.1080/19420862.2019.1589852 ",3.47,0,"6d4m_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",99.9066,"","",""
"6D4N","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG4","10.1080/19420862.2019.1589852 ",3.25,0,"6d4n_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",150.107,"","",""
"6D4N","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG4","10.1080/19420862.2019.1589852 ",3.25,0,"6d4n_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",154.221,"","",""
"6D58","CRYSTAL STRUCTURE OF A FC FRAGMENT OF HUMAN IGG3","",2.39,0,"6d58_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",148.324,"","",""
"6D58","CRYSTAL STRUCTURE OF A FC FRAGMENT OF HUMAN IGG3","",2.39,0,"6d58_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",137.351,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo30","DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_g_)-[NAG(8_g_)-MAN(7_g_)-[NAG(6_g_)-[NAG(5_g_)]-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)]-NAG(1_g_)-ASN(637_D_)",80.832,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo26","DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_r_)-[NAG(8_r_)-MAN(7_r_)-[NAG(6_r_)-[NAG(5_r_)]-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)]-NAG(1_r_)-ASN(637_F_)",97.8233,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo28","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_f_)-[GAL(8_f_)-NAG(7_f_)-[GAL(6_f_)-NAG(5_f_)]-MAN(4_f_)-[MAN(9_f_)]-BMA(3_f_)-NAG(2_f_)]-NAG(1_f_)-ASN(611_D_)",69.7595,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo27","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_s_)-[GAL(8_s_)-NAG(7_s_)-[GAL(6_s_)-NAG(5_s_)]-MAN(4_s_)-BMA(3_s_)-NAG(2_s_)]-NAG(1_s_)-ASN(611_F_)",76.7788,"","",""
"6DRU","XYLOSIDASE FROM ASPERGILLUS NIGER","10.1021/ACSSUSCHEMENG.9B07073 ",2.7,67.01,"6dru_oligo6","DGalpb1-2DXylpa1-6[DGlcpb1-4]DGlcpb1-4DGlcpb1-ROH","GAL(4_J_)-XYS(3_J_)-[BGC(5_J_)]-BGC(2_J_)-BGC(1_J_)",93.28,"","",""
"6DRU","XYLOSIDASE FROM ASPERGILLUS NIGER","10.1021/ACSSUSCHEMENG.9B07073 ",2.7,67.01,"6dru_oligo1","DGalpb1-2DXylpa1-6[DGlcpb1-4]DGlcpb1-4DGlcpb1-ROH","GAL(4_F_)-XYS(3_F_)-[BGC(5_F_)]-BGC(2_F_)-BGC(1_F_)",92.0113,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo15","DManpb1-2DManpx1-","MAN(2_i_)-MAN(1_i_)",12.7924,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo5","DManpb1-2DManpx1-","MAN(2_Y_)-MAN(1_Y_)",12.7924,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo13","DManpb1-2DManpx1-","MAN(2_g_)-MAN(1_g_)",12.7924,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo21","DManpb1-2DManpx1-","MAN(2_o_)-MAN(1_o_)",12.7924,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo3","DManpb1-2DManpx1-","MAN(2_N_)-MAN(1_N_)",12.7924,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo18","DManpb1-2DManpx1-","MAN(2_l_)-MAN(1_l_)",12.7924,"","",""
"6EA5","STRUCTURE OF BDBV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878","10.1128/MBIO.01674-18 ",4.75,0,"6ea5_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)",204.991,"","",""
"6EA7","STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878","10.1128/MBIO.01674-18 ",4.25,0,"6ea7_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_K_)-MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(563_F_)",205.134,"","",""
"6EA7","STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878","10.1128/MBIO.01674-18 ",4.25,0,"6ea7_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_J_)-NAG(5_J_)-MAN(4_J_)-[NAG(8_J_)-MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(563_D_)",178.133,"","",""
"6EA7","STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878","10.1128/MBIO.01674-18 ",4.25,0,"6ea7_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_I_)-NAG(5_I_)-MAN(4_I_)-[NAG(8_I_)-MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(563_B_)",208.453,"","",""
"6EAQ","GLYCOSYLATED FCGR3B / CD16B IN COMPLEX WITH AFUCOSYLATED IGG1 FC","10.1074/JBC.RA118.005273 ",2.22,0,"6eaq_oligo1","LArapa1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",42.5249,"","",""
"6EAQ","GLYCOSYLATED FCGR3B / CD16B IN COMPLEX WITH AFUCOSYLATED IGG1 FC","10.1074/JBC.RA118.005273 ",2.22,0,"6eaq_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",56.5409,"","",""
"6EG0","CRYSTAL STRUCTURE OF DPR4 IG1-IG2 IN COMPLEX WITH DIP-ETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.9,0,"6eg0_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(291_B_)",98.2293,"","",""
"6EN3","CRYSTAL STRUCTURE OF FULL LENGTH ENDOS FROM STREPTOCOCCUS PYOGENES IN COMPLEX WITH G2 OLIGOSACCHARIDE.","10.1038/S41467-018-04300-X ",2.9,0,"6en3_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_B_)-NAG(7_B_)-MAN(6_B_)-[GAL(5_B_)-NAG(4_B_)-MAN(3_B_)]-BMA(2_B_)-NAG(1_B_)",87.1648,"","",""
"6EVV","X-RAY STRUCTURE OF THE COMPLEX BETWEEN HUMAN ALPHA THROMBIN AND NU172, A DUPLEX/QUADRUPLEX 26-MER DNA APTAMER, IN THE PRESENCE OF POTASSIUM IONS.","10.1093/NAR/GKY990 ",2.5,48.2,"6evv_oligo12","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_A_)-GAL(6_A_)-NAG(5_A_)-MAN(4_A_)-[MAN(8_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(60_H_)",71.1303,"","",""
"6F1H","C1RC1S COMPLEX","10.1073/PNAS.1718709115 ",4.5,255.4,"6f1h_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(7_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",295.58,"","",""
"6F2Z","STRUCTURE OF A FC MUTANT","",2.3,53.42,"6f2z_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_B_)",76.6274,"","",""
"6F2Z","STRUCTURE OF A FC MUTANT","",2.3,53.42,"6f2z_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",60.2502,"","",""
"6F9T","CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-1 CONVERTING ENZYME IN COMPLEX WITH SAMPATRILAT.","10.1111/FEBS.14421 ",1.6,0,"6f9t_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",51.383,"","",""
"6FGO","FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z","10.1016/J.JMB.2018.06.004 ",2.5,65.2,"6fgo_oligo2","DGlcpNAcb1-2DManpa1-6[DManp[2<R1>]a1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_K_)-MAN(6_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(297_C_)",63.1947,"","",""
"6FGO","FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z","10.1016/J.JMB.2018.06.004 ",2.5,65.2,"6fgo_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_I_)-[NAG(7_I_)-MAN(6_I_)-[NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_A_)",47.6119,"","",""
"6FGO","FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z","10.1016/J.JMB.2018.06.004 ",2.5,65.2,"6fgo_oligo3","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_J_)-[NAG(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(297_B_)",86.9288,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo3","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-N3","FUC(6_O_)-[NAG(5_O_)-MAN(4_O_)-BMA(3_O_)-NAG(2_O_)]-C4W(1_O_)",45.6217,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo6","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-N3","FUC(7_S_)-[NAG(5_S_)-MAN(4_S_)-[MAN(6_S_)]-BMA(3_S_)-NAG(2_S_)]-C4W(1_S_)",48.3782,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo5","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(7_Q_)-[NAG(5_Q_)-MAN(4_Q_)-[MAN(6_Q_)]-BMA(3_Q_)-NAG(2_Q_)]-C4W(1_Q_)",44.8705,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo12","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(6_M_)-[NAG(5_M_)-MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-C4W(1_M_)",52.3867,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo1","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-N3","FUC(6_R_)-[NAG(5_R_)-MAN(4_R_)-BMA(3_R_)-NAG(2_R_)]-C4W(1_R_)",49.7197,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo11","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(6_X_)-[NAG(5_X_)-MAN(4_X_)-BMA(3_X_)-NAG(2_X_)]-C4W(1_X_)",56.2018,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo8","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(8_U_)-[NAG(7_U_)-MAN(6_U_)-[NAG(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)]-C4W(1_U_)",45.1991,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(8_N_)-[NAG(7_N_)-MAN(6_N_)-[NAG(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-C4W(1_N_)",49.9314,"","",""
"6FX2","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH A DECASACCHARIDE","10.1002/ANIE.201805165 ",1.7,28.56,"6fx2_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-N3","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-C4W(1_C_)",39.6573,"","",""
"6FX2","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH A DECASACCHARIDE","10.1002/ANIE.201805165 ",1.7,28.56,"6fx2_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-N3","FUC(7_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-C4W(1_D_)",33.4188,"","",""
"6FX3","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH A DODECASACCHARIDE","10.1002/ANIE.201805165 ",1.7,26.6,"6fx3_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-N3","FUC(10_C_)-[SIA(7_C_)-GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(9_C_)-MAN(8_C_)]-BMA(3_C_)-NAG(2_C_)]-C4W(1_C_)",36.0636,"","",""
"6FX3","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH A DODECASACCHARIDE","10.1002/ANIE.201805165 ",1.7,26.6,"6fx3_oligo2","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-N3","FUC(8_D_)-[SIA(7_D_)-GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-C4W(1_D_)",28.679,"","",""
"6G1E","BEAT FC WITH IMPROVED HETERODIMERIZATION (Q3A-D84.4Q)","10.1074/JBC.RA119.012335 ",1.88,56.12,"6g1e_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",71.6165,"","",""
"6G1E","BEAT FC WITH IMPROVED HETERODIMERIZATION (Q3A-D84.4Q)","10.1074/JBC.RA119.012335 ",1.88,56.12,"6g1e_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",95.0465,"","",""
"6GFE","HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY","10.1016/J.BPJ.2019.03.036 ",1.8,35.64,"6gfe_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_B_)-[NAG(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_K_)",42.4825,"","",""
"6GFE","HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY","10.1016/J.BPJ.2019.03.036 ",1.8,35.64,"6gfe_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_A_)-[NAG(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(297_H_)",33.1592,"","",""
"6GN7","X-RAY STRUCTURE OF THE COMPLEX BETWEEN HUMAN ALPHA THROMBIN AND NU172, A DUPLEX/QUADRUPLEX 26-MER DNA APTAMER, IN THE PRESENCE OF SODIUM IONS.","10.1093/NAR/GKY990 ",2.8,52.15,"6gn7_oligo18","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_A_)-GAL(6_A_)-NAG(5_A_)-MAN(4_A_)-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(60_H_)",122.001,"","",""
"6I01","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE IN COMPLEX WITH SUBSTRATE","10.1073/PNAS.1818333116 ",2.1,50.72,"6i01_oligo4","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_G_)-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(225_B_)",86.5484,"","",""
"6I01","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE IN COMPLEX WITH SUBSTRATE","10.1073/PNAS.1818333116 ",2.1,50.72,"6i01_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(225_A_)",85.052,"","",""
"6I02","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE IN COMPLEX WITH PRODUCT","10.1073/PNAS.1818333116 ",2.45,54.73,"6i02_oligo4","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(225_A_)",98.1355,"","",""
"6I3F","CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN ANGIOTENSINOGEN AND RENIN AT 2.55 ANGSTROM","10.1074/JBC.RA118.006608 ",2.55,40.39,"6i3f_oligo1","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(14_A_)",87.7704,"","",""
"6IDN","CRYSTAL STRUCTURE OF ICCHI CHITINASE FROM IPOMOEA CARNEA","10.1016/J.PHYTOCHEM.2019.112221 ",1.5,26.03,"6idn_oligo3","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_D_)-[XYP(4_D_)]-BMA(3_D_)-NAG(2_D_)-[FUC(6_D_)]-NAG(1_D_)-ASN(194_A_)",33.2274,"","",""
"6IFJ","STRUCTURE OF BISPECIFIC FC","",2.4,43.53,"6ifj_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_E_)-[NAG(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",54.7644,"","",""
"6IFJ","STRUCTURE OF BISPECIFIC FC","",2.4,43.53,"6ifj_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_F_)-[NAG(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",58.2293,"","",""
"6IMV","THE COMPLEX STRUCTURE OF ENDO-BETA-1,2-GLUCANASE FROM TALAROMYCES FUNICULOSUS WITH SOPHOROSE","10.1074/JBC.RA118.007087 ",2,18.73,"6imv_oligo5","DGlcpb1-2DGlcpa1-ROH","BGC(2_E_)-GLC(1_E_)",23.165,"","",""
"6IMV","THE COMPLEX STRUCTURE OF ENDO-BETA-1,2-GLUCANASE FROM TALAROMYCES FUNICULOSUS WITH SOPHOROSE","10.1074/JBC.RA118.007087 ",2,18.73,"6imv_oligo4","DGlcpb1-2DGlcpa1-ROH","BGC(2_D_)-GLC(1_D_)",16.4605,"","",""
"6IMW","THE COMPLEX STRUCTURE OF ENDO-BETA-1,2-GLUCANASE MUTANT (E262Q) FROM TALAROMYCES FUNICULOSUS WITH BETA-1,2-GLUCAN","10.1074/JBC.RA118.007087 ",2.1,19.35,"6imw_oligo2","DGlcpb1-2DGlcpb1-2DGlcpb1-2DGlcpb1-2DGlcpb1-2DGlcpb1-2DGlcpb1-ROH","BGC(7_D_)-BGC(6_D_)-BGC(5_D_)-BGC(4_D_)-BGC(3_D_)-BGC(2_D_)-BGC(1_D_)",25.9009,"","",""
"6IMW","THE COMPLEX STRUCTURE OF ENDO-BETA-1,2-GLUCANASE MUTANT (E262Q) FROM TALAROMYCES FUNICULOSUS WITH BETA-1,2-GLUCAN","10.1074/JBC.RA118.007087 ",2.1,19.35,"6imw_oligo1","DGlcpb1-2DGlcpb1-2DGlcpb1-2DGlcpb1-2DGlcpb1-ROH","BGC(5_C_)-BGC(4_C_)-BGC(3_C_)-BGC(2_C_)-BGC(1_C_)",27.2518,"","",""
"6IQG","X-RAY CRYSTAL STRUCTURE OF FC AND PEPTIDE COMPLEX","10.1021/ACS.BIOCONJCHEM.8B00865 ",3,0,"6iqg_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",60.6374,"","",""
"6IQG","X-RAY CRYSTAL STRUCTURE OF FC AND PEPTIDE COMPLEX","10.1021/ACS.BIOCONJCHEM.8B00865 ",3,0,"6iqg_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",57.5967,"","",""
"6IQH","X-RAY CRYSTAL STRUCTURE OF COVALENT-BONDED COMPLEX OF FC AND PEPTIDE","10.1021/ACS.BIOCONJCHEM.8B00865 ",3,0,"6iqh_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",65.2675,"","",""
"6IQH","X-RAY CRYSTAL STRUCTURE OF COVALENT-BONDED COMPLEX OF FC AND PEPTIDE","10.1021/ACS.BIOCONJCHEM.8B00865 ",3,0,"6iqh_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",53.7805,"","",""
"6JG7","CRYSTAL STRUCTURE OF BARLEY EXOHYDROLASEI W286F IN COMPLEX WITH METHYL 2-THIO-BETA-SOPHOROSIDE","10.1038/S41467-022-33180-5 ",2.16,26.66,"6jg7_oligo1","DGlcpb1-2DGlcp[2<R1>]b1-OME","BGC(2_B_)-U2A(1_B_)",40.2664,"","",""
"6JGE","CRYSTAL STRUCTURE OF BARLEY EXOHYDROLASEI W434A MUTANT IN COMPLEX WITH METHYL 2-THIO-BETA-SOPHOROSIDE.","10.1038/S41467-022-33180-5 ",1.92,20.71,"6jge_oligo1","DGlcpb1-2DGlcp[2<R1>]b1-OME","BGC(2_B_)-U2A(1_B_)",42.2664,"","",""
"6JGG","CRYSTAL STRUCTURE OF BARLEY EXOHYDROLASEI W434F MUTANT IN COMPLEX WITH METHYL 2-THIO-BETA-SOPHOROSIDE.","10.1038/S41467-022-33180-5 ",1.9,30.52,"6jgg_oligo1","DGlcpb1-2DGlcp[2<R1>]b1-OME","BGC(2_B_)-U2A(1_B_)",46.6345,"","",""
"6JGQ","CRYSTAL STRUCTURE OF BARLEY EXOHYDROLASEI W434Y MUTANT IN COMPLEX WITH METHYL 2-THIO-BETA-SOPHOROSIDE.","10.1038/S41467-022-33180-5 ",2.01,27.37,"6jgq_oligo1","DGlcpb1-2DGlcp[2<R1>]b1-OME","BGC(2_B_)-U2A(1_B_)",40.9318,"","",""
"6KA7","THE COMPLEX STRUCTURE OF HUMAN IGG FC AND ITS BINDING REPEBODY","",3,57.46,"6ka7_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_C_)",85.4357,"","",""
"6KA7","THE COMPLEX STRUCTURE OF HUMAN IGG FC AND ITS BINDING REPEBODY","",3,57.46,"6ka7_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_D_)",68.6768,"","",""
"6KRU","CRYSTAL STRUCTURE OF MOUSE IGG2B FC","10.3390/IJMS21010147 ",2.3,59.68,"6kru_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_L_)-[GAL(6_L_)-NAG(5_L_)-MAN(4_L_)-[NAG(8_L_)-MAN(7_L_)]-MAN(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(297_F_)",65.093,"","",""
"6KRU","CRYSTAL STRUCTURE OF MOUSE IGG2B FC","10.3390/IJMS21010147 ",2.3,59.68,"6kru_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_K_)-NAG(5_K_)-MAN(4_K_)-[NAG(8_K_)-MAN(7_K_)]-MAN(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(297_E_)",109.683,"","",""
"6KRU","CRYSTAL STRUCTURE OF MOUSE IGG2B FC","10.3390/IJMS21010147 ",2.3,59.68,"6kru_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_J_)-[GAL(6_J_)-NAG(5_J_)-MAN(4_J_)-[NAG(8_J_)-MAN(7_J_)]-MAN(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(297_D_)",66.0174,"","",""
"6KRU","CRYSTAL STRUCTURE OF MOUSE IGG2B FC","10.3390/IJMS21010147 ",2.3,59.68,"6kru_oligo5","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[NAG(8_H_)-MAN(7_H_)]-MAN(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",63.1105,"","",""
"6KRU","CRYSTAL STRUCTURE OF MOUSE IGG2B FC","10.3390/IJMS21010147 ",2.3,59.68,"6kru_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_I_)-[GAL(6_I_)-NAG(5_I_)-MAN(4_I_)-[NAG(8_I_)-MAN(7_I_)]-MAN(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_C_)",72.5033,"","",""
"6KRU","CRYSTAL STRUCTURE OF MOUSE IGG2B FC","10.3390/IJMS21010147 ",2.3,59.68,"6kru_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[NAG(8_G_)-MAN(7_G_)]-MAN(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",76.5933,"","",""
"6KRV","CRYSTAL STRUCTURE OF MOUSE IGG2B FC COMPLEXED WITH B DOMAIN OF PROTEIN A","10.3390/IJMS21010147 ",3.3,150.8,"6krv_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-MAN(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",144.018,"","",""
"6KRV","CRYSTAL STRUCTURE OF MOUSE IGG2B FC COMPLEXED WITH B DOMAIN OF PROTEIN A","10.3390/IJMS21010147 ",3.3,150.8,"6krv_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_C_)",190.445,"","",""
"6KRV","CRYSTAL STRUCTURE OF MOUSE IGG2B FC COMPLEXED WITH B DOMAIN OF PROTEIN A","10.3390/IJMS21010147 ",3.3,150.8,"6krv_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-4DGlcpNAcx1-","NAG(6_F_)-MAN(5_F_)-[NAG(4_F_)-MAN(3_F_)]-MAN(2_F_)-NAG(1_F_)",227.744,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo5","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(54_K_)",87.8047,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo2","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_P_)-MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(87_A_)",69.9073,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo4","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_N_)-MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(87_K_)",81.4722,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo10","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-[NAG(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(87_G_)",82.4494,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo7","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[NAG(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(54_E_)",78.3845,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo31","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_o_)-[NAG(9_o_)-MAN(8_o_)-[NAG(7_o_)-[GAL(6_o_)-NAG(5_o_)]-MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)]-NAG(1_o_)-ASN(637_F_)",172.364,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo30","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_n_)-[GAL(8_n_)-NAG(7_n_)-[GAL(6_n_)-NAG(5_n_)]-MAN(4_n_)-[MAN(9_n_)]-BMA(3_n_)-NAG(2_n_)]-NAG(1_n_)-ASN(611_F_)",146.443,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo17","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(11_T_)-[GAL(8_T_)-NAG(7_T_)-[GAL(6_T_)-NAG(5_T_)]-MAN(4_T_)-[NAG(10_T_)-MAN(9_T_)]-BMA(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(611_B_)",188.354,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo2","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_U_)-[NAG(9_U_)-MAN(8_U_)-[NAG(7_U_)-[GAL(6_U_)-NAG(5_U_)]-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)]-NAG(1_U_)-ASN(637_B_)",190.606,"","",""
"6MD6","CRYSTAL STRUCTURE ANALYSIS OF PLANT EXOHYDROLASE IN COMPLEX WITH METHYL 2-THIO-BETA-SOPHOROSIDE","10.1038/S41467-019-09691-Z ",1.68,21.53,"6md6_oligo1","DGlcpb1-2DGlcp[2<R1>]b1-OME","BGC(2_B_)-U2A(1_B_)",36.0332,"","",""
"6MDS","CRYSTAL STRUCTURE OF STREPTOCOCCUS PYOGENES ENDO-BETA-N- ACETYLGLUCOSAMINIDASE (ENDOS2) WITH COMPLEX BIANTENNARY GLYCAN","10.1021/ACSCENTSCI.8B00917 ",2.5,48.7,"6mds_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_D_)-NAG(7_D_)-MAN(6_D_)-[GAL(5_D_)-NAG(4_D_)-MAN(3_D_)]-BMA(2_D_)-NAG(1_D_)",69.5976,"","",""
"6MDS","CRYSTAL STRUCTURE OF STREPTOCOCCUS PYOGENES ENDO-BETA-N- ACETYLGLUCOSAMINIDASE (ENDOS2) WITH COMPLEX BIANTENNARY GLYCAN","10.1021/ACSCENTSCI.8B00917 ",2.5,48.7,"6mds_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_C_)-NAG(7_C_)-MAN(6_C_)-[GAL(5_C_)-NAG(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",64.8303,"","",""
"6MGK","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN FROM GH74 ENZYME POGH74 FROM PAENIBACILLUS ODORIFER, IN COMPLEX WITH XLX XYLOGLUCAN","10.1042/BCJ20180763 ",2.1,0,"6mgk_oligo4","DGalpb1-2DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-ROH","XYS(5_G_)-[GAL(4_G_)-XYS(3_G_)-BGC(2_G_)]-BGC(1_G_)",37.1047,"","",""
"6MGK","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN FROM GH74 ENZYME POGH74 FROM PAENIBACILLUS ODORIFER, IN COMPLEX WITH XLX XYLOGLUCAN","10.1042/BCJ20180763 ",2.1,0,"6mgk_oligo2","DGalpb1-2DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-ROH","XYS(5_E_)-[GAL(4_E_)-XYS(3_E_)-BGC(2_E_)]-BGC(1_E_)",33.9135,"","",""
"6MGK","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN FROM GH74 ENZYME POGH74 FROM PAENIBACILLUS ODORIFER, IN COMPLEX WITH XLX XYLOGLUCAN","10.1042/BCJ20180763 ",2.1,0,"6mgk_oligo3","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-ROH","XYS(7_F_)-[GAL(6_F_)-XYS(5_F_)-[XYS(4_F_)-BGC(3_F_)]-BGC(2_F_)]-BGC(1_F_)",31.8813,"","",""
"6MGK","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN FROM GH74 ENZYME POGH74 FROM PAENIBACILLUS ODORIFER, IN COMPLEX WITH XLX XYLOGLUCAN","10.1042/BCJ20180763 ",2.1,0,"6mgk_oligo1","DGalpb1-2DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-ROH","XYS(5_H_)-[GAL(4_H_)-XYS(3_H_)-BGC(2_H_)]-BGC(1_H_)",39.7653,"","",""
"6MGL","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN FROM GH74 ENZYME POGH74 FROM PAENIBACILLUS ODORIFER, D60A MUTANT IN COMPLEX WITH XXLG AND XGXXLG XYLOGLUCAN","10.1042/BCJ20180763 ",1.5,0,"6mgl_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(8_B_)-XYS(7_B_)-[XYS(6_B_)-[XYS(5_B_)-BGC(4_B_)]-BGC(3_B_)]-BGC(2_B_)-BGC(1_B_)",27.2939,"","",""
"6MGL","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN FROM GH74 ENZYME POGH74 FROM PAENIBACILLUS ODORIFER, D60A MUTANT IN COMPLEX WITH XXLG AND XGXXLG XYLOGLUCAN","10.1042/BCJ20180763 ",1.5,0,"6mgl_oligo2","DXylpa1-6DGlcpb1-4DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(11_C_)-XYS(10_C_)-[XYS(9_C_)-[XYS(8_C_)-[XYS(7_C_)-BGC(6_C_)-BGC(5_C_)]-BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-BGC(1_C_)",25.1909,"","",""
"6MJ3","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX","10.3389/FIMMU.2022.960411 ",3.8,0,"6mj3_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_J_)-[NAG(7_J_)-MAN(6_J_)-[NAG(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(297_E_)",118.352,"","",""
"6MJ3","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX","10.3389/FIMMU.2022.960411 ",3.8,0,"6mj3_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_I_)-[NAG(7_I_)-MAN(6_I_)-[NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_D_)",107.428,"","",""
"6MJ3","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX","10.3389/FIMMU.2022.960411 ",3.8,0,"6mj3_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",109.917,"","",""
"6MJ3","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX","10.3389/FIMMU.2022.960411 ",3.8,0,"6mj3_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",128.198,"","",""
"6N9T","STRUCTURE OF A PEPTIDE-BASED PHOTO-AFFINITY CROSS-LINKER WITH HERCEPTIN FC","10.1021/ACS.BIOCONJCHEM.8B00809 ",2.58,0,"6n9t_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_D_)-[NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",56.9825,"","",""
"6N9T","STRUCTURE OF A PEPTIDE-BASED PHOTO-AFFINITY CROSS-LINKER WITH HERCEPTIN FC","10.1021/ACS.BIOCONJCHEM.8B00809 ",2.58,0,"6n9t_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",55.6258,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo22","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_f_)-[GAL(8_f_)-NAG(7_f_)-[GAL(6_f_)-NAG(5_f_)]-MAN(4_f_)-[MAN(9_f_)]-BMA(3_f_)-NAG(2_f_)]-NAG(1_f_)-ASN(611_D_)",142.411,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo21","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_e_)-[NAG(8_e_)-MAN(7_e_)-[GAL(6_e_)-NAG(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)]-NAG(1_e_)-ASN(637_D_)",126.382,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo20","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_V_)-[MAN(8_V_)-[NAG(7_V_)-[GAL(6_V_)-NAG(5_V_)]-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(637_B_)",122.313,"","",""
"6P2L","CRYSTAL STRUCTURE OF NIASTELLA KOREENSIS GH74 (NKGH74) ENZYME","10.1074/JBC.RA119.009861 ",1.08,0,"6p2l_oligo2","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpa1-ROH","GAL(8_B_)-XYS(7_B_)-[XYS(6_B_)-[XYS(5_B_)-BGC(4_B_)]-BGC(3_B_)]-BGC(2_B_)-GLC(1_B_)",18.6744,"","",""
"6P2M","CRYSTAL STRUCTURE OF THE CALDICELLULOSIRUPTOR LACTOACETICUS GH74 (CLGH74A) ENZYME IN COMPLEX WITH LLG XYLOGLUCAN","10.1074/JBC.RA119.009861 ",1.98,0,"6p2m_oligo1","DGalpb1-2DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(7_B_)-XYS(6_B_)-[GAL(5_B_)-XYS(4_B_)-BGC(3_B_)]-BGC(2_B_)-BGC(1_B_)",47.2924,"","",""
"6P2O","CRYSTAL STRUCTURE OF STREPTOMYCES RAPAMYCINICUS GH74 IN COMPLEX WITH XYLOGLUCAN FRAGMENTS XLLG AND XXXG","10.1074/JBC.RA119.009861 ",1.88,0,"6p2o_oligo3","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(9_E_)-XYS(8_E_)-[GAL(7_E_)-XYS(6_E_)-[XYS(5_E_)-BGC(4_E_)]-BGC(3_E_)]-BGC(2_E_)-BGC(1_E_)",29.6569,"","",""
"6P2O","CRYSTAL STRUCTURE OF STREPTOMYCES RAPAMYCINICUS GH74 IN COMPLEX WITH XYLOGLUCAN FRAGMENTS XLLG AND XXXG","10.1074/JBC.RA119.009861 ",1.88,0,"6p2o_oligo1","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(9_C_)-XYS(8_C_)-[GAL(7_C_)-XYS(6_C_)-[XYS(5_C_)-BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-BGC(1_C_)",32.1234,"","",""
"6P3S","CRYSTAL STRUCTURE OF HUMAN FAB H5.28 IN COMPLEX WITH INFLUENZA A H5N1 VIETNAM HEMAGGLUTININ HEAD DOMAIN","",4,0,"6p3s_oligo4","DNeup5Aca2-6DGalpa1-4DGlcpNAcb1-2DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_b_)-GLA(6_b_)-NAG(5_b_)-MAN(4_b_)-MAN(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(163_K_)",152.064,"","",""
"6P3S","CRYSTAL STRUCTURE OF HUMAN FAB H5.28 IN COMPLEX WITH INFLUENZA A H5N1 VIETNAM HEMAGGLUTININ HEAD DOMAIN","",4,0,"6p3s_oligo2","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_Z_)-GAL(6_Z_)-NAG(5_Z_)-BMA(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(163_H_)",134.551,"","",""
"6P6D","HUMAN IGG1 FC FRAGMENT, C239 INSERTION MUTANT","10.3390/PHARMACEUTICS11100546 ",2.31,53.83,"6p6d_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",74.0993,"","",""
"6P6D","HUMAN IGG1 FC FRAGMENT, C239 INSERTION MUTANT","10.3390/PHARMACEUTICS11100546 ",2.31,53.83,"6p6d_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",114.865,"","",""
"6PWR","CRYSTAL STRUCTURE OF THE COW C-TYPE CARBOHYDRATE-RECOGNITION DOMAIN OF CD23 IN THE PRESENCE OF GLCNAC-BETA1-2-MAN","10.1074/JBC.RA119.010572 ",1.2,10.12,"6pwr_oligo1","DGlcpNAcb1-2DManpa1-ROH","NAG(2_B_)-MAN(1_B_)",7.465,"","",""
"6PWT","CRYSTAL STRUCTURE OF THE COW C-TYPE CARBOHYDRATE-RECOGNITION DOMAIN OF CD23 IN THE PRESENCE OF GLCNAC2MAN3 OLIGOSACCHARIDE","10.1074/JBC.RA119.010572 ",2.7,85.3,"6pwt_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_B_)-MAN(4_B_)-[NAG(3_B_)-MAN(2_B_)]-MAN(1_B_)",78.1735,"","",""
"6PWU","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB","10.1016/J.JMB.2019.11.028 ",6.2,844820,"6pwu_oligo15","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(134_A_)",383.448,"","",""
"6Q4Z","STRUCTURE OF AN INACTIVE VARIANT (D94N) OF MPT-2, A GDP-MAN-DEPENDENT MANNOSYLTRANSFERASE FROM LEISHMANIA MEXICANA, IN COMPLEX WITH BETA-1, 2-MANNOBIOSE","10.1016/J.CHOM.2019.08.009 ",1.55,27.65,"6q4z_oligo1","DManpb1-2DManpa1-ROH","BMA(2_C_)-MAN(1_C_)",22.8214,"","",""
"6Q4Z","STRUCTURE OF AN INACTIVE VARIANT (D94N) OF MPT-2, A GDP-MAN-DEPENDENT MANNOSYLTRANSFERASE FROM LEISHMANIA MEXICANA, IN COMPLEX WITH BETA-1, 2-MANNOBIOSE","10.1016/J.CHOM.2019.08.009 ",1.55,27.65,"6q4z_oligo2","DManpb1-2DManpa1-ROH","BMA(2_D_)-MAN(1_D_)",26.7709,"","",""
"6S5A","CRYSTAL STRUCTURE OF FC P329G LALA WITH ANTI FC P329G FAB","10.1093/PROTEIN/GZZ027 ",1.72,48.94,"6s5a_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_D_)",43.4699,"","",""
"6S5A","CRYSTAL STRUCTURE OF FC P329G LALA WITH ANTI FC P329G FAB","10.1093/PROTEIN/GZZ027 ",1.72,48.94,"6s5a_oligo1","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_B_)-[NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",83.0861,"","",""
"6TKV","CRYSTAL STRUCTURE OF THE HUMAN FUT8 IN COMPLEX WITH GDP AND A BIANTENNARY COMPLEX N-GLYCAN","10.1038/S41467-020-14794-Z ",1.95,36.11,"6tkv_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",39.4397,"","",""
"6TKV","CRYSTAL STRUCTURE OF THE HUMAN FUT8 IN COMPLEX WITH GDP AND A BIANTENNARY COMPLEX N-GLYCAN","10.1038/S41467-020-14794-Z ",1.95,36.11,"6tkv_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",48.896,"","",""
"6TP5","CRYSTAL STRUCTURE OF HUMAN TRANSMEMBRANE PROLYL 4-HYDROXYLASE","10.1074/JBC.RA120.016542 ",2.25,87.78,"6tp5_oligo4","DManpb1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_F_)-MAN(8_F_)-[MAN(10_F_)]-MAN(7_F_)-[BMA(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(382_B_)",119.763,"","",""
"6TQK","CRYO-EM OF NATIVE HUMAN UROMODULIN (UMOD)/TAMM-HORSFALL PROTEIN (THP) FILAMENT.","10.15252/EMBJ.2020106807 ",3.35,0,"6tqk_oligo2","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-[NAG(7_G_)-[GAL(6_G_)-NAG(5_G_)]-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(396_C_)",161.743,"","",""
"6TQK","CRYO-EM OF NATIVE HUMAN UROMODULIN (UMOD)/TAMM-HORSFALL PROTEIN (THP) FILAMENT.","10.15252/EMBJ.2020106807 ",3.35,0,"6tqk_oligo4","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_E_)-[NAG(7_E_)-[GAL(6_E_)-NAG(5_E_)]-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(396_A_)",174.455,"","",""
"6TQL","CRYO-EM OF ELASTASE-TREATED HUMAN UROMODULIN (UMOD)/TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.15252/EMBJ.2020106807 ",3.96,"1.15243e-41","6tql_oligo3","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-6[DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-[GAL(6_E_)-NAG(5_E_)]-MAN(4_E_)-[NAG(10_E_)-[NAG(9_E_)]-MAN(8_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(396_A_)",233.983,"","",""
"6TQL","CRYO-EM OF ELASTASE-TREATED HUMAN UROMODULIN (UMOD)/TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.15252/EMBJ.2020106807 ",3.96,"1.15243e-41","6tql_oligo4","DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_G_)-MAN(7_G_)-[NAG(6_G_)-[NAG(5_G_)]-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(396_C_)",177.91,"","",""
"6UGW","CRYSTAL STRUCTURE OF THE FC FRAGMENT OF PF06438179/GP1111 AN INFLIXIMAB BIOSIMILAR IN A C-CENTERED ORTHORHOMBIC CRYSTAL FORM, LOT A","10.1007/S40259-019-00390-1 ",2,42.26,"6ugw_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManp[3<R1>]b1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(300_A_)",57.1612,"","",""
"6UGX","CRYSTAL STRUCTURE OF THE FC FRAGMENT OF PF06438179/GP1111 AN INFLIXIMAB BIOSIMILAR IN A PRIMATIVE ORTHORHOMBIC CRYSTAL FORM, LOT A","10.1007/S40259-019-00390-1 ",2.1,39.91,"6ugx_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(300_A_)",48.6664,"","",""
"6UGX","CRYSTAL STRUCTURE OF THE FC FRAGMENT OF PF06438179/GP1111 AN INFLIXIMAB BIOSIMILAR IN A PRIMATIVE ORTHORHOMBIC CRYSTAL FORM, LOT A","10.1007/S40259-019-00390-1 ",2.1,39.91,"6ugx_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_D_)-[NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(300_B_)",51.9827,"","",""
"6UGY","CRYSTAL STRUCTURE OF THE FC FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB (REMICADE) IN A PRIMATIVE ORTHORHOMBIC CRYSTAL FORM, LOT C","10.1007/S40259-019-00390-1 ",2.1,44.15,"6ugy_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(300_A_)",68.9984,"","",""
"6ULC","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB AT A NOMINAL RESOLUTION OF 4.6 ANGSTROM","10.1016/J.JMB.2019.11.028 ",4.6,"2.14959e+09","6ulc_oligo16","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(134_A_)",190.141,"","",""
"6UQC","MOUSE IGG2A BISPECIFIC FC","10.1080/19420862.2019.1685350 ",1.87,40.9,"6uqc_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(507_D_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(297_D_)",75.8019,"","",""
"6UQC","MOUSE IGG2A BISPECIFIC FC","10.1080/19420862.2019.1685350 ",1.87,40.9,"6uqc_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(297_F_)",46.501,"","",""
"6UQC","MOUSE IGG2A BISPECIFIC FC","10.1080/19420862.2019.1685350 ",1.87,40.9,"6uqc_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(507_C_)-MAN(6_A_)-[NAG(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(297_C_)",71.2319,"","",""
"6UQC","MOUSE IGG2A BISPECIFIC FC","10.1080/19420862.2019.1685350 ",1.87,40.9,"6uqc_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(297_E_)",46.0612,"","",""
"6UUH","CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY 438- B11","10.1126/SCIADV.ABB1328 ",2.7,60.13,"6uuh_oligo1","DManpa1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[NAG(7_G_)-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(27_B_)",109.495,"","",""
"6V06","CRYSTAL STRUCTURE OF BETA-2 GLYCOPROTEIN I PURIFIED FROM PLASMA (PB2GPI)","10.1074/JBC.RA120.013939 ",2.4,65.47,"6v06_oligo3","DManpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(8_C_)-MAN(7_C_)-[BMA(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",170.736,"","",""
"6V06","CRYSTAL STRUCTURE OF BETA-2 GLYCOPROTEIN I PURIFIED FROM PLASMA (PB2GPI)","10.1074/JBC.RA120.013939 ",2.4,65.47,"6v06_oligo5","DGlcpNAcb1-2DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_E_)-BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(164_A_)",199.785,"","",""
"6V06","CRYSTAL STRUCTURE OF BETA-2 GLYCOPROTEIN I PURIFIED FROM PLASMA (PB2GPI)","10.1074/JBC.RA120.013939 ",2.4,65.47,"6v06_oligo2","DManpa1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_B_)-MAN(7_B_)-[MAN(6_B_)-NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(143_A_)",207.568,"","",""
"6V08","CRYSTAL STRUCTURE OF HUMAN RECOMBINANT BETA-2 GLYCOPROTEIN I (HRB2GPI)","10.1074/JBC.RA120.013939 ",2.58,68.76,"6v08_oligo3","DManpa1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_B_)-MAN(7_B_)-[MAN(6_B_)-NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(143_A_)",204.617,"","",""
"6V08","CRYSTAL STRUCTURE OF HUMAN RECOMBINANT BETA-2 GLYCOPROTEIN I (HRB2GPI)","10.1074/JBC.RA120.013939 ",2.58,68.76,"6v08_oligo4","DManpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_C_)-MAN(7_C_)-[BMA(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(174_A_)",172.124,"","",""
"6VLD","CRYSTAL STRUCTURE OF HUMAN ALPHA 1,6-FUCOSYLTRANSFERASE, FUT8 BOUND TO GDP AND A2SGP","10.1074/JBC.RA120.013291 ",2.28,64.03,"6vld_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(601_A_)",56.7987,"","",""
"6VLD","CRYSTAL STRUCTURE OF HUMAN ALPHA 1,6-FUCOSYLTRANSFERASE, FUT8 BOUND TO GDP AND A2SGP","10.1074/JBC.RA120.013291 ",2.28,64.03,"6vld_oligo6","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(601_H_)",48.2195,"","",""
"6VLD","CRYSTAL STRUCTURE OF HUMAN ALPHA 1,6-FUCOSYLTRANSFERASE, FUT8 BOUND TO GDP AND A2SGP","10.1074/JBC.RA120.013291 ",2.28,64.03,"6vld_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(601_G_)",74.1023,"","",""
"6VLD","CRYSTAL STRUCTURE OF HUMAN ALPHA 1,6-FUCOSYLTRANSFERASE, FUT8 BOUND TO GDP AND A2SGP","10.1074/JBC.RA120.013291 ",2.28,64.03,"6vld_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(601_B_)",70.2448,"","",""
"6VPX","NANODISC OF FULL-LENGTH HIV-1 ENVELOPE GLYCOPROTEIN CLONE AMC011 IN COMPLEX WITH ONE PGT151 FAB AND THREE 10E8 FABS","10.1016/J.CELREP.2020.107583 ",5,0.00048876,"6vpx_oligo21","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_l_)-[MAN(8_l_)-[NAG(7_l_)-[GAL(6_l_)-NAG(5_l_)]-MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)]-NAG(1_l_)-ASN(637_B_)",122.313,"","",""
"6VSL","CRYSTAL STRUCTURE OF A HUMAN FUCOSYLATED IGG1 FC EXPRESSED IN TOBACCO PLANTS (NICOTIANA BENTHAMIANA)","10.1128/JVI.00796-21 ",2.1,0,"6vsl_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.7808,"","",""
"6VSL","CRYSTAL STRUCTURE OF A HUMAN FUCOSYLATED IGG1 FC EXPRESSED IN TOBACCO PLANTS (NICOTIANA BENTHAMIANA)","10.1128/JVI.00796-21 ",2.1,0,"6vsl_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",94.7328,"","",""
"6VSZ","CRYSTAL STRUCTURE OF A HUMAN AFUCOSYLATED IGG1 FC EXPRESSED IN TOBACCO PLANTS (NICOTIANA BENTHAMIANA)","10.1128/JVI.00796-21 ",2.6,0,"6vsz_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",94.3261,"","",""
"6VSZ","CRYSTAL STRUCTURE OF A HUMAN AFUCOSYLATED IGG1 FC EXPRESSED IN TOBACCO PLANTS (NICOTIANA BENTHAMIANA)","10.1128/JVI.00796-21 ",2.6,0,"6vsz_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",111.767,"","",""
"6VV5","CRYO-EM STRUCTURE OF PORCINE EPIDEMIC DIARRHEA VIRUS (PEDV) SPIKE PROTEIN","10.1016/J.STR.2020.12.003 ",3.5,0,"6vv5_oligo7","DManpa1-2DManpa1-3[DGlcpNAcb1-2[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_N_)-[NAG(7_N_)]-MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(264_B_)",46.2131,"","",""
"6VV5","CRYO-EM STRUCTURE OF PORCINE EPIDEMIC DIARRHEA VIRUS (PEDV) SPIKE PROTEIN","10.1016/J.STR.2020.12.003 ",3.5,0,"6vv5_oligo8","DManpa1-2DManpa1-3[DGlcpNAcb1-2[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_D_)-[NAG(7_D_)]-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(264_A_)",46.2131,"","",""
"6VV5","CRYO-EM STRUCTURE OF PORCINE EPIDEMIC DIARRHEA VIRUS (PEDV) SPIKE PROTEIN","10.1016/J.STR.2020.12.003 ",3.5,0,"6vv5_oligo18","DManpa1-2DManpa1-3[DGlcpNAcb1-2[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_X_)-[NAG(7_X_)]-MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(264_C_)",46.2131,"","",""
"6W3H","BRAIN DELIVERY OF THERAPEUTIC PROTEINS USING AN FC FRAGMENT BLOOD- BRAIN BARRIER TRANSPORT VEHICLE IN MICE AND MONKEYS","10.1126/SCITRANSLMED.AAY1359 ",3.38,72.05,"6w3h_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_A_)",86.4807,"","",""
"6WIB","NEXT GENERATION MONOMERIC IGG4 FC","10.1038/S42003-021-02565-5 ",2.55,35.64,"6wib_oligo1","NAG1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_B_)-[NAG(7_B_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",56.8193,"","",""
"6WNA","NEXT GENERATION MONOMERIC IGG4 FC","10.1038/S42003-021-02565-5 ",2.4,45.39,"6wna_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4NAG1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_H_)",83.6889,"","",""
"6WOL","NEXT GENERATION MONOMERIC IGG4 FC BOUND TO NEONATAL FC RECEPTOR","10.1038/S42003-021-02565-5 ",2.49,45.35,"6wol_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_H_)",79.3048,"","",""
"6X5R","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A2-ASN","10.1074/JBC.RA120.014625 ",2.4,0,"6x5r_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(700_D_)",45.2336,"","",""
"6X5R","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A2-ASN","10.1074/JBC.RA120.014625 ",2.4,0,"6x5r_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(700_C_)",47.8686,"","",""
"6X5S","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A3'-ASN","10.1074/JBC.RA120.014625 ",3.3,0,"6x5s_oligo4","DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_F_)-MAN(7_F_)-[NAG(6_F_)-[NAG(5_F_)]-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(700_D_)",67.5676,"","",""
"6X5S","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A3'-ASN","10.1074/JBC.RA120.014625 ",3.3,0,"6x5s_oligo3","DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_E_)-MAN(7_E_)-[NAG(6_E_)-[NAG(5_E_)]-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(700_C_)",67.874,"","",""
"6X5T","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A3-ASN","10.1074/JBC.RA120.014625 ",2.47,0,"6x5t_oligo9","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)",60.8722,"","",""
"6X5T","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A3-ASN","10.1074/JBC.RA120.014625 ",2.47,0,"6x5t_oligo10","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)",58.0269,"","",""
"6X5T","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A3-ASN","10.1074/JBC.RA120.014625 ",2.47,0,"6x5t_oligo12","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(5_L_)-MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)",64.3784,"","",""
"6X5T","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A3-ASN","10.1074/JBC.RA120.014625 ",2.47,0,"6x5t_oligo11","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(5_K_)-MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)",74.5669,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo16","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(6_P_)-[NAG(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",73.6539,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo11","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(700_C_)",62.2491,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo14","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(5_N_)-[NAG(4_N_)-MAN(3_N_)]-BMA(2_N_)-NAG(1_N_)",72.5517,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo13","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-ROH","NAG(4_M_)-MAN(3_M_)-BMA(2_M_)-NAG(1_M_)",71.8882,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo9","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(700_A_)",67.9324,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo10","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(5_J_)-[NAG(4_J_)-MAN(3_J_)]-BMA(2_J_)-NAG(1_J_)",71.7953,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo15","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(5_O_)-MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)",79.2142,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo12","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(5_L_)-[NAG(4_L_)-MAN(3_L_)]-BMA(2_L_)-NAG(1_L_)",72.644,"","",""
"6YCE","STRUCTURE THE BROMELAIN PROTEASE FROM ANANAS COMOSUS WITH A THIOMETHYLATED ACTIVE CYSTEINE","10.1038/S41598-020-76172-5 ",1.8,25.01,"6yce_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","XYS(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUC(5_C_)]-NAG(1_C_)-ASN(117_A_)",29.7719,"","",""
"6YCF","STRUCTURE THE BROMELAIN PROTEASE FROM ANANAS COMOSUS IN COMPLEX WITH THE E64 INHIBITOR","10.1038/S41598-020-76172-5 ",1.85,29.03,"6ycf_oligo1","DXylpb1-2[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_C_)-[XYS(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)-ASN(117_A_)",38.3723,"","",""
"6YCG","STRUCTURE THE BROMELAIN PROTEASE FROM ANANAS COMOSUS IN COMPLEX WITH THE TLCK INHIBITOR","10.1038/S41598-020-76172-5 ",1.45,17.38,"6ycg_oligo1","DXylpb1-2[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_C_)-[XYS(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)-ASN(117_A_)",24.7054,"","",""
"6YSC","GLYCOSYLATED KNOB-HOLE/DUMMY FC FRAGMENT","10.1038/S41467-020-18477-7 ",2.05,47.89,"6ysc_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",79.578,"","",""
"6YSC","GLYCOSYLATED KNOB-HOLE/DUMMY FC FRAGMENT","10.1038/S41467-020-18477-7 ",2.05,47.89,"6ysc_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",47.605,"","",""
"6YT7","GLYCOSYLATED KNOB/DUMMY-HOLE FC FRAGMENT","10.1038/S41467-020-18477-7 ",1.55,36.54,"6yt7_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",43.4009,"","",""
"6YT7","GLYCOSYLATED KNOB/DUMMY-HOLE FC FRAGMENT","10.1038/S41467-020-18477-7 ",1.55,36.54,"6yt7_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",54.2184,"","",""
"6YTB","GLYCOSYLATED KNOB/DUMMY-HOLE/DUMMY FC FRAGMENT","10.1038/S41467-020-18477-7 ",1.65,38.23,"6ytb_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",42.0985,"","",""
"6YTB","GLYCOSYLATED KNOB/DUMMY-HOLE/DUMMY FC FRAGMENT","10.1038/S41467-020-18477-7 ",1.65,38.23,"6ytb_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",61.2668,"","",""
"6ZPU","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME C-DOMAIN WITH INSERTED SYMMETRY MOLECULE C-TERMINUS.","10.1111/FEBS.15601 ",2,39.6,"6zpu_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(109_A_)",57.8309,"","",""
"7API","THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM","10.1093/PROTEIN/2.6.407 ",3,0,"7api_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(46_A_)",53.2947,"","",""
"7C69","CRYSTAL STRUCTURE OF BETA-GLYCOSIDES-BINDING PROTEIN OF ABC TRANSPORTER IN A CLOSED STATE BOUND TO SOPHOROSE","10.1016/J.JMB.2020.08.021 ",2.35,26.38,"7c69_oligo1","DGlcpb1-2DGlcpb1-ROH","BGC(2_C_)-BGC(1_C_)",16.1159,"","",""
"7C69","CRYSTAL STRUCTURE OF BETA-GLYCOSIDES-BINDING PROTEIN OF ABC TRANSPORTER IN A CLOSED STATE BOUND TO SOPHOROSE","10.1016/J.JMB.2020.08.021 ",2.35,26.38,"7c69_oligo2","DGlcpb1-2DGlcpb1-ROH","BGC(2_D_)-BGC(1_D_)",19.4577,"","",""
"7C6I","CRYSTAL STRUCTURE OF BETA-GLYCOSIDES-BINDING PROTEIN (W177X) OF ABC TRANSPORTER IN AN OPEN-LIGANDED STATE BOUND TO SOPHOROSE","10.1016/J.JMB.2020.08.021 ",1.7,21.94,"7c6i_oligo1","DGlcpb1-2DGlcpb1-ROH","BGC(2_C_)-BGC(1_C_)",20.9564,"","",""
"7C6I","CRYSTAL STRUCTURE OF BETA-GLYCOSIDES-BINDING PROTEIN (W177X) OF ABC TRANSPORTER IN AN OPEN-LIGANDED STATE BOUND TO SOPHOROSE","10.1016/J.JMB.2020.08.021 ",1.7,21.94,"7c6i_oligo2","DGlcpb1-2DGlcpb1-ROH","BGC(2_D_)-BGC(1_D_)",24.8436,"","",""
"7EEB","STRUCTURE OF THE CATSPERMASOME","10.1038/S41586-021-03742-6 ",2.9,"1.35632e-19","7eeb_oligo1","DManpb1-2DManpb1-3[DManpb1-3DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_O_)-BMA(6_O_)-[BMA(5_O_)-BMA(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(90_E_)",79.3492,"","",""
"7EOX","PROTEASE STRUCTURE FROM EUPHORBIA RESINIFERA","10.1002/BAB.2307 ",1.7,26.67,"7eox_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(121_B_)",34.8843,"","",""
"7EQW","CRYSTAL STRUCTURE OF CAPSID P DOMAIN OF NOROVIRUS GI.3 DSV COMPLEXED WITH NA2 N-GLYCAN","10.1128/JVI.00420-22 ",2.15,33.49,"7eqw_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-ROH","GAL(3_C_)-NAG(2_C_)-MAN(1_C_)",72.1324,"","",""
"7KCZ","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX V158 MUTANT","10.3389/FIMMU.2022.960411 ",3.15,0,"7kcz_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_K_)-[NAG(7_K_)-MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(297_E_)",82.9721,"","",""
"7KCZ","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX V158 MUTANT","10.3389/FIMMU.2022.960411 ",3.15,0,"7kcz_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",78.367,"","",""
"7KCZ","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX V158 MUTANT","10.3389/FIMMU.2022.960411 ",3.15,0,"7kcz_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",66.2085,"","",""
"7KCZ","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX V158 MUTANT","10.3389/FIMMU.2022.960411 ",3.15,0,"7kcz_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_J_)-[NAG(7_J_)-MAN(6_J_)-[NAG(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(297_D_)",80.854,"","",""
"7L56","CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43","10.1016/J.CELREP.2021.108950 ",3.6,"1.08527e-19","7l56_oligo7","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-6DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_P_)-NAG(5_P_)-MAN(4_P_)-[MAN(8_P_)-MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(343_C_)",89.2622,"","",""
"7L56","CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43","10.1016/J.CELREP.2021.108950 ",3.6,"1.08527e-19","7l56_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[GAL(6_M_)-NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(343_B_)",97.9957,"","",""
"7L56","CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43","10.1016/J.CELREP.2021.108950 ",3.6,"1.08527e-19","7l56_oligo5","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_I_)-MAN(7_I_)-[GAL(6_I_)-NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(343_A_)",98.394,"","",""
"7L57","CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 15","10.1016/J.CELREP.2021.108950 ",5.87,"1.08527e-19","7l57_oligo1","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(343_A_)",268.189,"","",""
"7LBL","STRUCTURE OF HUMAN IGG1 FC","",2.13,59.11,"7lbl_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_B_)",89.7303,"","",""
"7LBL","STRUCTURE OF HUMAN IGG1 FC","",2.13,59.11,"7lbl_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",63.4261,"","",""
"7LF5","STRUCTURE OF HYPERGLYCOSYLATED HUMAN IGG1 FC (FC267)","",2.6,92.97,"7lf5_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",114.462,"","",""
"7LF9","STRUCTURE OF HYPERGLYCOSYLATED HUMAN IGG1 FC (FC329)","",2.2,64.68,"7lf9_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",70.1762,"","",""
"7LF9","STRUCTURE OF HYPERGLYCOSYLATED HUMAN IGG1 FC (FC329)","",2.2,64.68,"7lf9_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",117.126,"","",""
"7LFN","STRUCTURE OF HYPERGLYCOSYLATED HUMAN IGG1 FC (FC267_329)","",2.6,64,"7lfn_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",68.1181,"","",""
"7LFN","STRUCTURE OF HYPERGLYCOSYLATED HUMAN IGG1 FC (FC267_329)","",2.6,64,"7lfn_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",113.798,"","",""
"7LUS","IGG2 FC CHARGE PAIR MUTATION VERSION 1 (CPMV1)","10.1016/J.ISCI.2021.103447 ",2.45,39,"7lus_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",38.1909,"","",""
"7LUS","IGG2 FC CHARGE PAIR MUTATION VERSION 1 (CPMV1)","10.1016/J.ISCI.2021.103447 ",2.45,39,"7lus_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_B_)",37.042,"","",""
"7MXP","CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY LP5 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE","10.1002/AIC.17440 ",4.46,"5.50295e+11","7mxp_oligo6","[DGlcpNAcb1-2][DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_N_)-[BMA(7_N_)-[NAG(5_N_)-MAN(4_N_)]-[NAG(6_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(17_C_)",498.957,"","",""
"7MXP","CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY LP5 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE","10.1002/AIC.17440 ",4.46,"5.50295e+11","7mxp_oligo3","[DGlcpNAcb1-2][DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[BMA(7_F_)-[NAG(5_F_)-MAN(4_F_)]-[NAG(6_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(17_A_)",560.011,"","",""
"7MXP","CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY LP5 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE","10.1002/AIC.17440 ",4.46,"5.50295e+11","7mxp_oligo1","[DGlcpNAcb1-2]DManpa1-","NAG(5_E_)-[BMA(7_E_)-[NAG(6_E_)]-[FUC(8_E_)-NAG(1_E_)-NAG(2_E_)]-BMA(3_E_)]-MAN(4_E_)",919.847,"","",""
"7NWF","CRYSTAL STRUCTURE OF BACTEROIDES THETAIOTAMICRON ENDOBT-3987 IN COMPLEX WITH HYBRID-TYPE GLYCAN (GALGLCNACMAN5GLCNAC) PRODUCT","10.1016/J.JBC.2021.101011 ",2,25.67,"7nwf_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(8_B_)-[MAN(7_B_)]-MAN(6_B_)-[GAL(5_B_)-NAG(4_B_)-MAN(3_B_)]-BMA(2_B_)-NAG(1_B_)",32.2842,"","",""
"7NWL","CRYO-EM STRUCTURE OF HUMAN INTEGRIN ALPHA5BETA1 (OPEN FORM) IN COMPLEX WITH FIBRONECTIN AND TS2/16 FV-CLASP","10.1126/SCIADV.ABE9716 ",3.1,"1.35632e-19","7nwl_oligo5","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(275_A_)",109.242,"","",""
"7NXD","CRYO-EM STRUCTURE OF HUMAN INTEGRIN ALPHA5BETA1 IN THE HALF-BENT CONFORMATION","10.1126/SCIADV.ABE9716 ",4.6,0,"7nxd_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(275_A_)",141.757,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo5","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_L_)-[NAG(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(483_A_)",66.0927,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo3","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_g_)-[NAG(5_g_)-MAN(4_g_)-[MAN(6_g_)]-BMA(3_g_)-NAG(2_g_)]-NAG(1_g_)-ASN(483_H_)",61.3553,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_c_)-[NAG(5_c_)-MAN(4_c_)-[MAN(6_c_)]-BMA(3_c_)-NAG(2_c_)]-NAG(1_c_)-ASN(483_G_)",63.8999,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_F_)-NAG(8_F_)-MAN(7_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(232_A_)",354.721,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo14","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(9_Q_)-MAN(8_Q_)-[NAG(7_Q_)-[GAL(6_Q_)-NAG(5_Q_)]-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(396_C_)",303.191,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo12","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(9_I_)-MAN(8_I_)-[NAG(7_I_)-[GAL(6_I_)-NAG(5_I_)]-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(396_A_)",318.28,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo5","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_N_)-NAG(8_N_)-MAN(7_N_)-[GAL(6_N_)-NAG(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(232_C_)",323.928,"","",""
"7Q15","CRYSTAL STRUCTURE OF FCRN AND BETA-2-MICROGLOBULIN IN COMPLEX WITH IGG1-FC-MST-HN (EFGARTIGIMOD)","10.1038/S41467-022-33764-1 ",3.3,63.19,"7q15_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[MAN(7_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_F_)",129.195,"","",""
"7Q15","CRYSTAL STRUCTURE OF FCRN AND BETA-2-MICROGLOBULIN IN COMPLEX WITH IGG1-FC-MST-HN (EFGARTIGIMOD)","10.1038/S41467-022-33764-1 ",3.3,63.19,"7q15_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[NAG(8_G_)-MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_E_)",123.087,"","",""
"7Q3N","CRYO-EM OF THE COMPLEX BETWEEN HUMAN UROMODULIN (UMOD)/TAMM-HORSFALL PROTEIN (THP) AND THE FIMH LECTIN DOMAIN FROM UROPATHOGENIC E. COLI","10.1038/S41594-022-00729-3 ",7.4,13.2733,"7q3n_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(232_U_)",237.809,"","",""
"7Q3P","CRYSTAL STRUCTURE OF IGG1-FC-MST-HN (EFGARTIGIMOD)","10.1038/S41467-022-33764-1 ",2.1,50.78,"7q3p_oligo5","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcx1-","NAG(4_E_)-MAN(3_E_)-BMA(2_E_)-NAG(1_E_)",60.3587,"","",""
"7Q3P","CRYSTAL STRUCTURE OF IGG1-FC-MST-HN (EFGARTIGIMOD)","10.1038/S41467-022-33764-1 ",2.1,50.78,"7q3p_oligo8","DGlcpNAcb1-2DManpx1-","NAG(506_B_)-MAN(505_B_)",65.7413,"","",""
"7Q3P","CRYSTAL STRUCTURE OF IGG1-FC-MST-HN (EFGARTIGIMOD)","10.1038/S41467-022-33764-1 ",2.1,50.78,"7q3p_oligo7","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(507_B_)-MAN(504_B_)-BMA(503_B_)-NAG(502_B_)-NAG(501_B_)-ASN(297_B_)",68.5944,"","",""
"7Q3P","CRYSTAL STRUCTURE OF IGG1-FC-MST-HN (EFGARTIGIMOD)","10.1038/S41467-022-33764-1 ",2.1,50.78,"7q3p_oligo4","DGlcpNAcb1-2DManpx1-","NAG(2_F_)-MAN(1_F_)",100.624,"","",""
"7Q3P","CRYSTAL STRUCTURE OF IGG1-FC-MST-HN (EFGARTIGIMOD)","10.1038/S41467-022-33764-1 ",2.1,50.78,"7q3p_oligo6","DGlcpNAcb1-2DManpx1-","NAG(2_I_)-MAN(1_I_)",55.9302,"","",""
"7Q4D","LOCAL REFINEMENT STRUCTURE OF THE TWO INTERACTING N-DOMAINS OF FULL- LENGTH, DIMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.78,"1.15243e-41","7q4d_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(289_A_)",120.422,"","",""
"7Q4D","LOCAL REFINEMENT STRUCTURE OF THE TWO INTERACTING N-DOMAINS OF FULL- LENGTH, DIMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.78,"1.15243e-41","7q4d_oligo10","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_L_)-MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(25_B_)",101.383,"","",""
"7Q4D","LOCAL REFINEMENT STRUCTURE OF THE TWO INTERACTING N-DOMAINS OF FULL- LENGTH, DIMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.78,"1.15243e-41","7q4d_oligo2","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(25_A_)",100.57,"","",""
"7Q4D","LOCAL REFINEMENT STRUCTURE OF THE TWO INTERACTING N-DOMAINS OF FULL- LENGTH, DIMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.78,"1.15243e-41","7q4d_oligo11","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_M_)-[NAG(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(289_B_)",115.79,"","",""
"7Q4E","LOCAL REFINEMENT STRUCTURE OF A SINGLE N-DOMAIN OF FULL-LENGTH, DIMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.63,"1.15243e-41","7q4e_oligo5","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(25_A_)",109.553,"","",""
"7Q4E","LOCAL REFINEMENT STRUCTURE OF A SINGLE N-DOMAIN OF FULL-LENGTH, DIMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.63,"1.15243e-41","7q4e_oligo4","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(289_A_)",124.826,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo13","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3[DGalpb1-4DGlcpNAcb1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(12_O_)-[GAL(11_O_)-NAG(10_O_)-MAN(9_O_)-[GAL(8_O_)-NAG(7_O_)-[GAL(6_O_)-NAG(5_O_)]-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)]-NAG(1_O_)-ASN(4567_B_)",36.6591,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_C_)-[GAL(9_C_)-NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(4832_A_)",30.0909,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_K_)-NAG(8_K_)-MAN(7_K_)-[GAL(6_K_)-NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(4578_A_)",30.101,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo10","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_L_)-[GAL(9_L_)-NAG(8_L_)-MAN(7_L_)-[GAL(6_L_)-NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(4703_B_)",30.0909,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo5","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_G_)-[GAL(9_G_)-NAG(8_G_)-MAN(7_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(4703_A_)",30.0909,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo8","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_F_)-[GAL(9_F_)-NAG(8_F_)-MAN(7_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(4839_B_)",30.0909,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo9","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_J_)-[GAL(9_J_)-NAG(8_J_)-MAN(7_J_)-[GAL(6_J_)-NAG(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(4839_A_)",30.0909,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo4","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3[DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(14_D_)-[GAL(13_D_)-NAG(12_D_)-[GAL(11_D_)-NAG(10_D_)]-MAN(9_D_)-[GAL(8_D_)-NAG(7_D_)-[GAL(6_D_)-NAG(5_D_)]-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(4567_A_)",30.0649,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo14","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_Q_)-[GAL(9_Q_)-NAG(8_Q_)-MAN(7_Q_)-[GAL(6_Q_)-NAG(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)]-NAG(1_Q_)-ASN(4832_B_)",30.0909,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_H_)-NAG(8_H_)-MAN(7_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(4578_B_)",30.101,"","",""
"7RGF","PROTOCADHERIN GAMMAC4 EC1-4 CRYSTAL STRUCTURE DISRUPTED TRANS INTERFACE","10.7554/ELIFE.72416 ",2.4,73.39,"7rgf_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(236_A_)",88.4368,"","",""
"7RGF","PROTOCADHERIN GAMMAC4 EC1-4 CRYSTAL STRUCTURE DISRUPTED TRANS INTERFACE","10.7554/ELIFE.72416 ",2.4,73.39,"7rgf_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_D_)-[MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(236_B_)",93.0596,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo18","DGlcpNAcb1-2DManpx1-","NAG(2_h_)-MAN(1_h_)",0,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo16","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4NAG1-","NAG(5_n_)-MAN(4_n_)-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)",0,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo44","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","GAL(8_x_)-NAG(7_x_)-[GAL(6_x_)-NAG(5_x_)]-MAN(4_x_)-BMA(3_x_)-NAG(2_x_)-NAG(1_x_)",0,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo30","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","GAL(8_Q_)-NAG(7_Q_)-[GAL(6_Q_)-NAG(5_Q_)]-MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)",0,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo43","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4NAG1-","NAG(5_w_)-MAN(4_w_)-BMA(3_w_)-NAG(2_w_)-NAG(1_w_)",0,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo17","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","GAL(8_g_)-NAG(7_g_)-[GAL(6_g_)-NAG(5_g_)]-MAN(4_g_)-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)",0,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo31","DGlcpNAcb1-2DManpx1-","NAG(2_R_)-MAN(1_R_)",0,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo45","DGlcpNAcb1-2DManpx1-","NAG(2_y_)-MAN(1_y_)",0,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo29","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4NAG1-","NAG(5_P_)-MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",0,"","",""
"7SN0","CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF ESCAPE MUTANT SARS-COV-2 FROM IMMUNOCOMPROMISED PATIENT (D146*) IN COMPLEX WITH HUMAN RECEPTOR ACE2","10.1126/SCIENCE.ABL6251 ",3.08,97.77,"7sn0_oligo5","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(322_B_)",150.049,"","",""
"7SN0","CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF ESCAPE MUTANT SARS-COV-2 FROM IMMUNOCOMPROMISED PATIENT (D146*) IN COMPLEX WITH HUMAN RECEPTOR ACE2","10.1126/SCIENCE.ABL6251 ",3.08,97.77,"7sn0_oligo2","DGalpb1-4DGlcpNAcb1-4[DGlcpNAcb1-2]DManpa1-3[DGalpb1-4DGlcpNAcb1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(10_H_)-NAG(9_H_)-MAN(8_H_)-[GAL(6_H_)-NAG(5_H_)-[NAG(7_H_)]-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(53_A_)",163.886,"","",""
"7SN0","CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF ESCAPE MUTANT SARS-COV-2 FROM IMMUNOCOMPROMISED PATIENT (D146*) IN COMPLEX WITH HUMAN RECEPTOR ACE2","10.1126/SCIENCE.ABL6251 ",3.08,97.77,"7sn0_oligo3","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(10_I_)-MAN(9_I_)-[GAL(8_I_)-NAG(7_I_)-[GAL(6_I_)-NAG(5_I_)]-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(90_A_)",153.312,"","",""
"7SN0","CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF ESCAPE MUTANT SARS-COV-2 FROM IMMUNOCOMPROMISED PATIENT (D146*) IN COMPLEX WITH HUMAN RECEPTOR ACE2","10.1126/SCIENCE.ABL6251 ",3.08,97.77,"7sn0_oligo11","DGalpb1-4DGlcpNAcb1-4[DGlcpNAcb1-2]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(9_O_)-MAN(8_O_)-[GAL(6_O_)-NAG(5_O_)-[NAG(7_O_)]-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(90_B_)",154.758,"","",""
"7SN2","STRUCTURE OF HUMAN SARS-COV-2 NEUTRALIZING ANTIBODY C1C-A3 FAB","10.1126/SCIENCE.ABL6251 ",4.3,"1.08527e-19","7sn2_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(343_A_)",112.631,"","",""
"7SSQ","CRYSTAL STRUCTURE OF EBOLA ZAIRE ENVELOPE GLYCOPROTEIN GP IN COMPLEX WITH COMPOUND ARN0075231","",2.25,67.34,"7ssq_oligo4","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",87.7576,"","",""
"7UCF","STRUCTURE OF THE BG505 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",4,264.8,"7ucf_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_J_)-NAG(5_J_)-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(276_G_)",300.557,"","",""
"7UGO","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH MATURE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1-GT1","10.1038/S41467-022-33860-2 ",4.1,"1.52628e-19","7ugo_oligo14","DManpb1-2DManpx1-","MAN(2_e_)-MAN(1_e_)",79.7082,"","",""
"7UGO","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH MATURE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1-GT1","10.1038/S41467-022-33860-2 ",4.1,"1.52628e-19","7ugo_oligo17","DManpa1-2DManpa1-6[DManpb1-3]DManpa1-6[DManpb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_h_)-MAN(5_h_)-[MAN(7_h_)]-MAN(4_h_)-[MAN(9_h_)-MAN(8_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(332_C_)",98.9344,"","",""
"7URU","CRYSTAL STRUCTURE OF THE LOW AFFINITY FC GAMMA RECEPTOR IIIA VARIANT IN COMPLEX WITH THE FC OF IGG1.","",2.4,0,"7uru_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",89.1557,"","",""
"7URU","CRYSTAL STRUCTURE OF THE LOW AFFINITY FC GAMMA RECEPTOR IIIA VARIANT IN COMPLEX WITH THE FC OF IGG1.","",2.4,0,"7uru_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",92.0661,"","",""
"7VKY","THE COMPLEX STRUCTURE OF BETA-1,2-GLUCOSYLTRANSFERASE FROM IGNAVIBACTERIUM ALBUM WITH SOPHOROSE","10.1016/J.JBC.2022.101606 ",2,15.01,"7vky_oligo2","DGlcpb1-2DGlcpa1-ROH","BGC(2_D_)-GLC(1_D_)",18.0318,"","",""
"7VKY","THE COMPLEX STRUCTURE OF BETA-1,2-GLUCOSYLTRANSFERASE FROM IGNAVIBACTERIUM ALBUM WITH SOPHOROSE","10.1016/J.JBC.2022.101606 ",2,15.01,"7vky_oligo1","DGlcpb1-2DGlcpb1-ROH","BGC(2_C_)-BGC(1_C_)",8.32545,"","",""
"7WUH","SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7","10.1126/SCITRANSLMED.ABM0899 ",4.7,"5.50295e+11","7wuh_oligo21","DGlcpNAcb1-2[DManpa1-6]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_d_)-[NAG(5_d_)]-MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(331_E_)",185.229,"","",""
"7WYU","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyu_oligo5","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",139.536,"","",""
"7WYU","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyu_oligo8","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",143.179,"","",""
"7WYV","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP IN THE PRESENCE OF 40 MM MG2+","10.1073/PNAS.2123226119 ",3.7,"1.15243e-41","7wyv_oligo4","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",129.912,"","",""
"7WYV","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP IN THE PRESENCE OF 40 MM MG2+","10.1073/PNAS.2123226119 ",3.7,"1.15243e-41","7wyv_oligo7","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",130.728,"","",""
"7WYW","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE","10.1073/PNAS.2123226119 ",3.8,"1.15243e-41","7wyw_oligo7","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",151.224,"","",""
"7WYW","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE","10.1073/PNAS.2123226119 ",3.8,"1.15243e-41","7wyw_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",149.673,"","",""
"7WYX","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyx_oligo6","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",149.642,"","",""
"7WYX","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyx_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",151.553,"","",""
"7WYY","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.9,"1.15243e-41","7wyy_oligo7","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",125.568,"","",""
"7WYY","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.9,"1.15243e-41","7wyy_oligo3","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",123.146,"","",""
"7WYZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH OUABAIN","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyz_oligo9","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",161.85,"","",""
"7WYZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH OUABAIN","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyz_oligo5","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",160.914,"","",""
"7WZ0","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH OUABAIN","10.1073/PNAS.2123226119 ",3,"1.15243e-41","7wz0_oligo6","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",128.61,"","",""
"7WZ0","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH OUABAIN","10.1073/PNAS.2123226119 ",3,"1.15243e-41","7wz0_oligo5","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",128.258,"","",""
"7X87","THE COMPLEX STRUCTURE OF BETA-1,2-GLUCOSYLTRANSFERASE FROM IGNAVIBACTERIUM ALBUM WITH SOPHOTETRAOSE OBSERVED AS SOPHOROSE","10.1016/J.JBC.2022.101606 ",1.79,17.6,"7x87_oligo1","DGlcpb1-2DGlcpb1-ROH","BGC(2_F_)-BGC(1_F_)",19.0105,"","",""
"7XT6","STRUCTURE OF A MEMBRANE PROTEIN M3","10.1126/SCIENCE.ABO3828 ",3.63,"1.35632e-19","7xt6_oligo2","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(415_B_)",111.41,"","",""
"7Y45","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE","10.1002/1873-3468.14437 ",3.3,"1.15243e-41","7y45_oligo8","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_D_)",178.716,"","",""
"7Y45","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE","10.1002/1873-3468.14437 ",3.3,"1.15243e-41","7y45_oligo3","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_B_)",183.215,"","",""
"7Y46","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE AFTER ADDITION OF ATP","10.1002/1873-3468.14437 ",7.2,"1.15243e-41","7y46_oligo8","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_B_)",478.944,"","",""
"7Y46","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE AFTER ADDITION OF ATP","10.1002/1873-3468.14437 ",7.2,"1.15243e-41","7y46_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_D_)",474.941,"","",""
"8A48","LESS CRYSTALLISABLE"" IGG1 FC FRAGMENT (E382S VARIANT)","10.1038/S41467-022-35340-Z ",3.04,136.2,"8a48_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",201.009,"","",""
"8A48","LESS CRYSTALLISABLE"" IGG1 FC FRAGMENT (E382S VARIANT)","10.1038/S41467-022-35340-Z ",3.04,136.2,"8a48_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",154.664,"","",""
"8A49","ENDOGLYCOSIDASE S IN COMPLEX WITH IGG1 FC","10.1038/S41467-022-35340-Z ",3.45,146.6,"8a49_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",155.645,"","",""
"8API","THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM","10.1093/PROTEIN/2.6.407 ",3.1,0,"8api_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(46_A_)",25.9524,"","",""
"8BW5","X-RAY STRUCTURE OF THE COMPLEX BETWEEN HUMAN ALPHA THROMBIN AND THE DUPLEX/QUADRUPLEX APTAMER M08S-1_41MER","10.1093/NAR/GKAD634 ",2.8,77.14,"8bw5_oligo19","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_A_)-GAL(6_A_)-NAG(5_A_)-MAN(4_A_)-[MAN(8_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(60_H_)",104.268,"","",""
"8D3T","CRYSTAL STRUCTURE OF GALS1 FROM POPULUS TRICHOCARPAS","10.1038/S41477-023-01358-4 ",2.37,44.7,"8d3t_oligo8","DGlcpNAcb1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_L_)-MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(107_D_)",65.1504,"","",""
"8D87","FITTED CRYSTAL STRUCTURE OF THE HOMOTRIMER OF FUSION GLYCOPROTEIN E1 FROM SFV INTO SUBTOMOGRAM AVERAGED CHIKV E1 GLYCOPROTEIN DENSITY","10.1038/S41467-022-32431-9 ",27.2,"1.15243e-41","8d87_oligo1","DGlcpNAcb1-2DManpb1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_D_)-[NAG(5_D_)-BMA(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(141_A_)",134.071,"","",""
"8D87","FITTED CRYSTAL STRUCTURE OF THE HOMOTRIMER OF FUSION GLYCOPROTEIN E1 FROM SFV INTO SUBTOMOGRAM AVERAGED CHIKV E1 GLYCOPROTEIN DENSITY","10.1038/S41467-022-32431-9 ",27.2,"1.15243e-41","8d87_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(7_E_)-[MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NDG(1_E_)-ASN(141_B_)",134.96,"","",""
"8DIN","THE COMPLEX STRUCTURE BETWEEN HUMAN IGG1 FC AND ITS HIGH AFFINITY RECEPTOR FCGRI H174R VARIANT","10.3389/FIMMU.2023.1100499 ",2.5,68.26,"8din_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",59.0284,"","",""
"8DIN","THE COMPLEX STRUCTURE BETWEEN HUMAN IGG1 FC AND ITS HIGH AFFINITY RECEPTOR FCGRI H174R VARIANT","10.3389/FIMMU.2023.1100499 ",2.5,68.26,"8din_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",97.4553,"","",""
"8DIR","THE COMPLEX STRUCTURE BETWEEN HUMAN IGG1 FC AND ITS HIGH AFFINITY RECEPTOR FCGRI H174R VARIANT","10.3389/FIMMU.2023.1100499 ",2.3,61.7,"8dir_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",90.7651,"","",""
"8DIR","THE COMPLEX STRUCTURE BETWEEN HUMAN IGG1 FC AND ITS HIGH AFFINITY RECEPTOR FCGRI H174R VARIANT","10.3389/FIMMU.2023.1100499 ",2.3,61.7,"8dir_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",53.7698,"","",""
"8DJ7","THE COMPLEX STRUCTURE BETWEEN HUMAN IGG1 FC AND ITS HIGH AFFINITY RECEPTOR FCGRI H174R VARIANT","10.3389/FIMMU.2023.1100499 ",2.39,69.66,"8dj7_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",94.2131,"","",""
"8DJ7","THE COMPLEX STRUCTURE BETWEEN HUMAN IGG1 FC AND ITS HIGH AFFINITY RECEPTOR FCGRI H174R VARIANT","10.3389/FIMMU.2023.1100499 ",2.39,69.66,"8dj7_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",62.1081,"","",""
"8DKU","CRYOEM STRUCTURE OF THE A. AEOLICUS WZMWZT TRANSPORTER BOUND TO THE NATIVE O ANTIGEN","10.1038/S41467-022-32597-2 ",3.2,"1.08527e-19","8dku_oligo1","DRhap[3Me]a1-3DRhapb1-2DRhapa1-ROH","UBH(3_F_)-UBO(2_F_)-XXR(1_F_)",66.78,"","",""
"8DNC","CRYOEM STRUCTURE OF THE A. AEOLICUS WZMWZT TRANSPORTER BOUND TO THE NATIVE O ANTIGEN AND ADP","10.1038/S41467-022-32597-2 ",3.3,"1.08527e-19","8dnc_oligo2","DRhap[3Me]a1-3DRhapb1-2DRhapa1-ROH","UBH(3_E_)-UBO(2_E_)-XXR(1_E_)",56.65,"","",""
"8F8W","CRYSTAL STRUCTURE OF NB.X0 BOUND TO THE AFUCOSYLATED HUMAN IGG1 FRAGMENT CRYSTAL FORM I","",2.71,93.28,"8f8w_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_K_)-MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(297_E_)",73.2138,"","",""
"8F8W","CRYSTAL STRUCTURE OF NB.X0 BOUND TO THE AFUCOSYLATED HUMAN IGG1 FRAGMENT CRYSTAL FORM I","",2.71,93.28,"8f8w_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_I_)-MAN(6_I_)-[NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(297_A_)",77.1554,"","",""
"8F8W","CRYSTAL STRUCTURE OF NB.X0 BOUND TO THE AFUCOSYLATED HUMAN IGG1 FRAGMENT CRYSTAL FORM I","",2.71,93.28,"8f8w_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_J_)-MAN(6_J_)-[NAG(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(297_B_)",89.7328,"","",""
"8F8W","CRYSTAL STRUCTURE OF NB.X0 BOUND TO THE AFUCOSYLATED HUMAN IGG1 FRAGMENT CRYSTAL FORM I","",2.71,93.28,"8f8w_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_L_)-MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(297_F_)",82.2497,"","",""
"8F8X","CRYSTAL STRUCTURE OF NB.X0 BOUND TO THE AFUCOSYLATED HUMAN IGG1 FRAGMENT CRYSTAL FORM II","",2.6,79.15,"8f8x_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(297_B_)",85.9644,"","",""
"8F8X","CRYSTAL STRUCTURE OF NB.X0 BOUND TO THE AFUCOSYLATED HUMAN IGG1 FRAGMENT CRYSTAL FORM II","",2.6,79.15,"8f8x_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_A_)",84.3382,"","",""
"8FCZ","CRYSTAL STRUCTURE OF GROUND-STATE RHODOPSIN IN COMPLEX WITH A NANOBODY","",3.7,211.1,"8fcz_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(15_A_)",228.688,"","",""
"8FD0","CRYSTAL STRUCTURE OF BOVINE ROD OPSIN IN COMPLEX WITH A NANOBODY","",3.71,230.9,"8fd0_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(15_A_)",248.428,"","",""
"8FD1","CRYSTAL STRUCTURE OF PHOTOACTIVATED RHODOPSIN IN COMPLEX WITH A NANOBODY","",4.25,291.8,"8fd1_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(15_A_)",319.058,"","",""
"8JFZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE.","10.1002/1873-3468.14689 ",3.5,"1.15243e-41","8jfz_oligo5","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_B_)",151.463,"","",""
"8JFZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE.","10.1002/1873-3468.14689 ",3.5,"1.15243e-41","8jfz_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_D_)",153.56,"","",""
"8OG1","EXOSTOSIN-LIKE 3 APO ENZYME","",1.58,36.17,"8og1_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(790_A_)",64.0968,"","",""
"8OJO","GALECTIN-3 IN COMPLEX WITH 2,6-ANHYDRO-5-S-(BETA-D-GALACTOPYRANOSYL)- 5-THIO-D-ALTRITOL","10.1021/ACS.JMEDCHEM.3C00882 ",1.8,12.71,"8ojo_oligo1","DGalpb1-2DTalp[2<R1>]x1-","YIO(305_A_)-AH2(304_A_)",17.249,"","",""
"9API","THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM","10.1093/PROTEIN/2.6.407 ",3,0,"9api_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(46_A_)",57.3958,"","",""
